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Abstract 
ROLE AND REGULATION OF THE ACTIN-REGULATORY PROTEIN HS1 IN TCR 
SIGNALING 
Esteban Carrizosa 
Advisor:  Dr. Janis K. Burkhardt 
Numerous aspects of T cell function, including TCR signaling, migration, and execution 
of effector functions, depend on the actin cytoskeleton.  Cytoskeletal rearrangements are 
driven by the action of actin-regulatory proteins, which promote or antagonize the 
assembly of actin filaments in response to external cues.  In this work, we have examined 
the regulation and function of HS1, a poorly-understood actin regulatory protein, in T 
cells.  This protein, which becomes tyrosine phosphorylated upon T cell activation, is 
thought to function primarily by stabilizing existing branched actin filaments.  Loss of 
HS1 results in unstable actin responses upon TCR engagement and defective Ca2+ 
responses, leading to poor activation of the IL2 promoter.  TCR engagement leads to 
phosphorylation of HS1 at Tyr 378 and Tyr 397, creating binding sites for SH2 domain-
containing proteins, including Vav1 and Itk.  Phosphorylation at these residues is 
required for Itk-dependent recruitment of HS1 to the IS, Vav1 IS localization, and HS1-
dependent actin reorganization and IL2 production.  Therefore, in addition to directly 
interacting with branched actin filaments, HS1 regulation of Vav1 localization provides 
another mechanism by which HS1 signals to the actin cytoskeleton.  Analysis of Ca2+ 
responses in HS1-/- T cells reveals that the defect in these cells lies at the level of release 
from intracellular stores.  Phosphorylated HS1 interacts with PLCγ1, and mediates its 
 v 
association with the cytoskeleton and regulates microcluster dynamics.  Although HS1 is 
clearly important for signaling downstream of the TCR, HS1-/- mice exhibit normal T cell 
development and normal peripheral populations.  Surprisingly, HS1 is not required for T 
cell homing to lymphoid organs, for TCR endocytosis or for CD8+ T cell effector 
function.  However, T cells from HS1-/- mice produce reduced amounts of Ifnγ, and are 
subsequently less likely to become Ifnγ-producing TH1 effector cells.  These data 
demonstrate that HS1 functions as a cytoskeletal adaptor protein and plays specific roles 
downstream of TCR engagement. 
 vi 
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Chapter 1: Introduction1 
 
Regulated reorganization of the actin cytoskeleton is important for multiple 
aspects of T cell function, including signaling and differentiation along discrete 
developmental lineages, migration through tissues, and execution of effector functions.  
Early studies testing the role of actin in T cell activation were based on the use of actin-
disrupting agents such as cytochalasin D (CytoD).  These studies showed that actin is 
required for adherence to target cells and cytotoxic activity (Henney and Bubbers, 1973), 
as well as for signaling events associated with Ca2+ flux and downstream changes in gene 
expression (Valitutti et al., 1995).  However, these studies revealed a complex role for 
actin.  For example, in T cells stimulated with superantigen-pulsed antigen presenting 
cells (APCs), CytoD-treatment results in diminished Ca2+ flux, but stimulation with anti-
CD3 antibodies results in a prolonged Ca2+ response (Valitutti et al., 1995).  Similarly, 
while one study showed that CytoD treatment impairs the activation of the IL2 promoter 
(Holsinger et al., 1998), another found that at low doses of CytoD, Ca2+ signaling is 
prolonged and IL2 production increases (Rivas et al., 2004).  These findings and more 
recent data described below suggest that actin filaments play a dual role, enhancing T cell 
activation by promoting conjugate formation and the assembly of signaling complexes, 
                                                
1 This chapter is a modified version of a review article titled “The Actin Cytoskeleton in T Cell 
Activation.”  It was published in the 2008 issue of Annual Review of Immunology, Volume 26, pages 233-
259, with the following author list:  Janis K. Burkhardt, Esteban Carrizosa, and Meredith H. Shaffer. 
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but also down-regulating activation, perhaps by facilitating molecular movements that 
culminate in the internalization of the TCR.   
 
Interaction with APCs and immunological synapse formation 
Upon interaction with an APC bearing appropriate MHC-peptide complexes, the 
T cell extends large pseudopodia and lamellipodia toward the APC, a process resulting 
from the recruitment and localized activation of actin polymerizing and actin binding 
proteins.  This process results in the formation of a flattened, F-actin rich interface with 
the APC.  In parallel with these shape changes, the MTOC and associated secretory 
organelles reorient within the T cell cytoplasm, and come to lie just beneath the plasma 
membrane, near the center of the APC contact site.  This reorientation of T cell 
cytoskeletal elements was observed by several investigators in the early 1980s, and was 
recognized as a hallmark of productive T cell activation and a prerequisite for directed 
cytolysis and T cell help (Kupfer et al., 1985; Kupfer et al., 1994; Ryser et al., 1982).   
Actin responses at the T cell-APC contact site are important for organization of 
signaling molecules at this site, to form the immunological synapse (IS) (Campi et al., 
2005; Sims et al., 2007; Tskvitaria-Fuller et al., 2003; Wulfing et al., 2000).  Protein 
segregation within the IS was initially described as forming a “supramolecular activation 
cluster (SMAC)” comprised of a central region (c-SMAC) containing TCR and 
associated signaling proteins within a peripheral ring (p-SMAC) containing LFA-1 and 
associated adhesion molecules (Monks et al., 1998).  Recent studies have shown, 
however, that IS architecture and dynamics vary greatly depending on several variables, 
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including the nature of the T cell and the APC, agonist strength, costimulatory 
interactions, and the tissue context in which the interaction is taking place (Friedl et al., 
2005; Jacobelli et al., 2004).  Our understanding of IS function has evolved considerably 
over the past decade.  Once thought to facilitate TCR signaling by bringing interacting 
molecules together, the c-SMAC was subsequently shown to be a site where signaling is 
terminated by internalization of TCR signaling complexes (Cemerski et al., 2007; 
Mossman et al., 2005; Varma et al., 2006).  The role for the c-SMAC in downregulating 
T cell signaling is supported by studies in which signaling is enhanced under conditions 
in which c-SMAC formation is blocked and inhibited under conditions in which c-SMAC 
formation is induced (Cemerski et al., 2007; Lee et al., 2003; Mossman et al., 2005).  An 
interesting study combining empirical analysis with mathematical modeling has shown 
that both ideas are probably correct, and that parameters such as peptide-MHC half life 
determine the balance between these two interrelated facets of IS function (Cemerski et 
al., 2007).  A more recent study supports and refines this idea, suggesting that c-SMAC 
formation serves to regulate signal strength (Cemerski et al., 2008).  Enforced c-SMAC 
formation reduces proliferative responses for strong agonists, but enhances responses for 
weak agonists.  Moreover, stimulation with low doses of antigenic peptide results in 
detectable signaling in the c-SMAC, whereas with high peptide doses, signaling is 
detectable only in the p-SMAC. 
 Video analysis of molecular movements during IS formation show that the TCR 
and associated signaling molecules form microclusters around the periphery of the cell-
cell contact site, and converge to form the c-SMAC (Bunnell et al., 2002; Campi et al., 
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2005; Varma et al., 2006; Yokosuka et al., 2005).  Sustained signaling occurs in the 
peripheral clusters, while central clusters are destined for degradation, at least in the 
context of a strong signal.  Microcluster formation and centripetal movement are actin-
dependent processes, controlled in part by Cdc42 (Campi et al., 2005; Tskvitaria-Fuller et 
al., 2003; Varma et al., 2006).  Once formed, however, these signaling complexes are 
highly stable and are largely unaffected by actin-depolymerizing agents.  It will be 
interesting to learn how specific actin regulatory molecules work to orchestrate 
microcluster formation and movement, especially as this relates to parameters such as 
peptide-MHC half life and T cell subset. 
 
CONTROL OF ACTIN DYNAMICS AT THE IMMUNOLOGICAL 
SYNAPSE 
Engagement of the TCR activates multiple actin regulatory proteins that work in concert 
to drive actin polymerization at the IS (Figure 1.1).  The best understood of these 
molecules function downstream of Vav1 and other GEFs, which activate the Rho 
GTPases Rac1 and Cdc42 at sites of TCR engagement.  
 5 
 
Figure 1.1:  TCR signaling pathways leading to actin polymerization 
Encounter of an APC induces a signaling cascade comprised of tyrosine 
kinases (dark green), adaptor proteins (yellow), and immediate upstream actin 
regulatory proteins (dark blue), that transduce signals to several nucleation 
promoting factors (red) that direct the polymerization of branched actin 
filaments at sites of TCR engagement.  Engagement of costimulatory 
molecules leads to activation of proteins that sever actin filaments (peach), 
creating new barbed ends as substrates for filament growth.  Question marks 
indicate the unknown mechanisms by which actin remodeling leads to IL2 
promoter activation and other changes in gene expression. 
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Arp2/3 complex-dependent actin regulatory proteins 
The initiation of actin filament formation is a kinetically unfavorable process, 
requiring the action of nucleation-promoting factors (NPFs) to generate a “seed” from 
which a filament can elongate.  Many of the best-understood NPFs work in concert with 
the 7-subunit Arp2/3 complex to form new actin branches on the sides of existing actin 
filaments (Goley and Welch, 2006) (Figure 1.2).  This complex, which is composed of 
two actin-related proteins, Arp2 and Arp3, and five other proteins, ARPC1-5, binds to the 
side of an existing actin filament, where Arp2 and Arp3 mimic two actin monomers as 
part of the core nucleus.  NPFs such as WASp and WAVE2 then bind to Arp2/3 complex 
and present an actin monomer, allowing elongation to take place.  Using an RNAi-based 
strategy, the Billadeau group showed that suppression of either Arp2 or Arp3 in Jurkat T  
cells results in degradation of other complex components (Gomez et al., 2007).  Arp2/3 
complex-deficient cells do not polymerize branched actin at the IS, and they fail to form 
lamellipodia in spreading assays using anti-TCR coated coverslips.  Interestingly, these 
cells generate highly dynamic F-actin-rich filopodia in response to either APCs or anti-
TCR coated surfaces, a finding that points toward additional, Arp2/3 complex-
independent actin regulatory pathways.  Nonetheless, this study demonstrates that Arp2/3 
complex and its upstream activators are central effectors of actin polymerization at the IS. 
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Figure 1.2:  Model for branched actin polymerization by Arp2/3 complex. 
Model for branched actin polymerization by Arp2/3 complex. 
Arp2/3 complex complex nucleates a new actin filament at a 70º angle from 
the side of an existing filament.  NPFs function by binding to and inducing a 
conformational change in Arp2/3 complex and presenting actin monomers to 
form the new filament (Goley and Welch, 2006). 
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WASp 
The best-characterized activator of Arp2/3 complex is WASp, named for its 
causative role in Wiskott-Aldrich syndrome (WAS), a severe X-linked immune 
deficiency disorder (Derry et al., 1994; Orange et al., 2004).  The characteristic 
symptoms are thrombocytopenia, eczema, and recurrent infections.  Patients are also 
prone to malignancy and autoimmune disease.  Recent studies have shown that WASp is 
required for the function and, in certain contexts, the development of regulatory T cells 
(Adriani et al., 2007; Humblet-Baron et al., 2007; Maillard et al., 2007; Marangoni et al., 
2007).   
The domain structure of WASp is shown in Figure 1.3.  The N-terminal WASp-
homology region (WH1) binds constitutively to WASp interacting protein (WIP).  
Disruption of this interaction results in degradation of WASp (de la Fuente et al., 2007; 
Volkman et al., 2002).  Most mutations associated with WAS are found in this region and 
interfere with WIP binding (Notarangelo and Ochs, 2003).  WIP is almost certainly an 
important actin regulatory protein in its own right, but WIP function per se has not been 
tested, presumably because of the challenges associated with constructing WIP-deficient 
cells that express normal levels of WASp.  However, evidence that WIP and WASp play 
non-redundant roles comes from analysis of WIP/WASp double-knockout mice:  T cells 
lacking both proteins migrate less well than T cells from either of the single knockouts 
(Gallego et al., 2006).  WASp recruitment and activation at the IS are relatively well 
understood.   
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Figure 1.3:  Domain structures of selected Arp2/3 complex regulators.   
The domain structure of key Arp2/3 activating molecules is shown, with related 
regions colored similarly.  Important binding partners are listed below the domains to 
which they bind.  Known tyrosine (Y) and serine (S) phosphorylation sites are 
indicated, a predicted threonine phosphorylation site is indicated in italics (T), and 
total amino acid numbers are shown at the top right of each.   
Abbreviations:  NTA – N-terminal acidic region;  HTH – Helix-turn-helix; 
PRD – Proline rich domain; SH3 – Src homology 3; WH1 – Wasp homology 1; GBD 
– GTPase binding domain; VCA – verprolin, cofilin homology, acidic region; WHD – 
WAVE homology domain; WH2 – WASP homology 2 
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Recruitment occurs through an interaction between the WASp proline-rich domain (PRD) 
and the SH3 domains of the adaptors Nck and PST-PIP (Badour et al., 2003; Zeng et al., 
2003).  Localization to the IS facilitates WASp contact with Cdc42-GTP, which binds to 
the GTPase-binding domain (GBD) (Zeng et al., 2003), leading to a conformational 
change in WASp.  In resting cells, WASp exists in a closed, inactive state in which the 
GBD contacts the verprolin, cofilin, acidic (VCA) region.  Cdc42 binding releases the 
VCA domain, allowing the VCA to interact with Arp2/3 complex (Kim et al., 2000).   
Phosphorylation of WASp at tyrosine 291 by the Src family kinase Fyn, and subsequent 
binding of the SH2-SH3 domain module of Src kinases to WASp, works in a synergistic 
manner with Cdc42 binding to induce optimal WASp activity (Badour et al., 2004a; 
Torres and Rosen, 2003, 2006).  Binding of Nck or the SH3 domain of HS1 
(hematopoietic cell-specific lyn substrate 1) or cortactin may also activate WASp or N-
WASp (discussed below) (Kowalski et al., 2005; Rohatgi et al., 1999).  Analysis of 
WASp localization in T cells spreading on anti-CD3-coated coverslips reveals that 
WASp is initially recruited to signaling microclusters.  It then translocates to the cell 
periphery, presumably to aid in actin polymerization in lamellipodial protrusions (Barda-
Saad et al., 2005). 
WASp-deficient T cells from both mice and humans exhibit consistent defects in 
signaling pathways leading to IL2 production, but the literature is divided about the 
importance of WASp for controlling actin polymerization at the IS.  Although there are 
numerous reports that T cells from WAS patients exhibit defective actin responses 
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(reviewed in (Notarangelo and Ochs, 2003)), Jurkat cells depleted of WASp using RNAi 
polymerize actin normally (Nolz et al., 2006).  Moreover, T cells from two different 
WASp knockout mice behave differently with respect to their ability to polymerize actin 
in response to TCR engagement (Badour et al., 2004a; Cannon and Burkhardt, 2004; 
Krawczyk et al., 2002).  A possible explanation for these discrepancies is that other 
proteins (including the close homologue N-WASp, as well as less closely related proteins 
such as WAVE2 and HS1) have partially overlapping functions.  Indeed, loss of both 
WASp and N-WASp impairs thymocyte function and development much more severely 
than loss of either protein alone (Cotta-de-Almeida et al., 2007).  Recent work from the 
Dustin lab supports the idea that WASp-dependent actin polymerization is indispensable 
for T cell activation (Sims et al., 2007).  This study shows that naïve T cells contacting 
APCs or lipid bilayers containing MHC-peptide complexes and ICAM-1 form a short-
lived IS, then migrate some distance before generating a second, more stable contact.  
Intriguingly, although WASp-/- T cells form an initial contact in this assay, they continue 
to migrate and fail to re-form and maintain a long-lived IS.   
 
WAVE2 
Another important activator of Arp2/3 complex is the WAVE/SCAR family 
member WAVE2, an NPF that functions as an effector for Rac1.  RNAi-mediated 
suppression of WAVE2 in Jurkat T cells results in loss of actin polymerization at the IS 
(Nolz et al., 2006; Zipfel et al., 2006).  In addition, WAVE2 suppression perturbs 
conjugate formation, suggesting a role in integrin function. WAVE2 resembles WASp in 
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that it binds Arp2/3 complex via a C-terminal VCA domain (Figure 1.3), but WAVE2 
lacks a GBD and does not bind Rac1 directly (Miki et al., 1998).  WAVE2 exists as part 
of a constitutive complex containing Abi1/2, Sra1/PIR121, Hspc300, IRSp53 and HEM-1 
(Billadeau et al., 2007).  WAVE complex components stabilize one another against 
degradation, and suppression of Abi1/2 or HEM-1 also results in actin defects (Innocenti 
et al., 2004; Miki et al., 2000; Nolz et al., 2006; Zipfel et al., 2006).  WAVE complex 
components also function in WAVE2 targeting and activation.  IRSp53 acts as an adaptor 
between Rac1 and WAVE2, and this interaction leads to the recruitment of WAVE2 to 
the membrane (Miki et al., 2000).  Abi1/2 can mediate an interaction between Abl kinase 
and WAVE2, resulting in phosphorylation at Tyr 150, which increases the actin 
polymerization activity of WAVE2 (Leng et al., 2005).   
WAVE2-deficient mice have not been generated, due to embryonic lethality 
(Billadeau et al., 2007).  However, a mouse strain with a nonsense mutation in Hem-1 
resulting in termination at residue 445 was generated using random mutagenesis (Park et 
al., 2008).  These mice exhibit lymphopenia, neutrophilia, anemia, and pathology 
throughout a variety of tissues.  Thymocyte cellularity is severely reduced, and 
development is abnormal.  Actin responses in neutrophils, macrophages, and T cells from 
these mice are severely impaired.  As expected, this mutation in Hem-1 results in loss of 
other components of the WAVE complex.  Although the mutation responsible may leave 
a fragment of Hem-1 intact, this study makes it clear that the WAVE complex is integral 
to leukocyte development and function.  It is possible that the function of Hem-1 is 
 13 
attributable to its role in other complexes (Weiner et al., 2006); however, Hem-1 appears 
to associate exclusively with the WAVE2 complex in T cells (Nolz et al., 2006). 
 
HS1 and cortactin 
A third activator of Arp2/3 complex, and the focus of this dissertation, is HS1.  
HS1 is a hematopoietic-lineage restricted (Kitamura et al., 1989) homolog of the actin 
binding protein cortactin (product of the EMS1 gene).  Cortactin is the better studied of 
the two proteins, and both are discussed below.  The domain structures of HS1 and 
cortactin are shown in Figure 1.3, and a sequence comparison with key features indicated 
is shown in Figure 1.4. 
Like WASp and WAVE, HS1 and cortactin contain an acidic region (NTA) that 
binds Arp2/3 complex, and both can modestly activate Arp2/3-dependent actin 
polymerization (Uruno et al., 2001; Uruno et al., 2003b; Weaver et al., 2001).  However, 
HS1 and cortactin also bind to F-actin directly.  HS1 binds through its helix-turn-helix 
(HTH) repeats and coiled-coil (CC) domain (Hao et al., 2005).  Cortactin exists as at least 
two major isoforms, containing either 5.5 or 6.5 HTH repeats; the fourth full repeat is 
required for F-actin binding (Katsube et al., 2004; Uruno et al., 2001; Weed et al., 2000). 
Because of their ability to directly bind F-actin, it is thought that HS1 and cortactin 
function primarily to stabilize existing branched actin filaments by bridging Arp2/3 
complex with F-actin (Uruno et al., 2001; Uruno et al., 2003b; Weaver et al., 2001) 
(Figure 1.5).  In keeping with this idea, we have found that HS1-suppressed T cells 
exhibit unstable actin responses ((Gomez et al., 2006) and Chapter 2).  HS1 and cortactin 
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each contain a proline rich region (PRR) and an SH3 domain at the C-terminus (see 
below).  
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Figure 1.4:  Sequence alignments of HS1 and cortactin. 
Sequence alignments of human HS1 (hHS1), mouse HS1 (mHS1), human cortactin 
(hCTTN), and mouse cortactin (mCTTN), generated using the multiple sequence 
alignment function of MacVector, are shown.  The cortactin isoforms shown contain 
6.5 helix-turn-helix repeats.  Sequence identities are shaded in dark gray and sequence 
similarities are shaded in light gray.  Critical residues for Arp2/3 binding, DDW, are 
boxed in green.  The glutamic acid-proline (EP) repeat region in human HS1 is boxed 
in orange.  The tryptophan residue responsible for SH3 domain specificity is boxed in 
blue.  Tyrosine phosphorylation sites that have been empirically identified for the 
protein of either species are boxed in red and noted above or below the alignment.  A 
poly-proline region that may be involved in intramolecular SH3 domain binding is 
boxed in gray.  A potential MAP kinase recognition site is boxed in light blue.  Major 
domains for HS1 are noted below the alignment.  Residue numbering above sequences 
refers to human cortactin. 
 Genbank accession numbers of sequences used:  hHS1 – AAH16758.1, mHS1 
– NP_032251.1, hCTTN – NP_005222, mCTTN – NP_031829.2 
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Figure 1.5:  Model for HS1 interaction with Arp2/3 complex.   
HS1, through its NTA region, interacts with Arp2/3 complex and crosslinks new 
actin filaments by binding via the HTH repeats and CC region.  Model proposed 
by (Hao et al., 2005). 
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Interestingly, the repeat region has been used to trace the evolutionary origin of these 
molecules, as it is a unique feature (van Rossum et al., 2005).  Cortactin homologs are 
found in metazoans, but not in unicellular organisms or in plants.  In contrast, HS1 
expression is limited to vertebrates, and is thought to have originated from a gene 
duplication event.  
Both HS1 and cortactin are inducibly tyrosine phosphorylated.  Cortactin was 
initially identified as a Src kinase substrate in transformed cells overexpressing activated 
Src (Kanner et al., 1990; Wu et al., 1991).  At least three Src target sites have been 
identified:  Tyr 421, Tyr 466, Tyr 482 (these numbers refer to murine cortactin, and 
correspond to Tyr 421, Tyr 470, and Tyr 486 in the human protein).  Loss of Csk, a 
negative regulator of Src kinases, leads to increased tyrosine phosphorylation of 
cortactin, further implicating Src in cortactin phosphorylation  (Thomas et al., 1995).   
Src-dependent cortactin tyrosine phosphorylation is physiologically important.  
Phosphorylation regulates the role of cortactin in cell migration, although the effect may 
vary depending on the molecular and cellular context.  Mutation of the three 
phosphorylated tyrosines substantially impairs migration in a wound healing assay 
(Huang et al., 1998).  One study suggests that tyrosine phosphorylation impairs the ability 
of cortactin to activate Arp2/3 complex (Martinez-Quiles et al., 2004), but another study 
demonstrates that, in the presence of Nck, Src phosphorylation potentiates Arp2/3 
complex activation (Tehrani et al., 2007).  It is thought that tyrosine phosphorylation of 
cortactin imparts a conformational change, highlighted by increased susceptibility to 
cleavage by calpain (Huang et al., 1997b; Perrin et al., 2006). 
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Early studies showed that HS1 undergoes tyrosine phosphorylation in response to 
B cell receptor (BCR) (Hata et al., 1994; Yamanashi et al., 1993), T cell receptor (TCR) 
(Takemoto et al., 1995), Fcε Receptor I (FcεRI) (Fukamachi et al., 1994), FcγRIIIA 
(Zeng et al., 1995), and IL-5 receptor (Sato et al., 1994) stimulation.  In vitro 
phosphorylation experiments have identified Tyr 378 and Tyr 397 (these numbers refer to 
human HS1, and are equivalent to Tyr 388 and Tyr 405, respectively, in the mouse 
homolog) as targets of Syk family kinases (Brunati et al., 1995; Gomez et al., 2006), and 
studies in B cells (Yamanashi et al., 1997), T cells (Gomez et al., 2006), NK cells (Butler 
et al., 2008), and platelets (Brunati et al., 2005) have confirmed that these sites are 
phosphorylated, most likely by Syk family kinases, in intact cells.  Phosphorylation at 
Tyr 378 and Tyr 397 creates a binding site for SH2 domains ((Gomez et al., 2006), 
Chapters 2 and 3).  This allows HS1 to act as a cytoskeletal adaptor protein, linking 
signaling machinery to the actin cytoskeleton.  HS1 can also be phosphorylated at Tyr 
222 by Src family kinases in vitro and in intact platelets (Brunati et al., 1999; Brunati et 
al., 1995); whether this occurs in T cells is not known.  Phosphorylation at this site is 
contingent on phosphorylation at Tyr 378 and Tyr 397 to create a docking site for Src 
family kinases (Ruzzene et al., 1996).  The functional relevance of phosphorylation at 
this site has not been explored; however, it lies within the CC domain, and may regulate 
F-actin binding. 
Phosphorylation at Tyr 378 and Tyr 397 is a crucial event for HS1 function.  The 
WEHI-231 mutant line M1 is resistant to BCR-induced activation-induced cell death 
(AICD), due to low expression of HS1 (Fukuda et al., 1995).  While forced expression of 
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wild-type HS1 can rescue the AICD response in one of this line, expression of a Tyr to 
Phe mutant at both of these sites fails to rescue the AICD response (Yamanashi et al., 
1997).  Our own studies have confirmed that phosphorylation at these sites in T cells is 
physiologically important ((Gomez et al., 2006) and Chapter 2).  
There is also evidence that HS1 can also be tyrosine phosphorylated at other sites.  
The c-Abl tyrosine kinase can phosphorylate HS1 in vitro, and is required for efficient 
HS1 phosphorylation in Jurkat cells (Huang et al., 2008).  Although the target site is not 
known, Tyr 421 in cortactin is an Abl target (Boyle et al., 2007), and the HS1 homolog, 
Tyr 360, is a consensus site for Abl-mediated phosphorylation.  Phosphorylation at Tyr 
198 has been identified in a proteomic screen in Jurkat cells stimulated with anti-CD3 
and anti-CD4 (Salomon et al., 2003), although the physiological relevance of 
phosphorylation at this site has not been determined.  Interestingly, this tyrosine is 
conserved in HS1 and cortactin, and lies within the half HTH repeat in HS1 (Figure 1.3 
and Figure 1.4), suggesting that it may regulate F-actin binding.  
Although most work on HS1 phosphorylation has focused on antigen receptor 
signaling, ligation of other cell-surface molecules may induce HS1 phosphorylation or 
enhance antigen receptor-induced phosphorylation. Ligation of the costimulatory 
receptors CD2 and CD28 alone or in conjunction with the TCR does not affect total HS1 
tyrosine phosphorylation (Hutchcroft et al., 1998).  In contrast, a recent study from 
Cooper and colleagues has shown that, in human NK cells plated on integrin ligands, 
HS1 undergoes tyrosine phosphorylation, an event that is required for adhesion (Butler et 
al., 2008).  
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 Interestingly, WASp, WAVE2 and HS1 are highly modular in structure and can 
interact with multiple signaling molecules at the IS.  This structure undoubtedly 
facilitates coordination of actin polymerization.  Cortactin can cooperate with various 
combinations of WIP, WASp, and Nck1 to activate Arp2/3 complex (Tehrani et al., 
2007), and we have explored the possibility that HS1 participates in similar interactions 
((Gomez et al., 2006) and Chapter 2).  In addition to the actin-regulatory domains 
described above, HS1 and cortactin contain a proline-rich region and an SH3 domain at 
the C terminus.  The SH3 domain of cortactin has been shown to enhance N-WASp-
dependent actin polymerization, at least in vitro (Martinez-Quiles et al., 2004). 
It is also likely that HS1, as well as WASP and WAVE2, facilitate T cell 
activation by coordinating other signaling molecules independently of their role in actin 
polymerization.  For example, the SH3 domain of the Src family kinase Lck (leukocyte-
specific protein tyrosine kinase) binds to the proline-rich region of HS1 constitutively 
(Takemoto et al., 1995), and the SH2 domain of Lck interacts with HS1, probably 
through Tyr 378 and Tyr 397 (Gomez et al., 2006).  This interaction may permit 
phosphorylation at Tyr 222 by Src family kinases in vitro and in intact platelets (Brunati 
et al., 2005; Brunati et al., 1999; Ruzzene et al., 1996).  However, the functional 
significance of this interaction is unknown. 
Although the function of the HS1 SH3 domain has not been elucidated, the SH3 
domain of cortactin interacts with dynamin family members and is important for 
endocytosis (McNiven et al., 2000; Sauvonnet et al., 2005).  The SH3 domain of cortactin 
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also interacts with WIP and WASp or N-WASP and can potentiate actin polymerization 
through that pathway (Kinley et al., 2003; Martinez-Quiles et al., 2004). 
 In addition to activation by tyrosine phosphorylation, HS1 and cortactin may be 
regulated by serine/threonine phosphorylation.  Phosphorylation of cortactin at Ser 405 
and Ser 418 promotes actin polymerization (Martinez-Quiles et al., 2004).  This may 
occur by relieving an intramolecular interaction between the SH3 domain and the proline-
rich region.  HS1 also undergoes serine/threonine phosphorylation, although the sites are 
unknown (Ruzzene et al., 2000).  Although HS1 lacks homologs to cortactin Ser 405 and 
Ser 418, HS1 does have a potential MAP kinase recognition site at Thr 352 (Figure 1.4) 
(Takemoto et al., 1995).  HS1 becomes a substrate of caspase 3 upon induction of 
apoptosis (Chen et al., 2001), and serine/threonine phosphorylation by CK2 renders HS1 
resistant to caspase 3-mediated cleavage (Ruzzene et al., 2002).  Although the 
physiological relevance of this phenomenon is unclear, it suggests that phosphorylation 
induces a conformational change, as described above for cortactin. 
 No crystal structures for HS1 or cortactin have been published, presumably 
because conformational flexibility of the HTH repeat region makes the protein difficult to 
crystallize (Pant et al., 2006).  However, low-resolution studies have been conducted on 
the cortactin.  Electron microscopy experiments have suggested that cortactin exists as a 
relatively long, unstructured molecule, with a length of approximately 220-290 Å 
(Weaver et al., 2002).  In contrast, a more recent study using a combination of small 
angle X-ray scattering, circular dichroism, and chemical crosslinking suggested an 
ordered, globular structure with a length of approximately 110 Å (Cowieson et al., 2008).  
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In this model, cortactin folds in such a way that the SH3 domain is close to the HTH 
repeats; the authors do not exclude an interaction with the PRR.  The differences between 
these two structures may reflect a conformational change that cortactin may undergo, 
from a closed, globular state to a more open, unstructured conformation.   
However, the differences between the two structures may also be partially attributable to 
the differences in the methodologies between the two studies.  To date, no such structural 
studies on HS1 have been published, but its structure is likely to bear some resemblance 
to that of cortactin.  Differences between the conformations of the molecules, in 
particular from the differences in the HTH repeat region, may reflect the differences in 
the signaling machinery between hematopoietic and non-hematopoeitic cells. 
 
HS1 knockout mice 
 Mice lacking HS1 have been described (Taniuchi et al., 1995).  These mice 
develop normally, and no overt pathology has been detected.  A limited analysis of B cell 
and T cell development revealed normal progression through developmental stages, and 
peripheral lymphoid populations appeared to be normal.  However, responses to antigen 
receptor ligation, for both B cells and T cells, were blunted:  proliferative responses were 
reduced, peritoneal B cells were abnormally resistant to activation-induced cell death 
(AICD) resulting from multivalent BCR crosslinking, and thymocytes exhibited a defect 
in negative selection in an H-Y transgenic model system.  The phenotype of T cells from 
these mice is further explored in Chapter 4. 
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HS1 and cortactin in disease 
 Both HS1 and cortactin have been linked to disease.  A variant of HS1 that lacks 
the third HTH repeat, due to an exon-skipping mutation, was found in a SLE (systemic 
lupus erythematosus) patient, as well as in the patient’s father and a sister, who also 
displayed anti-nuclear antibodies (Sawabe et al., 2003); henceforth, this variant is 
referred to as HS1HTH2.5.  Moreover, an allelic variant with eight glutamic acid-proline 
repeats (referred to as HS1EP8) instead of the more common six (HS1EP6) within the 
proline-rich region (Figure 1.4), is significantly more common in SLE patients than in the 
healthy population (Otsuka et al., 2004).  18.4% of SLE patients examined in this study 
were homozygous for HS1EP8, whereas 9.8% of healthy individuals had this genotype.  In 
these studies, expression of HS1HTH2.5 or HS1EP8 promoted AICD more strongly than did 
HS1EP6 in the WEHI231 cell death assay described above.  The reason for this has not 
been explored.  
 Numerous studies have linked cortactin expression to malignancy.  Cortactin 
overexpression has been associated with higher metastatic potential and poor prognoses 
in many cancers, including breast, colorectal, and gastric cancers (Weaver, 2008).  The 
role of cortactin in cancer most likely stems from its effects on cell migration.  It is a 
component of invadopodia, actin-rich membrane protrusions that allow migrating cells to 
invade tissues by degrading extracellular matrix (Bowden et al., 1999).  Additionally, a 
switch in expression from HS1 to cortactin has been found in certain B lymphoid tumor 
lines (Miglarese et al., 1994).  The reason for this switch is unclear; however, cortactin is 
a more potent activator of Arp2/3 complex than HS1, and thus may be a more potent 
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promoter of tumor metastasis.  However, HS1 has also been linked to malignancy 
(Scielzo et al., 2005).  Constitutive phosphorylation of HS1 in chronic lymphocytic 
leukemia is associated with a significantly shorter survival time. 
 Cortactin has also been shown to play a role in bacterial invasion at the level of 
pathogen uptake and trafficking.  Several studies have demonstrated that cortactin is 
involved in cell invasion by intracellular bacteria, including Shigella flexneri, a causative 
agent of dysentery (Bougneres et al., 2004; Dehio et al., 1995; Dumenil et al., 1998); 
Staphylococcus aureus (Agerer et al., 2005); Neisseria meningitidis, which can cause 
life-threatening meningitis (Hoffmann et al., 2001); and food-borne pathogens 
Salmonella typhimurium and Listeria monocytogenes (Barroso et al., 2006; Unsworth et 
al., 2004; Veiga and Cossart, 2005) (reviewed in (Selbach and Backert, 2005)).  Although 
no such role has been demonstrated for HS1, HIV depends on intact T cell cytoskeletal 
dynamics for proper assembly (Jolly et al., 2007).  It would be interesting to determine 
whether HS1 deficiency imparts increased resistance to pathogen invasion. 
 The various disease associations of both HS1 and cortactin highlight the 
importance of understanding the basic biology of these proteins and the broader 
immunological and cell biological processes in which they are involved. 
 
INTERPLAY BETWEEN T CELL SIGNALING AND ACTIN 
DYNAMICS 
TCR signaling to and through the actin cytoskeleton 
TCR engagement induces a tyrosine phosphorylation cascade that facilitates the assembly 
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of the signaling machinery into multimolecular signaling complexes (Smith-Garvin et al., 
2009).  One of the earliest events after TCR engagement is the activation of the Src 
family kinase Lck, which phosphorylates ITAMs (immunotyrosine-based activation 
motifs) within the TCR complex.  This creates a docking site for the Syk family kinase 
ZAP-70 (ζ-chain associated protein kinase-70 kDa).  ZAP-70, in turn, phosphorylates the 
adapter proteins LAT (linker for activation of T cells) and Slp-76 (SH2-domain 
containing leukocyte protein of 76 kDa).  Slp-76 and LAT nucleate the assembly of large 
multimolecular complexes, often referred to as signalosomes.  Although the specific 
composition is likely to vary between individual complexes, signaling proteins that 
participate include PLCγ1 (phospholipase C γ1), the Rho GEF (guanine nucleotide 
exchange factor) Vav-1, and the Tec family kinase Itk (IL2-inducible T cell kinase) 
(Figure 1.6).  Other adaptors, including Nck (non-catalytic region of tyrosine kinase), 
Grb2, and GADS are also involved.  
These proteins stabilize one another at sites of TCR engagement, and loss of any 
of these molecules results in disruption of actin polymerization at the IS (Bubeck 
Wardenburg et al., 1998; Bunnell et al., 2001; Fischer et al., 1998).  Interaction with 
complex components promotes the activation of Vav1 by phosphorylation and 
phosphoinositide-dependent engagement of its PH domain (Bustelo, 2002).  Vav1 then 
generates localized pools of active Cdc42 and Rac1, promoting actin polymerization by 
WASp and WAVE2, respectively (Dombroski et al., 2005; Labno et al., 2003).  As 
discussed above, other events also contribute to WASp and WAVE2 activation; however, 
Vav1 function is clearly critical (Fischer et al., 1998; Holsinger et al., 1998).  
 27 
Importantly, Vav1 binds to multiple actin regulatory molecules, suggesting that its central 
role in controlling actin dynamics involves adaptor functions as well as GEF activity. 
Itk plays a key role in T cell activation, regulating both cytoskeletal 
rearrangements and Ca2+ flux.  The domain structure of Itk is shown in Figure 1.6.  Itk 
contains a pleckstrin homology domain that mediates inducible binding to PtIns(3,4,5)P3 
generated by PI3K (phosphoinositide 3-kinase) upon T cell activation, a proline-rich 
region, an SH3 domain, an SH2 domain, and the kinase region.  The proline rich region,  
SH3 domain, and SH2 domain are involved in intermolecular interactions with other 
signalosome components (Bunnell et al., 2000).   
Although it lacks domains that interact directly with the actin cytoskeleton, Itk is 
required for actin polymerization at the IS.  T cells from Itk-/- mice or Jurkat cells 
depleted of Itk by RNAi exhibit severe defects in actin polymerization at the IS 
(Dombroski et al., 2005; Grasis et al., 2003; Labno et al., 2003).  Interestingly, control of 
actin dynamics is an adaptor function of Itk, since an intact SH2 domain, but not kinase 
activity, is required.  Itk regulates cytoskeletal dynamics in part by recruiting Vav1 to the 
IS.  The link between Itk and the actin cytoskeleton is further explored in Chapter 3.  
Interactions between signalosome components, as well as interactions between the 
SH3 domain and proline rich region of Itk (in cis or in trans) are important for regulating 
its kinase activity.  Phosphorylation of Itk at Tyr 180 and Tyr 511 induces conformational 
changes that result in full activation of kinase activity (Joseph et al., 2007; Wilcox and 
Berg, 2003).  Binding of Slp-76 to the SH2 and SH3 domain of Itk promotes kinase 
activity by preserving the open, active conformation (Bogin et al., 2007).  Upon 
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activation, Itk phosphorylates PLCγ1 at activating tyrosines (Bogin et al., 2007), leading 
to Ca2+ and DAG signaling, discussed below. 
 
Costimulation-dependent actin regulatory pathways 
Costimulatory signaling also controls actin responses at the IS (Tskvitaria-Fuller 
et al., 2003).  A major consequence of costimulation via CD28 is the activation of PI3K.  
Through the production of PtIns(3,4,5)P3, PI3K can influence the localization and 
activation of PH-domain containing signaling molecules including Vav1 and Itk, leading 
to enhanced and/or sustained activation of the pathways described above (Finkelstein and 
Schwartzberg, 2004; Han et al., 1998; Michel et al., 2000). CD28 can also signal through 
a PI3K-Ras pathway to dephosphorylate and activate cofilin, an actin filament severing 
protein (Wabnitz et al., 2006).  Though less well studied, costimulatory signaling via 
other molecules such as CD2, CD82, CD46 and ICOS also affects TCR-induced actin 
responses (Delaguillaumie et al., 2002; Nukada et al., 2006; Wabnitz et al., 2007; Zaffran 
et al., 2001).  Thus, one way that costimulation promotes full T cell activation is by 
augmenting actin-dependent signaling events at the IS. 
 
Pathways leading to Ca2+ signaling in T cells 
A common consequence of disruption of actin dynamics in T cells is perturbation 
in Ca2+ signaling events.  Ca2+ signaling pathways downstream of TCR engagement are 
therefore summarized here, starting from phosphorylation and activation of PLCγ1. 
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Figure 1.6:  Domain structures of signaling molecules of interest. 
 
The domain structure of key signaling molecules is shown, with related regions 
colored similarly.  Important binding partners and targets of catalytic activity are listed 
below the relevant domains.  Key tyrosine phosphorylation sites (Y) are indicated, and 
total amino acid numbers are shown at the top right of each. 
 Abbreviations:  CH  - calponin homology; Ac – acidic; DH – Dbl homology; 
PH – Pleckstrin homology; sPH – split PH; SH2 – Src homology 2; TH – Tec 
homology 
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PLCγ1 is a key signaling protein responsible for translating the tyrosine 
phosphorylation cascade and signalosomes assembly events into Ca2+ flux responses that 
lead to transcription factor activation.  TCR engagement leads to rapid (within one 
minute) tyrosine phosphorylation of PLCγ1.  Although it contains numerous tyrosine 
phosphorylation sites, Tyr 775 and Tyr 783 are considered most important:  
phosphorylation at both sites is required for full activation (Serrano et al., 2005) (by 
convention, PLCγ1 residues are numbered according to their position within the bovine 
protein).  
PLCγ1 is a large (145 kDa) protein composed of a pleckstrin homology (PH) 
domain followed by an EF hand at the amino terminus (Figure 1.6).  The catalytic region 
is divided into the X and Y fragments, which are situated N-terminal and C-terminal, 
respectively, to a segment containing two SH2 domains and one SH3 domain.  A C2 
domain is located at the C-terminus of the molecule.   
The split nature of the catalytic region and presence of multiple Src homology 
domains underscore the importance of regulation by protein conformation and intra- and 
intermolecular interactions.  Recruitment of PLCγ1 to the membrane and to signaling 
microclusters requires its N-terminal SH2 domain, which interacts with phosphorylated 
Tyr 132 of LAT (Braiman et al., 2006; Stoica et al., 1998; Zhang et al., 2000).  
Paradoxically, this domain appears not to be necessary for tyrosine phosphorylation of 
PLCγ1 (Braiman et al., 2006) or downstream transcription factor activation by PLCγ1 
(Irvin et al., 2000), although these requirements may vary depending on the experimental 
system.  In contrast, the C-terminal SH2 domain is required for enzymatic activity, but 
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not for recruitment to microclusters or for phosphorylation at Tyr 783 (Braiman et al., 
2006; Poulin et al., 2005).  In keeping with this, phosphorylation at Tyr 783 is 
insufficient to activate lipase activity; additional events are required (Sekiya et al., 2004).  
Phosphorylation at Tyr 783 can activate PLCγ1 by creating a binding site for the C-
terminal SH2 domain.  This intramolecular interaction induces a conformational change 
that causes the X and Y domains to assemble into a fully functional catalytic region 
(Poulin et al., 2005).  Intermolecular interactions can also activate PLCγ1, most likely by 
inducing conformational changes:  binding of SHIP1 to the SH3 domain results in 
increased Ins(1,4,5)P3 production in transfected COS7 cells (Song et al., 2005). 
Several studies have demonstrated that PLCγ1 interacts with components of the 
actin cytoskeleton.  In rat embryo fibroblasts, immunofluorescence microscopy studies 
have shown an SH3 domain-dependent localization of PLCγ1 to the actin cytoskeleton 
(Bar-Sagi et al., 1993).  Several studies have biochemical approaches to show that PLCγ1 
or PLCγ2 inducibly interact with F-actin in a manner dependent on either SH2 domain 
(Dearden-Badet and Mouchiroud, 2005; Nojiri and Hoek, 2000; Pei et al., 1996).  
Although the physiological relevance of this cytoskeletal interaction is unclear, poisoning 
of actin dynamics with CytoD could impair PLCγ1 activity (Suzuki and Takahashi, 
2001).  No such studies have been conducted in T cells; however, pharmacological 
disruption of actin dynamics or loss of actin regulatory proteins in T cells commonly 
disrupts Ca2+ signaling, as discussed above.  We have shown that the C-terminal SH2 
domain of PLCγ1 interacts with HS1 ((Gomez et al., 2006) and Chapter 2).  This may 
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serve to regulate PLCγ1 localization and/or function by linking it to the actin 
cytoskeleton.  This idea is explored in chapter 3. 
Upon activation, PLCγ1 hydrolyzes the membrane lipid PtIns(4,5)P2 
(phosphatidylinositol 4,5 bisphosphate) to generate Ins(1,4,5)P3 (inositol 1,4,5 
trisphosphate) and DAG (diacylglycerol).  Ins(1,4,5)P3 binds to Ins(1,4,5)P3 receptors on 
the ER (endoplasmic reticulum), inducing the release of Ca2+ (calcium ions) from ER 
stores (Majerus et al., 1986; Rhee, 2001; Singer et al., 1997).  Depletion of ER Ca2+ 
stores induces a conformational change in the Ca2+ sensor STIM1 (stromal interacting 
molecule 1) that allows it to interact with and activate CRAC (Ca2+ release-activated 
Ca2+) channels (Luik et al., 2006; Park et al., 2009; Wu et al., 2006).  Although 
electrophysiological experiments had permitted functional characterization of the CRAC 
channel, its molecular identity was not known until three groups independently identified 
Orai1 as a critical component of CRAC channels (Feske et al., 2006; Prakriya et al., 
2006; Vig et al., 2006; Zhang et al., 2006).  
Activation of CRAC channels causes the influx of Ca2+ from the extracellular 
milieu (Oh-hora and Rao, 2008).  The increase in intracellular Ca2+ is detected by the 
calcium binding protein calmodulin.  Ca2+ binding causes calmodulin to interact with and 
activate the phosphatase calcineurin, which dephosphorylates cytosolic NF-AT (nuclear 
factor of activated T cells) family transcription factors.  This reveals the nuclear 
localization sequence of NF-AT, allowing it to translocate to the nucleus to drive gene 
expression.  
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While significant progress has been made in understanding the upstream events 
linking TCR engagement to actin remodeling, our understanding of how actin contributes 
to downstream signaling events is largely restricted to activation of the IL2 promoter.  
Disruption of the actin network perturbs the activation of each of the three key elements 
within the IL2 promoter (NF-AT, NFκB, and AP-1).  Virtually every condition that 
affects actin dynamics affects Ca2+ signaling pathways leading to NF-AT activation. 
Treatment of T cells with CytoD affects Ca2+ flux and NF-AT activation, though as noted 
above, the effects vary depending on the time of treatment and dose of inhibitor 
(Holsinger et al., 1998; Rivas et al., 2004; Valitutti et al., 1995).  Diminished Ca2+ influx 
and inefficient NF-AT activation have also been observed in T cells deficient for Vav1, 
WASp, WAVE2 and HS1 (Cannon and Burkhardt, 2004; Cianferoni et al., 2005; Fischer 
et al., 1998; Gomez et al., 2006; Holsinger et al., 1998; Nolz et al., 2006; Zhang et al., 
1999).  However, the requirement is not simply for actin per se, because individual actin 
regulatory proteins facilitate Ca2+ signaling in distinct ways.  For example, WAVE2 
deficient T cells exhibit defects in coupling store release to CRAC channel activation 
(Nolz et al., 2006), while HS1-deficient T cells exhibit a defect at the level of release 
from stores, as shown in Chapter 3.  T cells deficient for Vav1 and WASp also fail to 
activate AP1, likely stemming from upstream defects in ERK activation (Cianferoni et 
al., 2005; Costello et al., 1999).  Activation of NFκB is defective in T cells lacking Vav1 
or HS1 (Costello et al., 1999; Gomez et al., 2006).  The molecular basis for this defect 
has not been established, but it may reflect defects in PKCθ signaling.  
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Additional analysis of signaling events in T cells lacking actin regulatory proteins 
will be required to fill in the “black box” linking actin polymerization and changes in T 
cell gene expression.  It is unlikely that these events represent simple, linear pathways. 
There is growing evidence that actin networks facilitate formation of or stabilize protein-
protein interactions to promote sustained signaling (Campi et al., 2005; Gomez et al., 
2006).  In addition, actin promotes the internalization of TCR signaling complexes and 
costimulatory molecules, an event that is thought in some cases downregulate signaling, 
and in others, to sustain it (Badour et al., 2007; McGavin et al., 2001).   
This dissertation describes an analysis of the regulation of HS1 and its role in T 
cell receptor signaling.  As shown in Chapter 2, I have found that HS1-/- T cells exhibit 
profound defects in actin polymerization at the IS in response to TCR engagement, and 
that these cells exhibit dampened signaling Ca2+ signaling, resulting in a defect in IL2 
production.  Tyr 378 and Tyr 397 were identified as key phosphorylation sites, and HS1 
function in T cells depends on the integrity of phosphorylation at these sites.  In Chapter 
3, I describe an interaction between HS1 and Itk that is required for recruitment of HS1 to 
the IS.  In addition, I explore the role of HS1 in Ca2+ signaling, finding that HS1 is 
important for proper recruitment of PLCγ1 to the actin cytoskeleton and to signaling 
microclusters. Chapter 4 describes a characterization of T cells from the HS1-/- mouse.  
Thymocyte and peripheral populations develop normally; however, HS1-/- T cells exhibit 
defects in TH1 skewing, likely a result of defects in IFNγ production.  This may reflect a 
defect in Ca2+ signaling.  Finally, in Chapter 5, I discuss the implications of these 
findings and propose future avenues for research. 
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Chapter 2: HS1 functions as an essential actin-regulatory 
adapter protein at the Immune Synapse2 
Summary 
HS1, the leukocyte-specific homologue of cortactin, regulates F-actin in vitro and is 
phosphorylated in response to TCR ligation, but its role in lymphocyte activation has not 
been addressed.  We demonstrate that HS1-deficient T cells fail to accumulate F-actin at the 
immune synapse (IS), and upon TCR ligation form actin-rich structures that are disordered 
and unstable.  Early TCR activation events are intact in these cells, but Ca2+ influx and IL2 
gene transcription are defective.  Importantly, HS1 tyrosine phosphorylation is required for 
its targeting to the IS, and for its function in regulating actin dynamics and IL2 promoter 
activity.  Phosphorylation also links HS1 to multiple signaling proteins, including Lck, 
PLCγ1, and Vav1, and is essential for the stable recruitment of Vav1 to the IS.  Taken 
together, our studies show that HS1 is indispensable for signaling events leading to actin 
assembly and IL2 production during T cell activation. 
 
Introduction 
                                                
2 This chapter is a modified version of a manuscript titled, “HS1 functions as an essential 
actin-regulatory adapter protein at the immune synapse.”  It was published in the June 
2006 Issue of Immunity (volume 24, page 741) with the following author list:  Timothy 
S. Gomez, Sean D. McCarney, Esteban Carrizosa, Christine M. Labno, Erin O. 
Comiskey, Jeffrey C. Nolz, Peimin Zhu, Bruce D. Freedman, Marcus R. Clark, Daniel D. 
Billadeau, and Janis K. Burkhardt 
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In response to interaction with APCs, T cells undergo dramatic shape changes to 
form a flattened contact site enriched in F-actin and signaling molecules, termed the 
immune synapse (IS) (Bromley et al., 2001; Kupfer and Kupfer, 2003).  Actin 
polymerization at the IS stabilizes conjugate formation and facilitates T cell activation 
(Fuller et al., 2003).  Several proteins have been implicated in regulating actin dynamics 
at the IS, including the proximal tyrosine kinases Lck and ZAP-70 and the adaptors LAT 
and SLP-76 (Bubeck Wardenburg et al., 1998; Bunnell et al., 2001; Morgan et al., 2001; 
Zeng et al., 2003).  In addition, the Rho family guanine nucleotide exchange factor Vav1 
regulates actin responses through the small GTPases Cdc42 and Rac1 (Turner and 
Billadeau, 2002; Zeng et al., 2003).  Finally, we recently showed that the Tec kinase Itk 
and the large GTPase Dynamin 2 collaborate with Vav1 to control actin responses at the 
IS (Dombroski et al., 2005; Gomez et al., 2005; Labno et al., 2003).  While much has 
been learned about upstream signaling pathways, the immediate effectors controlling 
actin dynamics are still poorly understood.  The two Rho family proteins regulated by 
Vav1, Rac1 and Cdc42, both play pivotal roles.  Rac1 activates the WAVE2 complex, 
which we recently showed is required for actin-dependent signaling at the IS (Nolz et al., 
2006), while Cdc42 regulates Wiskott-Aldrich Syndrome protein (WASp) (Cannon et al., 
2001).  Although WASp activation is required for T cell activation (Badour et al., 2004b), 
recent experiments indicate that WASp-deficient T cells can retain the ability to 
polymerize actin at the IS (Cannon and Burkhardt, 2004).  Thus, other mechanisms must 
contribute to the regulation of actin dynamics at the IS. 
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Hematopoietic lineage cell-specific protein 1 (HS1, HCLS1, LckBP1) is a major 
substrate for tyrosine phosphorylation during T and B cell activation (Ruzzene et al., 
1996; Takemoto et al., 1996; Yamanashi et al., 1993).  HS1, which is expressed only in 
hematopoietic cells, is related to cortactin (EMS1), a widely expressed oncogene that was 
recently identified as an actin regulatory protein (Daly, 2004).  Similarly to cortactin, 
HS1 contains an Arp2/3 complex binding domain, a region of 37 amino acid tandem 
repeats and a coil-coiled region that bind F-actin (Hao et al., 2005), a proline rich domain 
that binds to Lck (Takemoto et al., 1996), and a C terminal SH3 domain.  In vitro studies 
show that HS1 and cortactin can activate Arp2/3-dependent actin polymerization and 
prolong the half-life of branched actin structures (Uruno et al., 2003a; Weaver et al., 
2002; Weaver et al., 2001).  HS1-/- mice display defects in antigen-induced clonal 
expansion and lymphocyte deletion (Taniuchi et al., 1995), but the role of HS1 in T cell 
signaling has not been tested.  Here we demonstrate that HS1 is required for sustained 
actin responses at the IS and Ca2+ signaling events leading to IL2 gene expression. 
 
Results 
HS1 regulates the accumulation of F-actin at the immune synapse 
We began our analysis by examining HS1 distribution in T cells responding to 
APCs.  HS1 co-localized with F-actin at the IS in conjugates formed with Jurkat T cells, 
primary human CD4+ T cells, and murine DO11.10 TCR Tg T cells (Figure 2.1A).  
Recruitment of HS1 to the cell-cell contact site was antigen-dependent, as was the 
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accumulation of F-actin (data not shown and Figure 2.1E).  Thus, T cell activation 
induces recruitment of HS1 to the IS, where it co-localizes closely with F-actin. 
 To test HS1 function, we suppressed HS1 expression in Jurkat T cells using 
shRNA-mediated gene silencing.  Two different HS1 targeting vectors (shHS1b and 
shHS1f), but not empty vector or a scrambled version of shHS1b (shHS1mut), suppressed 
HS1 protein to 10% of control or less (Figure 2.1B).  All studies were performed using 
both shHS1b and shHS1f, with similar results.  HS1-suppressed T cells formed 
conjugates efficiently with SEE-pulsed B cells (Figure 2.1C).  To assess actin responses, 
conjugates were fixed at 15 minutes and analyzed by microscopy.  As expected, control 
transfectants showed accumulation of HS1 and F-actin at the IS (Figure 2.1D).  HS1-
suppressed cells no longer stained for HS1, verifying that HS1 was efficiently depleted.  
Although these cells flattened relatively normally against the APCs, F-actin labeling at 
the IS was absent or greatly reduced.  Time-course analysis revealed that HS1-suppressed 
cells initially polymerized actin efficiently (Figure 2.1E), but failed to maintain F-actin at 
the IS, such that by 5 minutes, the response was reduced to background levels (defined by 
control cells without SEE).   
 To validate these findings, we analyzed primary lymph node T cells from HS1-/- 
mice responding to P815 cells decorated with anti-TCR antibodies.  Wild type T cells 
formed a well-defined F-actin-rich IS in this assay (Figure 2.1F).  In contrast, although T 
cells from HS1-/- mice formed conjugates with P815 cells efficiently, they failed to 
exhibit clear F-actin polymerization at the IS.  After 30 minutes, the frequency of HS1-/- 
T cells showing F-actin labeling at the IS was at baseline levels (Figure 2.1G).  
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Moreover, this defect was not restored by the addition of costimulatory antibody.  Thus, 
we conclude that HS1 is required for the stable accumulation of F-actin at the IS. 
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Figure 2.1:  HS1 regulates the accumulation of F-actin at the IS 
A, Conjugates were formed between Jurkat T cells and SEE-pulsed NALM6 B cells, 
primary human CD4+ T cells and sAg-pulsed Raji B cells, or 2° DO11.10 Tg T cells 
and ova-pulsed A20 B cells.  Conjugates were labeled with anti-HS1 and phalloidin to 
label F-actin.  B cells were labeled with CMAC (blue and not shown).  B, Short 
hairpin RNA (shRNA) suppression time-course for HS1.  Jurkat cells were transiently 
transfected with RNA targeting vectors (shHS1b or shHS1f), a mutated form of 
shHS1b (shHS1mut), or vector control.  Lysates were prepared at the indicated times 
post-transfection and immunoblotted for HS1 and ZAP70.  C, To assess conjugation 
efficiency, Jurkat cells were transfected with shHS1b or shHS1mut control vectors 
containing a separate GFP cassette.  T cells were incubated with SEE-pulsed, PKH26-
stained EBV-B cells and the % transfected T cells in conjugates was determined by 
flow cytometry.  D, To assess actin responses at the IS, Jurkat cells transfected as in C 
(GFP) were incubated with SEE-pulsed NALM6 B cells (blue).  Fixed conjugates with 
labeled with phalloidin to visualize F-actin and anti-HS1.  E, Conjugates formed as in 
D were fixed at the indicated times following initial contact and labeled with 
phalloidin.  Conjugates containing GFP+ T cells were scored for F-actin at the IS.  F, 
WT and HS1-/- T cells (∗) were conjugated to P815 cells bearing anti-CD3 antibodies 
and stained with phalloidin (red).  G, Conjugates were formed between HS1+/+ or HS1-
/- T cells and P815 cells bound with the indicated stimulating antibodies and scored for 
F-actin at the IS.  Data are from one representative experiment.  Bars in C and E 
represent mean ±StDev from three experiments. 
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HS1-deficient cells fail to stabilize actin following TCR engagement 
In non-hematopoietic cells, the HS1 homologue cortactin is thought to stabilize F-
actin (Daly, 2004).  We confirmed that neither Jurkat cells nor primary mouse T cells 
expressed detectable levels of cortactin mRNA (Figure 2.2), and we observed no 
compensatory upregulation of cortactin in HS1-/- T cells or HS1-suppressed Jurkat cells.  
To ask if HS1 functions by stabilizing F-actin, we analyzed the spreading of Jurkat cells 
stably expressing GFP-actin on anti-TCR-coated coverslips (Bunnell et al., 2001).  
Control cells spread in a highly ordered fashion, forming a round lamellipodial structure 
with uniform width (Figure 2.3A and Supplemental Movies 2.1-2.3).  Spreading was 
typically maximal by 2 minutes, with retraction after about 5 minutes.  DIC images (not 
shown) showed ruffling at the cell periphery and radial retrograde flow within the 
lamellar region; this process is also evident in the GFP-actin videos (Supplemental 
Movies 2.4-2.7).  In contrast, HS1-suppressed cells spread erratically.  These cells 
continuously sent out actin-rich protrusions, but these were asymmetric and quickly 
retracted, and they frequently failed to maintain contact with the coverslip (Figure 2.3B).  
Quantitation of the coverslip contact area vs. time revealed that HS1-suppressed cells 
spread poorly and failed to undergo the sharp increase in contact area observed in control 
cells during the first 90 seconds (Figure 2.3C).  To measure the irregular shape of HS1-
suppressed cells, the variance in radial length was calculated.  Control cells became 
round (low variance) by 120 seconds, while HS1-suppressed cells were irregularly 
shaped at all times (Figure 2.3D).  These data show that TCR-stimulated actin 
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polymerization, ruffling and lamellipodial protrusion can occur in the absence of HS1, 
but HS1 is required for organizing and maintaining these structures.   
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Figure 2.2:  RT-PCR analysis of HS1 and cortactin expression.   
RT-PCR analysis of HS1 and cortactin expression.  Total RNA was extracted from 
secondary LN T cells from wild type or HS1-/- mice, or from total mouse thymus (A).  
Alternatively, RNA was extracted from Jurkat T cells transfected for 72 hours with 
empty suppression vector or shHS1b, or from MCF7 breast cancer cells (B).  RT-PCR 
analysis was conducted for mouse (A) and human (B) HS1, cortactin and actin. 
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Figure 2.3:  HS1-deficient cells exhibit abnormal actin dynamics in response to TCR 
engagement 
Jurkat cells stably expressing GFP-actin were transfected with empty vector (A) or 
shHS1b (B).  Actin dynamics were monitored by video confocal microscopy as the 
cells spread on anti-TCR-coated coverslips.  Selected time-lapse image projections 
acquired at the indicated times after contact with the coverslip are shown.  C,  The 
contact area of each cell at each time point was determined, and the average calculated 
for each cell population at each 5s timepoint (17 cells for each condition).  The 
difference in area was statistically significant (p=0.0002 at 135s).  D, Irregularity of cell 
shape was assessed by measuring the radial variance of the cell outline for each cell at 
each time point, and calculating the average values for each time point.  C and D, black 
circles, control transfectants; red triangles, HS1-suppressed cells. 
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Tyrosine phosphorylation of HS1 is required for actin remodeling 
As reported previously (Hutchcroft et al., 1998; Takemoto et al., 1996; 
Yamanashi et al., 1993), TCR and CD28 ligation induced transient tyrosine 
phosphorylation of HS1 (Figure 2.4A).  Stimulation with APCs had a similar effect, 
although phosphorylation was more sustained (Figure 3B).  Phosphorylation requires 
both Lck and ZAP-70, since cells lacking these kinases failed to phosphorylate HS1 
(Figure 2.4A).   
 To map the sites of HS1 phosphorylation, we conducted phosphopeptide mapping 
by mass spectrometry.  We first tested recombinant HS1, which is phosphorylated in 
vitro by Syk at Y378 and Y397 (Brunati et al., 1999).  HS1 yields a tryptic peptide of 
4610 Da, which is shifted by the 80 Da mass of a single phosphate after phosphorylation 
by Syk (Figure 2.4C).  This peptide includes both Y378 and Y360, but other peptides 
containing Y360 showed no evidence of phosphorylation (data not shown), indicating 
that phosphorylation occurs at Y378.  This peptide, and another that includes Y397 (not 
shown) were confirmed as the major peptides phosphorylated by Syk in vitro.  The 
phospho-peptide containing Y378 was also evident in HS1 immunoprecipitated from 
pervanadate-treated T cells, though it could not be identified with confidence in lysates 
from CD3-stimulated cells.  A phosphopeptide containing only Y397 was clearly visible 
in material isolated from both pervanadate-treated and anti-CD3-activated cells.  In vitro 
phosphorylation of HS1 at Y222 has been documented (Brunati et al., 1999; Ruzzene et 
al., 1996; Takemoto et al., 1996), and there is a report of Y198 phosphorylation in T cells 
(Salomon et al., 2003), however we did not detect phosphorylation at these sites.  Thus, 
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we conclude that Y378 and Y397 are the principal sites for HS1 tyrosine phosphorylation 
in response to TCR stimulation.  Consistent  
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Figure 2.4:  HS1 is phosphorylated at tyrosines 378 and 397 in stimulated T cells 
A, Jurkat T cells or the Jurkat-derived cell lines JCaM1 (Lck-deficient) and P116 
(ZAP-70-deficient) were stimulated with anti-TCR/anti-CD28.  HS1 
immunoprecipitates were immunoblotted for phospho-tyrosine.  B, Jurkat T cells were 
unstimulated (time 0) or stimulated using fixed Raji B cells pulsed with SEE, and HS1 
immunoprecipitates were immunoblotted for phospho-tyrosine.  In A and B, rabbit 
IgG (NRS) was used as an immunoprecipitation control.  C, Recombinant HS1 (rHS1, 
a and b) was incubated +/- Syk kinase.  Alternatively, endogenous HS1 was 
immunoprecipitated from unstimulated (c and f), pervanadate-treated (d and g), or 
anti-CD3 stimulated (e and h) Jurkat cells.  Following proteolysis, peptides were 
analyzed by Mass Spectroscopy.  Top panel, tryptic peptides containing pY378 
(asterisks), detected by MALDI-TOFF.  Bottom panel, Glu-C peptides containing 
pY397 (asterisks) detected by v-MALDI ion trap.  D, Jurkat T cells were transfected 
with FLAG-tagged WT HS1 or the Y378F, Y397F, and 2YF mutants.  Cells were 
pervanadate-treated, the FLAG-tagged proteins immunoprecipitated, and 
immunoblotted with anti-phosphotyrosine. 
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with this, mutation of either individual residue (Y378F or Y397F) permitted tyrosine 
phosphorylation of the protein, whereas mutation of both sites (2YF) abrogated 
phosphorylation (Figure 2.4D). 
 To test the function of HS1 phosphorylation, T cells were transfected with YFP-
tagged HS1 or HS1-2YF, and targeting to the IS was assessed.  As shown in Figure 2.5A 
and B, YFP-HS1 colocalized with F-actin at the IS, but the 2YF mutant remained 
diffusely distributed.  To express the HS1 mutant in cells lacking endogenous protein, we 
used a "suppression-re-expression" vector that encodes the HS1 shRNA targeting 
sequence together with shRNA-resistant wild type HS1 or HS1-2YF cDNA.  This vector 
allows re-expression at near-endogenous levels (Figure 2.5C, right).  Wild type HS1 
restored actin polymerization at the IS, but the 2YF mutant did not (Figure 2.5C), 
indicating that phosphorylation of HS1 at Y378/Y397 is required for actin regulation at 
the IS.   
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Figure 2.5:  Phosphorylation at Y378/Y397 is required for HS1 localization and 
actin accumulation at the IS   
A, Jurkat cells were transfected with YFP or YFP-tagged HS1 (WT or 2YF) and conjugated to 
SEE-pulsed Raji B cells (blue), and fixed conjugates were labeled with phalloidin.  B, Conjugates 
formed as in A were scored for YFP-HS1 localization to the IS.  C, Jurkat T cells transfected with 
the indicated constructs to allow suppression and re-expression of HS1 in the same cell.  After 
48h, cells were conjugated to SEE-pulsed NALM6 B cells, labeled with phalloidin, and 
conjugates containing GFP+ T cells were scored for actin polarization.  Immunoblot analysis 
shows HS1 suppression and re-expression.  ZAP-70 serves as a loading control.   
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Tyrosine phosphorylation of HS1 mediates binding to key signaling molecules  
SH2 domains from several proteins known to participate in T cell actin-regulatory 
pathways could bind phospho-HS1 in GST-pulldown assays (Figure 2.6A).  In addition to 
Lck and Fyn, which are known to bind HS1 (Takemoto et al., 1996), both SH2 domains 
from the p85 subunit of PI3K, the second SH2 domain of PLCγ1 and the SH2 domains 
from all three Vav isoforms also interacted with phospho-HS1.  To confirm these 
interactions in vivo, coimmunoprecipitation analysis was performed.  Both PLCγ1 and 
Vav1 co-immunoprecipitated with HS1, with kinetics that mirrored HS1 tyrosine 
phosphorylation (Figure 2.6B).  In contrast, Lck bound constitutively to HS1, with 
enhanced binding upon activation.  This is consistent with previous work showing that 
HS1 binds both the SH3 and SH2 domains of Lck (Takemoto et al., 1996). 
 
HS1 and Vav1 interact specifically and directly 
Given the role of Vav1 in controlling actin responses, we focused on this 
interaction.  As shown in Figure 2.6C, the GST-Vav1-SH2 fusion protein did not interact 
with overexpressed HS1-2YF from lysates of pervanadate-treated Jurkat cells; it bound 
weakly to the Y397F, and more strongly to Y378F HS1.  An inactivating mutant of the 
GST-Vav1-SH2 (R696A) failed to bind HS1, confirming the specificity of binding.  We 
conclude that the Vav1 SH2 domain can bind to both Y378 and Y397, but binds 
preferentially to Y397.  To ask if HS1 binds Vav1 directly phosphorylated GST fusion 
peptides (p-GST) encompassing HS1 amino acids 361-436 were used in an in vitro 
pulldown of MBP-Vav1-SH2.  The Vav1-SH2 bound directly to the WT, Y378F and 
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Y397F p-GST peptides, but not to the 2YF mutant (Figure 2.6D), mirroring the results 
from pervanadate-treated cells (Figure 2.6C).  Direct interaction was also verified in a 
far-western blot (data not shown).  These data show that the Vav1 SH2 domain binds 
directly to tyrosine phosphorylated HS1. 
 
HS1 is required for maintaining Vav1 at the IS  
Since Y378 and Y397 are required for HS1 targeting to the IS and for binding to 
Vav1, we reasoned that Vav1 might recruit HS1 to the IS.  However, we found that HS1 
recruitment was normal in T cells suppressed for Vav1 expression (Figure 2.6E).  The 
converse experiment revealed a requirement for HS1 in localizing Vav1 to the IS (Figure 
2.6F); HS1-suppressed cells initially recruit Vav1 to the IS, but Vav1 recruitment is 
abnormally short-lived.  The kinetics of Vav1 loss closely resembles the kinetics of F-
actin loss (Figure 2.1E).  Importantly, this effect is specific to Vav1; WASp and WIP 
were recruited normally in HS1-suppressed cells (Figure 2.6G).  These data show that 
one important function of HS1 is to stabilize Vav1 at the IS.  As discussed below, this is 
likely to involve both direct and indirect interactions.  Given the other actin-regulatory 
functions of HS1, it seems likely that HS1 and Vav1 function together to coordinate actin 
dynamics at the IS. 
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Figure 2.6:  HS1 interacts with T cell signaling intermediates and functions to 
maintain Vav1 at the IS 
A, Lysates from pervanadate-treated Jurkat cells were incubated with GSH-agarose-bound GST fusion 
proteins of various SH2 domains, and bound HS1 was detected by immunoblotting.  Loading of fusion 
proteins was visualized with Coomassie.  B, HS1 was immunoprecipitated from Jurkat cells following 
TCR/CD28 ligation, and interacting proteins were detected by immunoblotting.  Rabbit IgG (NRS) was 
used as an immunoprecipitation control.  C, Jurkat T cells were transfected with the indicated versions 
of FLAG-tagged HS1 and treated with pervanadate as in Figure 3D.  Lysates were incubated with GSH-
agarose-bound GST-Vav1-SH2 and the bound HS1 proteins were detected by immunoblotting with 
anti-FLAG.  Loading of fusion proteins was visualized with Coomassie.  D, GST fusion peptides 
encompassing AA361-436 of HS1 were created in a phosphorylated form (p-GST) as described in 
Experimental Procedures.  HS1 p-GST fusion proteins corresponding to WT, Y378F, Y397F and 2YF 
were bound to GSH-agarose and tested for their ability to bind MBP-Vav1-SH2 in vitro.  
Phosphorylation of the p-GST fusions was visualized using anti-pTyr and bound MBP-Vav1 SH2 was 
detected with anti-MBP.  ‘Input’ indicates the total amount of MBP-Vav-SH2 and Vav-SH2 R696A 
used per tube.  In C and D, Vav1-SH2 domain containing an inactivating mutation (R696A) serves as 
control.  E, Jurkat T cells were transfected with control or shVav1-GFP vectors, incubated for 15 min 
with NALM6 B cells +/- SEE, fixed, and labeled with anti-HS1.  The frequency of conjugates 
containing GFP+ T cells exhibiting HS1 localization to the IS was scored.  F, Jurkat cells were 
transfected with control or shHS1b-GFP vectors, fixed at the indicated times, and labeled with anti-
Vav1.  Conjugates containing GFP+ T cells were scored for Vav1 localization to the IS.  G, Jurkat T 
cells were treated as in F, but labeled with anti-WASp or anti-WIP.  Conjugates containing GFP+ T 
cells were scored for WASp or WIP localization to the IS.  Data represent mean ±StDev from three 
experiments.  Data in E and F are from one representative experiment. 
 
 57 
 
HS1-mediated actin stabilization is required for sustained TCR signaling 
Since T cells from HS1-/- mice have proliferative defects (Taniuchi et al., 1995), 
we asked if they exhibit defects in IL2 production.  T cells from wild type and HS1-/- 
mice were cultured for 24 hours in the presence of SEB and wild type T-depleted 
splenocytes, and IL2 levels were measured.  HS1-/- T cells produced significantly reduced 
levels of IL2 at all doses of SEB (Figure 2.7A).  Analysis of IL2 reporter activity showed 
that HS1 suppression strongly inhibited activation of the IL2 promoter, demonstrating 
that IL2 defects occur at the transcriptional level (Figure 2.7B).   
 The defects in HS1-/- T cells are not attributable to alterations in basal TCR 
expression levels, or in activation-induced downregulation of CD3 or upregulation of the 
activation markers CD25 and CD69 (Figure 2.7C).  However, single cell analysis using 
ratiometric imaging showed a significant decrease in TCR-crosslinking-induced Ca2+ 
influx in HS1-suppressed cells and T cells from HS1-/- mice (Figure 2.8 A,B).  Because 
Ca2+ signaling is required for NF-AT translocation, we assessed NF-AT-reporter 
activation.  As shown in Figure 2.8C, NF-AT activity was significantly reduced in HS1-
suppressed cells.  Parallel analysis of NFκB also showed defects in this pathway (Figure 
2.8D).  Taken together, these results show that HS1 is dispensable for early TCR 
signaling events, but required for sustained signaling events leading to gene activation.   
 In the course of asking if HS1’s role in controlling gene activation requires 
tyrosine phosphorylation of Y378/397, we found that IL2 reporter activity is exquisitely 
sensitive to the expression level of HS1.  Overexpression of FLAG-tagged (or untagged) 
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HS1 inhibited IL2 promoter activity in a dose-dependent fashion (Figure 2.8E and data 
not shown).  Similar effects have been observed with other adapters, presumably because 
superstoichiometric expression leads to disruption of signaling complexes.  In keeping 
with the idea that HS1 function involves tightly controlled protein levels, high-level 
overexpression of HS1 led to diminished levels of endogenous protein (Figure 2.8E, top).  
Although this overexpression effect made it impossible for us to conduct transcriptional 
analysis based upon re-expression of HS1 mutants in shRNA-suppressed cells, we found 
that the 2YF mutant lacks the inhibitory effects of the wild type molecule on IL2 
promoter activity (Figure 2.8F).  Thus, phosphorylation of HS1 is also important for 
activation of IL2 promoter activity.   
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Figure 2.7:   HS1 is required for IL-2 production 
A, T cells isolated from wt or HS1-/- mice were cultured for 24 h in the presence of WT T-
depleted splenocytes and the indicated doses of SEB.  Total IL-2 levels were measured by 
ELISA.  Data are mean +/- StDev from replicate wells of one representative experiment.  B, 
Jurkat T cells were co-transfected with IL2p-luc reporter and either vector control, shHS1b, or 
shHS1f plasmid.  Cells were un-stimulated or stimulated with SEE-pulsed NALM6 B cells for 
5h, and luciferase activity was measured hourly.  Data represent mean ±StDev from triplicate 
samples.  C, T cells isolated from WT and HS1-/- mice were unstimulated (shaded profiles) or 
stimulated for 24h with anti-CD3 and wt T-depleted splenocytes (open profiles).  CD4+ T 
cells were analyzed for surface expression of CD3, CD25 and CD69 by flow cytometry. 
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Figure 2.8:  HS1 is required for sustained TCR-mediated signaling events leading to 
gene activation 
A, Jurkat cells were transfected with control or shHS1 vectors.  After 72h, TCR-
induced Ca2+ signaling was examined using Fura-2 imaging.  In Ca2+-free bath, 
increases in Fura-2 ratio reflect Ca2+ release from intracellular stores.  Extracellular 
Ca2+ entry via activated CRAC channels was then assessed by addition of extracellular 
Ca2+.  Each trace represents the average response of at least 100 cells.  B, CD4+ LN T 
cells from WT or HS1-/- mice were loaded with Fura-2, incubated with biotinylated 
anti-CD3 and activated by crosslinking with streptavidin.  Analysis was as in A.  
Jurkat T cells were co-transfected with an NF-AT-luc (C) or NFkB-luc (D) reporter 
construct along with vector control, shHS1b, or shHS1f.  Cells were un-stimulated or 
stimulated with SEE-pulsed NALM6 B cells and luciferase activity was measured.  
Jurkat cells were transfected with IL-2p-luc along with (E) vector control (40 µg) or 
an increasing concentration of FLAG-HS1 expression vector (10µg, 20µg, 40µg) or 
with (F) vector control, FLAG-HS1, or FLAG-HS1 2YF.  Cells were un-stimulated or 
stimulated and luciferase activity was measured.  The accompanying immunoblots 
show endogenous HS1 and FLAG-HS1 expression in whole cell lysates from each cell 
population.  All bars represent mean ±StDev from triplicate samples. 
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HS1 is recruited to the periphery of spreading T cells 
To more closely examine the localization of HS1 upon after TCR engagement, we 
generated a Jurkat cell clone stably expressing a variant of HS1 tagged at the N-terminus 
with the bright YFP variant Venus (Nagai et al., 2002).  These cells expressed 
approximately a 1:1 ratio of tagged:endogenous HS1 (not shown).  Cells spreading on 
anti-CD3-coated coverslips were observed by confocal microscopy over 3 minutes.  HS1 
was initially observed in discrete puncta and was enriched at the periphery throughout, in 
a pattern much like that observed for GFP-actin (Figure 2.9 and Supplementary Movies 
2.8 and 2.9).  These data suggest that HS1 is primarily localized to F-actin rich 
lamellipodia. 
 
HS1 binding to F-actin is important for actin polymerization at the IS 
A variant of HS1 lacking the third HTH repeat has been isolated from a patient with SLE 
(Sawabe et al., 2003).  Since the HTH repeat region is involved in binding to F-actin 
(Hao et al., 2005), we reasoned that this disease-associated variant would provide an 
interesting opportunity to examine the role of actin binding in HS1 function.  Hao et al. 
have reported that F-actin binding in vitro does not explicitly require the HTH repeat 
region and is instead more dependent on the CC domain, although F-actin binding in cells 
appears to be more complicated (Hao et al., 2005).  To test the effect of loss of one HTH 
repeat on F-actin binding, recombinant GST-HS1EP6 or GST-HS1HTH2.5 was incubated 
with increasing concentrations of F-actin and ultracentrifuged to separate F-actin-bound 
(pellet, P) from unbound (supernatant, s) protein.  As shown in Figures 2.9A and 2.9B, 
 64 
HS1EP6 bound F-actin at all doses tested.  In contrast, HS1HTH2.5 bound less efficiently at 
all doses, and was fully unbound at the lowest dose of F-actin.  We then asked if this 
defect in actin binding influences the ability of HS1 to promote Arp2/3 complex-
dependent actin polymerization.  Recombinant HS1 was incubated with Arp2/3 complex, 
and polymerization was initiated by the addition of actin.  WASp VCA fragment was 
included as a positive control.  HS1EP6 promoted actin polymerization more efficiently 
than HS1HTH2.5 (Figure 2.9C). 
HS1 deficiency or mutation of Tyr 378 and Tyr 397 result in a failure to stabilize 
F-actin at the IS (Figure 2.1 and Figure 2.5, respectively).  To determine if IS-associated 
F-actin structures depend on HS1, we expressed HS1EP6 or HS1HTH2.5 in T cells from 
HS1-/- mice, conjugated these cells to P815 cells bearing anti-CD3, and assessed actin 
responses.  HS1EP6 expression was able to rescue actin responses to WT levels, but 
HS1HTH2.5 expression resulted only in a partial rescue of F-actin responses (Figures 2.11D 
and Figures 2.11E).  These experiments need to be repeated to validate these results. 
 
Discussion 
In this study, we show that HS1 is required for the stabilization of F-actin filaments 
following TCR engagement, for maximal Ca2+ influx, and for NF-AT and NFkB-mediated 
gene transcription.  In addition, we find that tyrosine phosphorylation is necessary for HS1 
recruitment to the IS, and regulates its interaction with Lck, PLCγ1, and Vav1.  These 
findings identify HS1 as an actin-regulatory adapter protein essential for T cell activation. 
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Figure 2.9:  HS1 is recruited to the actin-rich periphery upon TCR engagement.   
Top, Jurkat cells stably expressing Venus-HS1 were plated on anti-CD3-coated 
coverslips and imaged by confocal microscopy over the indicated time course after 
contact with the coverslip (seconds).  Bottom, The 20 second time point is expanded, 
and HS1-rich clusters are marked with red arrows.  This time-lapse sequence 
corresponds to supplemental movie 2.8 
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Figure 2.10:  HS1-F-actin binding is important for actin responses.   
A, GST-HS1EP6 or GST-HS1HTH2.5 was incubated with the indicated concentrations of 
F-actin and fractionated by ultracentrifugation.  F-actin bound (pellet, P) and unbound 
(supernatant, S) fractions were analyzed by immunoblotting for GST.  B, Quantitation 
of the blot shown in A.  Data are expressed as the ratio of HS1 in the supernatant to 
HS1 in the pellet.  C, GST-HS1EP6 or GST-HS1HTH2.5 was incubated with Arp2/3 and 
G-actin containing 20% pyrene-labeled monomers.  Polymerization was measured 
over the indicated time course.  WASp VCA fragment was included as a positive 
control.  D, WT or HS1-/- T cells (red) were transduced with the indicated constructs 
and conjugated to P815 cells (blue) and stained as in Figure 2.1F.  E, Conjugates in D 
were analyzed for the conjugates of cells with F-actin at the IS. 
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HS1-deficient T cells show unique defects in actin polymerization at the IS; actin-rich 
structures are formed initially, but are unstable and erratic.  This phenotype is distinct 
from that of cells lacking WASp or WAVE2, both of which also bind Arp2/3 complex.  
Cells lacking WASp spread essentially normally, while cells lacking WAVE2 fail to 
spread altogether (Nolz et al., 2006).  The phenotype of HS1-deficient T cells resembles 
that of cortactin-deficient fibroblasts, which display disorganized lamellipodial formation 
(Bryce et al., 2005; Kempiak et al., 2005).  These phenotypes are consistent with the idea 
that by binding F-actin as well as Arp2/3 complex, these proteins inhibit debranching and 
stabilize cortical actin (Uruno et al., 2003b).  An unresolved question is whether HS1 also 
acts via direct interactions with WASp and WIP, as reported for cortactin (Kempiak et 
al., 2005; Kinley et al., 2003; Tehrani et al., 2007; Uruno et al., 2003a; Weaver et al., 
2002; Weaver et al., 2001).  Though we can readily detect binding of HS1 to the 
WIP/WASp complex in vitro, we have so far failed to verify interaction by co-
immunoprecipitation from T cell lysates.  This may reflect weak interactions that are 
disrupted upon T cell lysis.  Nonetheless, we show that HS1 is not required for 
recruitment of WASp or WIP to the IS.  Indeed, their continued presence likely 
contributes to the residual actin dynamics in HS1-deficient cells. 
We mapped the major sites of HS1 tyrosine phosphorylation in activated T cells 
to amino acids 378 and 397, and our data suggest that ZAP-70 is responsible for 
phosphorylating these sites.  Y378 and Y397 are critical for several aspects of HS1 
function.  Mutation of these residues leads to defective HS1 targeting to the IS, abrogates 
binding to Vav1, and perturbs actin responses.  Finally, these residues are required for 
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overexpression-induced inhibition of IL2 promoter activation.  Phosphorylation-
dependent membrane targeting may be a general feature of HS1 function; in B cells, 
tyrosine phosphorylation of HS1 mediates its recruitment to lipid rafts (Hao et al., 2004).  
Although we have failed to detect HS1 in lipid raft fractions from T cell (not shown), we 
have found that the Tec family kinase Itk binds to these tyrosines, and mediates HS1 
recruitment to the IS.  These studies are described in Chapter 3.  While it is possible that 
the functional defects observed in T cells expressing HS1 2YF are solely attributable to 
the aberrant localization of this mutant, it seems more likely that phosphorylation 
regulates multiple aspects of HS1 function.  In addition to mediating binding to other 
signaling molecules (discussed below), phosphorylation may induce conformational 
changes that influence HS1 function, as already shown for cortactin (Huang et al., 1997a; 
Martinez-Quiles et al., 2004).   
One clear role of HS1 phosphorylation is to mediate binding to SH2-domain-
containing proteins, including Lck, Vav1, and PLCγ1.  The functional significance of 
Vav1 binding is underscored by the finding that HS1-suppressed T cells progressively 
lose Vav1 from the IS.  Interestingly, the loss of Vav1 from the IS in HS1-suppressed 
cells parallels the loss of F-actin at this site.  This, and finding that the kinetics Vav1/F-
actin loss differ from those of HS1 phosphorylation, suggest that HS1 stabilizes Vav1 at 
the IS via a complex mechanism.  Since Vav1 recruitment to the IS dependents on 
interactions with SLP-76 and Itk (Dombroski et al., 2005; Zeng et al., 2003), we propose 
that SLP-76, Itk and HS1 coordinately recruit Vav1 to the IS at early time points.  Once 
this complex is localized to the IS, Vav1 initiates actin polymerization through activation 
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of Cdc42 and Rac.  HS1 participates in forming and/or stabilizing F-actin at later times, 
and this feeds back to stabilize Vav1 interactions with the SLP-76 complex.  Stabilization 
could occur through direct interactions or via the F-actin scaffold.  The fact that HS1 
binds directly to Vav1 suggests that these important actin regulatory proteins function 
coordinately.  It will be interesting to ask if this interaction modifies the activity of either 
protein.   
Phosphorylation also mediates HS1 interaction with PLCγ1, and studies further 
probing this interaction are described in Chapter 3.  Regulated interactions with PLCγ1 
and the p85a subunit of PI-3K may also play a role in HS1-mediated actin regulation via 
effects on inositol phospholipids. 
High-resolution live-cell microscopy has shown that signaling molecules coalesce 
within signaling microclusters at sites of TCR engagement (Bunnell et al., 2002; 
Yokosuka et al., 2005).  We have found that HS1 is transiently recruited to puncta 
reminiscent of these microclusters, but primarily redistributes to the actin-rich periphery, 
where active signaling predominates.  Phosphorylation likely occurs at both sites.  These 
data support the idea that HS1 primarily functions to link active signaling complexes to 
the actin cytoskeleton, although further investigation is necessary.  In Chapter 3, this 
concept is explored further. 
 We showed here, using a disease-associated variant of HS1, that efficient F-actin 
binding is important for HS1-mediated Arp2/3 complex-dependent actin polymerization 
and for actin responses at the IS.  From the data presented here, it is not possible to judge 
whether the observed partial defect in actin polymerization in vitro represents a true 
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defect in Arp2/3 complex activation, or whether it is due to premature disassembly of 
polymerized actin throughout the course of the assay.  It will be interesting to examine 
the effect of this actin binding mutation on signaling to the IL2 promoter. 
Initial analysis of HS1-/- mice demonstrated defects in T cell proliferation and 
negative selection (Taniuchi et al., 1995) but did not address the molecular basis of these 
defects.  We show that HS1-/- T cells have defective actin and Ca2+ responses, as well as 
defective IL2 production associated with defects in activation of NF-AT and NFkB 
transcriptional elements.  It remains to be determined how alterations in HS1 function 
result in the observed changes in IL2 promoter activation.  Perturbations in signaling 
through Vav1 and/or PLCγ1 may be involved, since both proteins are required for 
activation of NF-AT and NFkB (Cao et al., 2002; Costello et al., 1999; Dolmetsch et al., 
1998; Irvin et al., 2000).  The role of HS1 in regulating Ca2+ signaling is further explored 
in Chapter 3. 
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Chapter 3: Recruitment of HS1 to the immunological synapse 
by Itk regulates actin responses and PLCγ1 microcluster 
dynamics3 
Summary 
Productive T cell activation requires efficient reorganization of the actin 
cytoskeleton.  We showed previously that the actin regulatory protein hematopoietic 
lineage cell-specific protein 1 (HS1) is required for the stabilization of F-actin and Vav1 
at the immunological synapse (IS) and for efficient calcium responses.  The Tec family 
kinase Itk regulates similar aspects of T cell activation, suggesting that these proteins act 
in the same pathway.  Using video microscopy, we show that T cells lacking Itk or HS1 
exhibited similar defects in actin responses, extending unstable lamellipodial protrusions 
upon TCR stimulation.  HS1 and Itk could be co-immunoprecipitated from T cell lysates, 
and GST-pulldown studies showed that Itk’s SH2 domain binds directly to two 
phosphotyrosines in HS1.  In the absence of Itk, or in T cells overexpressing an Itk SH2-
domain mutant, HS1 failed to localize to the IS, indicating that Itk serves to recruit HS1 
to sites of TCR engagement.  Since Itk is required for PLCγ1 phosphorylation and 
                                                
3 This chapter is a modified form of paper entitled, “Hematopoietic lineage cell-specific 
protein 1 is recruited to the immunological synapse by IL-2-inducible T cell kinase and 
regulates phospholipase Cγ1 microcluster dynamics during T cell spreading,” published 
in the December 1 issue of the Journal of Immunology, Volume 183, pages 7352-7361, 
with the following author list:  Esteban Carrizosa, Timothy S. Gomez, Christine M. 
Labno, Deborah A. Klos Dehring, Xiaohong Liu, Bruce D. Freedman, Daniel D. 
Billadeau, and Janis K. Burkhardt.  Copyright 2009.  The American Association of 
Immunologists, Inc. 
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calcium store release, we examined the calcium signaling pathway in HS1-/- T cells in 
greater detail.  In response to TCR engagement, T cells lacking HS1 exhibited abnormal 
calcium store release but normal TCR-dependent PLCγ1 phosphorylation.  However, 
these cells exhibited defective cytoskeletal association of PLCγ1 and altered formation of 
PLCγ1 microclusters.  We conclude that Itk-dependent recruitment of HS1 mediates actin 
stabilization at the IS, and directs the spatial organization of PLCγ1 signaling complexes. 
 
Introduction 
Effective T cell activation requires reorganization of the actin cytoskeleton.  The 
interaction between a T cell and an antigen presenting cell (APC) bearing cognate antigen 
results in the activation of multiple actin regulatory proteins, which promote the 
polymerization of actin filaments at the immunological synapse (IS) (Burkhardt et al., 
2008).  T cells lacking these molecules or treated with pharmacological agents that 
disrupt actin dynamics exhibit functional defects in their responses to antigen.  
Commonly, diminished calcium (Ca2+) mobilization responses are observed, resulting in 
poor IL2 production and proliferation.  Although the molecular mechanisms by which 
actin dynamics influence T cell signaling are poorly understood, visualization of high-
order signaling complexes using live-cell imaging has begun to yield some insights.  
Proper actin dynamics are required for the formation of signaling microclusters at the cell 
periphery and for their movement toward the center, while the maintenance of centralized 
microclusters is largely independent of the actin cytoskeleton (Campi et al., 2005; Varma 
et al., 2006).  Peripheral and central microclusters also appear to be functionally distinct 
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with respect to their role in signaling.  Though details differ depending on experimental 
conditions (Cemerski et al., 2008), newly formed, peripheral, microclusters are thought to 
be the predominant sites for early phosphorylation events, while central microclusters are 
usually associated with signal down-regulation (Seminario and Bunnell, 2008).  Thus, 
actin dynamics are required to assemble active signaling complexes, and to drive the 
mechanism that ultimately extinguishes signaling.   
HS1 is an actin regulatory protein expressed throughout the hematopoeitic system 
(Kitamura et al., 1989).  Like its more widely expressed homologue, cortactin, HS1 binds 
to the Arp2/3 complex and actin filaments, and is thought to stabilize branched actin 
filaments (Uruno et al., 2003b; Weaver et al., 2001).  We have shown that T cells lacking 
HS1 can generate actin-rich lamellipodial protrusions in response to T cell receptor 
(TCR) engagement, but these protrusions are disordered and rapidly collapse (Gomez et 
al., 2006).  Consistent with this observation, accumulation of F-actin at the IS is 
abnormally short-lived.  HS1-deficient T cells also exhibit defects in Ca2+ signaling 
leading to diminished IL2 production.  The regulation of HS1 activity is not fully 
understood.  TCR engagement leads to rapid phosphorylation of HS1 at tyrosines 378 and 
397.  This is required for recruitment of HS1 to the IS, and for its binding to numerous 
key signaling proteins, including the Rac-1/Cdc42 guanine nucleotide exchange factor 
Vav1.  While T cells lacking HS1 exhibit defects in the maintenance of Vav1 at the IS, 
Vav1 is dispensable for recruitment of HS1 to the IS (Gomez et al., 2006).  How HS1 is 
recruited to the IS is unknown. 
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TCR ligation-induced activation of actin-regulatory proteins, including HS1, 
depends on signaling through tyrosine kinases and adapter proteins (Reviewed in 
(Burkhardt et al., 2008)).  Although these molecules do not directly influence the actin 
cytoskeleton, cells lacking them exhibit severe defects in actin dynamics.  We and others 
have shown that T cells lacking the Tec family kinase Itk fail to polymerize actin 
properly in response to TCR ligation (Dombroski et al., 2005; Grasis et al., 2003; Labno 
et al., 2003), and fail to recruit Vav1 to the IS (Dombroski et al., 2005).  Interestingly, the 
actin-regulatory role of Itk is independent of kinase activity, and depends instead on 
adapter functions carried out by its SH2 domain (Dombroski et al., 2005; Grasis et al., 
2003).   
To begin to understand how the interactions between actin regulatory proteins and 
upstream regulators lead to productive T cell activation, we examined the possibility of 
an interaction between HS1 and Itk.  Using live cell imaging, we now show that cells 
lacking Itk exhibit similar defects in actin dynamics to those lacking HS1.  The SH2 
domain of Itk binds to phosphotyrosines in HS1, and this interaction is required for the 
recruitment of HS1 to the IS.  Recruitment of HS1 to the IS then promotes productive 
Ca2+ signaling by modulating the formation of PLCγ1 microclusters.  Taken together, 
these studies show that Itk-HS1 interactions play an important role in controlling actin-
driven dynamics of TCR signaling microclusters leading to productive T cell activation.  
 
Results 
Itk-deficient T cells show unstable lamellipodial protrusions 
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Previous studies have shown that Itk is required for proper actin responses in a 
manner dependent on its SH2 domain, but not its kinase activity (Dombroski et al., 2005; 
Grasis et al., 2003; Labno et al., 2003).  To better understand how Itk regulates T cell 
actin responses, we generated Itk-deficient T cells using RNA interference (RNAi), 
(Figure 3.1E), and visualized actin dynamics in these cells during spreading on coverslips 
coated with anti-CD3.  As previously shown (Bunnell et al., 2001), control Jurkat T cells 
expressing GFP-actin extended stable actin-rich lamellipodia and exhibited retrograde 
actin flow from the periphery of the cell toward the center (Figure 3.1A and Supp. Videos 
3.1 and 3.2).  Itk-deficient T cells also extended actin-rich lamellipodia, but these 
structures were disordered and retracted frequently (Figure 3.1B and Supp. Videos 3.3 
and 3.4).  The overall spreading area of Itk-suppressed cells was less than that of wild-
type cells (Figure 3.1C).  Furthermore, whereas control cells maintained a regular, round 
profile, Itk-suppressed cells were irregularly shaped.  This difference is illustrated by an 
increased radial variance in the Itk-suppressed cells relative to controls (Figure 3.1D).  
The phenotype of Itk-deficient T cells in this assay is strikingly similar to that of T cells 
lacking HS1, an actin-binding protein that is thought to stabilize branched actin filaments 
generated in response to TCR engagement.  Like Itk-suppressed cells, HS1-suppressed 
cells exhibit diminished spreading and irregular and unstable lamellipodial protrusions 
(Chapter 2, (Gomez et al., 2006), and Supp. Videos 3.5 and 3.6). 
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Figure 3.1:  Itk-deficient T cells exhibit unstable lamellipodial protrusions. 
 A, Jurkat T cells stably expressing GFP-actin were transfected with empty 
suppression vector.  After 72 hours, cells were plated on coverslips coated with 
anti-CD3 and imaged by confocal microscopy for the indicated times (seconds).  
Selected images from one time-lapse series are shown; these correspond to 
Supplemental video 1.  B, Jurkat cells stably expressing GFP-actin were 
transfected with Itk suppression vector and analyzed as in A.  Selected images 
from one time-lapse series are shown; these correspond to Supplemental video 3.  
C, The contact area of each cell at each time point was determined and the average 
was calculated for each cell population at each 5 s time point (control=46 cells, 
shItk=49 cells).  D, Irregularity of cell shape was assessed by measuring the radial 
variance for each cell at each time point and calculating the average values.  E, 
Western blot analysis showing suppression of Itk or HS1 in GFP-actin Jurkat cells 
transfected with the indicated suppression vectors. 
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The SH2 domain of Itk mediates binding to HS1  
To test the possibility that HS1 is an effector for Itk in the T cell actin regulatory 
pathway, we assessed interaction between these two proteins by co-immunoprecipitation.  
As shown in Figure 3.2, Itk was found in association with HS1 in both activated and 
resting mouse CD4+ T cell blasts.  Similar results were obtained using Jurkat T cells; 
moreover, HS1 was present in Itk immunoprecipitated (data not shown).  
To map the site(s) of interaction between the two proteins, we used a GST 
pulldown approach.  Domain maps of HS1 and Itk are shown in Figure 3.3A.  Itk has 
SH3 and SH2 domains that could bind to proline-rich sequences or phosphotyrosines in 
HS1, respectively.  Conversely, the SH3 domain of HS1 could bind to the proline-rich 
region of Itk.  To test the role of the Itk SH3 and SH2 domains, we generated a panel of 
GST-fusion constructs encoding the wild-type SH3-SH2 domain fragment of Itk, or with  
inactivating point mutations in the SH3 domain, the SH2 domain or both.  These 
fragments were used to probe Jurkat T cell lysates for binding of HS1.  As shown in 
Figure 3.3B, HS1 bound to the wild-type Itk fragment in an activation-dependent manner.  
This binding was unaffected by mutation of the Itk SH3 domain, but was abolished upon 
mutation of the SH2 domain, consistent with binding mediated by SH2 domain-
phosphotyrosine interactions.  In some experiments, we detected modest HS1 binding to 
the wild-type construct in the absence of pervanadate treatment (data not shown).  
However, this was also abolished upon mutation of the SH2 domain, suggesting that this 
interaction is attributable to basal tyrosine phosphorylation of HS1.  To ask if the SH3  
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Figure 3.2:  HS1 and Itk interact in T cells 
HS1 and Itk interact in T cells.  CD4+ T cell blasts were stimulated with anti-CD3 
for the indicated times (minutes), treated with pervanadate (PV), or left untreated.  
HS1 was immunoprecipitated from lysates, and immunoprecipitates were 
analyzed by western blotting for HS1, phosphorylated HS1 (by blotting for total 
phosphotyrosine, pTyr), or Itk.  Control immunoprecipitation was performed 
using pre-immune rabbit serum. 
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Figure 3.3:  The SH2 domain of Itk binds directly to phosphorylated HS1.   
A, Domain maps of HS1 and Itk.  B, A panel of recombinant GST fusion proteins 
comprised of the wild-type SH3-SH2 fragment of Itk and inactivating point mutants in 
either domain were coupled to glutathione resin and incubated with lysates from 
Jurkat cells that had been treated with pervanadate (PV) or left untreated.  The 
pulldown reactions were washed and analyzed by western blotting for HS1 (top) or 
Coomassie staining to monitor the GST-Itk proteins (bottom).  C, The wild-type GST-
HS1-SH3 domain or an inactivating point mutant were coupled to glutathione resin 
and incubated with lysates from Jurkat cells that had been treated with pervanadate 
(PV) or left untreated.  The pulldown reactions were washed and analyzed by western 
blotting for Itk or Dynamin 2.  D, Jurkat cells were transfected with expression vectors 
encoding wild-type FLAG-tagged HS1 or the indicated point mutants.  These cells 
were treated with pervanadate, lysed, and probed with GST-Itk SH2 domain.  Left, 
bound proteins were analyzed by western blotting for FLAG or Coomassie staining to 
monitor the GST-Itk proteins.  Right, FLAG immunoprecipitates were probed for 
phosphotyrosine and FLAG to monitor phosphorylation status of HS1 mutants.  E, 
Purified recombinant GST-Itk SH2 domain was incubated with recombinant HS1 
phosphopeptide fused to myelin basic protein (MBP).  Left, bound proteins were 
analyzed by western blotting and Coomassie staining.  Right, purified MBP fusion 
peptides were analyzed by western blotting for phosphotyrosine and MBP.   
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domain of HS1 provides an additional means of interaction with Itk, we conducted 
reciprocal pulldown experiments using the HS1 SH3 domain.  However, Itk binding to 
the HS1 SH3 domain could not be detected, even under conditions where interactions 
with other binding partners could be verified (Figure 3.3C).  We conclude that HS1 
binding to Itk depends predominantly on interactions between the SH2 domain of Itk and 
tyrosine phosphorylation sites in HS1.  
Phosphorylation at Y378 and Y397 of HS1 mediates binding to many SH2 
domains (Chapter 2 and (Gomez et al., 2006)), making these sites the likely points of 
interaction between HS1 and Itk.  To test this hypothesis, we transfected Jurkat cells with 
vectors expressing wild-type FLAG-tagged HS1, or HS1 point mutants at one or both 
tyrosines.  Transfected T cells were treated with pervanadate and lysates were probed for 
binding of FLAG-HS1 to the SH2 domain of Itk.  As shown in Figure 3.3D, wild-type 
HS1 bound efficiently.  Mutation of either tyrosine substantially reduced binding, and  
mutation of both sites abolished the interaction altogether.  This shows that both tyrosines 
378 and 397 contribute to the interaction with Itk.  
To determine if HS1 and Itk interact directly, we asked whether the recombinant 
GST-Itk SH2 domain could bind to phosphorylated recombinant HS1 fusion protein in 
the absence of other components of the T cell signaling machinery.  As Figure 3.3E 
shows, HS1 and Itk interacted directly, and efficient binding required both Y378 and 
Y397.  We conclude that HS1 and Itk interact in T cells and that this interaction involves 
direct binding between the SH2 domain of Itk and tyrosines 378 and 397 of HS1.  Since 
we have shown previously that these sites on HS1 are phosphorylated transiently upon 
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TCR engagement ((Gomez et al., 2006) and Chapter 2), direct interaction between HS1 
and Itk is predicted to be transient, and the observed constitutive association between 
these proteins (Figure 3.2) is likely to involve additional interactions with mutual binding 
partners.    
 
Itk is required for HS1 recruitment to the IS 
We have shown previously that phosphorylation of HS1 at Y378 and Y397 is 
required for its recruitment to the IS (Chapter 2 and (Gomez et al., 2006)).  Since these 
sites mediate direct binding to the SH2 domain of Itk, we asked if Itk is required for 
recruitment of HS1 to the IS.  As shown in Figure 3.4A, control Jurkat cells conjugated to 
superantigen-pulsed B cells recruited HS1 to the IS, but this recruitment was impaired in 
cells transfected with an Itk suppression vector.  In contrast, T cells lacking HS1 showed 
no defect in recruitment of Itk to the IS (Figure 3.4B), indicating that the requirement for 
recruitment is unidirectional.  To quantitate the requirement for Itk in recruiting HS1 to 
the IS, conjugates were prepared using control and Itk-suppressed Jurkat cells, and the 
frequency of conjugates showing a bright band of HS1 at the IS was scored.  As shown in 
Figure 3.4C, Itk suppression diminished HS1 recruitment to frequencies similar to those 
observed in the absence of superantigen.  Using a similar approach, we asked what 
portions of Itk are required to mediate HS1 recruitment.  Jurkat T cells were transfected 
with wild-type Itk, the kinase-dead (K390R) mutant, or the SH2 domain (R265A) mutant, 
and HS1 recruitment to the IS was assessed.  As shown in Figure 3.4D, overexpression of 
wild-type or kinase dead Itk had no effect on HS1 localization, but overexpression of the 
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Itk SH2 domain mutant efficiently inhibited HS1 recruitment to the IS.  The requirements 
for HS1 recruitment with respect to Itk parallel those for actin recruitment (Dombroski et 
al., 2005).  We conclude that Itk, through its SH2 domain, recruits HS1 to the IS to 
promote TCR-induced actin responses. 
 
HS1 is required for efficient Ca2+ store release 
In addition to its role in regulating actin responses, Itk is a key signaling 
intermediate in TCR signaling-induced Ca2+ responses (Liu et al., 1998; Schaeffer et al., 
1999).  Itk is required for phosphorylation of PLCγ1, leading to Ins(1,4,5)P3 production 
and release of Ca2+ from intracellular stores.  HS1 is also required for normal T cell Ca2+ 
responses (Gomez et al., 2006), but the level at which HS1 functions in this pathway has 
not been addressed.  To test this, HS1-/- T cells were stimulated with anti-CD3 in the 
absence of extracellular Ca2+ to visualize ER store release, and then exposed to 
extracellular Ca2+ to permit Ca2+ influx via CRAC channels.  HS1-/- T cells showed a 
significant blunting of Ca2+ responses (Figure 3.5A).  Expansion of the Y-axis to better  
show the response in the absence of extracellular Ca2+ (Figure 3.5A, right panel) reveals 
that HS1-deficient T cells fail to show significant release of Ca2+ from ER stores.  To 
confirm this finding, T cells were treated with the SERCA pump inhibitor thapsigargin to 
pharmacologically induce store depletion, and Ca2+ responses were assessed.  As shown 
in Figure 3.5B, treatment with thapsigargin rescued the Ca2+ defect in HS1-deficient T 
cells, indicating that HS1, like Itk, is required for Ca2+ store release.   
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Figure 3.4:  The SH2 domain of Itk is required for recruitment of HS1 to the IS.   
A, Jurkat cells transfected with Itk suppression or control vectors were conjugated 
to CMAC-stained, SEE-loaded Raji B cells (blue) for 15 minutes.  Conjugates 
were fixed and stained for HS1 (red) or F-actin (green).  B, CD4+ T cells from 
HS1+/- or HS1-/- AND TCR transgenic mice were conjugated to CMAC-stained, 
MCC peptide-loaded CH27 B cells for 3 minutes and stained for Itk (red).  C, Itk-
suppressed or control Jurkat T cells conjugated to Raji B cells were scored for 
recruitment of HS1 to the cell-cell contact site.  D, Jurkat cells were transfected 
with expression vectors for wild-type, SH2 domain mutant (SH2m), or kinase-
dead (KD) Itk.  Conjugates were prepared and analyzed as in C.  Data in C and D 
represent averages of at least 50 conjugates from one representative experiment.   
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Figure 3.5:  HS1 is required for release of Ca2+ from intracellular stores.   
HS1 is required for release of Ca2+ from intracellular stores.  A, CD4+ T cells from 
HS1+/+ or HS1-/- mice were loaded with the Fura-2AM and plated on poly-L-lysine-
coated coverslips.  Immediately before TCR stimulation, the cells were superfused 
with Ca2+-free bath solution.  At the indicated time, cells were stimulated by the 
addition of anti-CD3 (500.A2) and analyzed by fluorescence microscopy to visualize 
a rise in cytoplasmic Ca2+ indicative of release from ER stores.  Extracellular Ca2+ 
was then added to visualize Ca2+ influx.  Right, an expansion of the Y-axis to 
visualize release from ER stores.  B, Cells prepared as in A were treated with 1 µM 
thapsigargin (Tg) and imaged as in A. 
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Previous studies have demonstrated that at least one Itk binding partner, SLP-76, can 
activate Itk kinase activity toward PLCγ1 (Bogin et al., 2007).  To ask if HS1 plays a 
similar role, T cells from wild-type and HS1-/- mice were stimulated with anti-CD3 for 
various times and the phosphorylation of PLCγ1 was analyzed by western blotting using 
site-specific antibodies.  As shown in Figure 3.6A, phosphorylation of PLCγ1 at tyrosine 
783 proceeded normally in the absence of HS1.  Phosphorylation at tyrosine 775 was also 
intact (data not shown).  Thus, we conclude that HS1 is not required for phosphorylation-
dependent activation of PLCγ1.  PLCγ1 activation is characterized not only by 
phosphorylation, but also by localization to the IS, in association with other components 
of the LAT signalosome (Braiman et al., 2006).  We therefore analyzed PLCγ1 
localization in wild-type and HS1-/- AND TCR transgenic T cells conjugated to MCC-
pulsed CH27 B cells.  As shown Figure 3.6B, PLCγ1 localized efficiently to the IS at 
early time points in both control and HS1-deficient T cells.  Time course analysis showed 
that wild-type cells were able to maintain PLCγ1 at the IS for 20 minutes, whereas HS1-/- 
cells showed significant loss of IS-associated PLCγ1 by 10 minutes.  This mirrors the 
defects we have previously observed for F-actin and Vav1 (Gomez et al., 2006).  
Nonetheless, given the rapid kinetics of Ca2+ store release relative to the defects we  
observed in PLCγ1 localization, the Ca2+ signaling defects we observe in HS1-deficient T 
cells cannot be explained by a gross failure to recruit PLCγ1 to the IS.   
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Figure 3.6:  HS1 is dispensable for PLCγ1 phosphorylation and early recruitment to 
the IS.   
A, T cells from HS1+/+ or HS1-/- mice were stimulated as indicated and lysates were 
analyzed by western blotting for PLCγ1 phosphorylated at Y783, total PLCγ1, and 
HS1.  B, CD4+ T cells from HS1+/- or HS1-/- AND TCR transgenic mice were 
conjugated to CMAC-stained, MCC peptide-loaded CH27 B cells (blue) and stained 
for PLCγ1 (red).  C,  The fraction of conjugates with PLCγ1 at the indicated times was 
determined. 
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The finding that sustained PLCγ1 localization to the IS depends on HS1 led us to 
examine earlier actin-driven aspects of PLCγ1 signaling in greater detail.  To ask if HS1 
functions to modulate PLCγ1 association with the cytoskeleton, we prepared insoluble 
actin-rich fractions from wild-type or HS1-/- T cells, and assessed the association of total 
and phospho-PLCγ1 with these fractions by western blotting.  In wild-type T cells, a 
fraction of PLCγ1 became associated with the cytoskeleton within 1 minute of TCR 
engagement (Figure 3.7A).  PLCγ1 continued to accumulate in the cytoskeletal fraction 
over the next five minutes (Figure 3.7B).  Importantly, this pool was enriched in 
phospho-PLCγ1 such that the vast majority of phospho-PLCγ1 was cytoskeletally 
associated (Figures 3.7A and 3.7C).  In contrast, little or no activation-induced 
cytoskeletal association of PLCγ1 was observed in lysates from HS1-/- T cells.  Although 
the experiment shown in Figure 7A shows increased phospho-PLCγ1 in the cytoskeletal 
fraction at 3 minutes in HS1-/- T cells, this result was not reproducible.  The significance 
of the insoluble pool of PLCγ1 remains to be defined; however, given that the 
phosphorylated pool of the molecule is thought to represent the active pool, it seems 
likely that cytoskeletal association is intimately linked with PLCγ1 function.  
Nonetheless, these results support the idea that HS1 affects PLCγ1 organization during 
early phases of TCR signaling. 
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Figure 3.7:  HS1 is required for PLCγ1 cytoskeletal association 
A, T cells from HS1+/+ or HS1-/- mice were stimulated as indicated, lysed in 
cytoskeletal stabilizing lysis buffer, and separated into cytosol-enriched supernatant 
and F-actin rich pellet fractions.  Fractions were analyzed by western blotting as 
indicated.  pPLCγ1 was detected using an antibody specific for PLCγ1 phosphorylated 
at Y783.   B, The amount of PLCγ1 in the pellet fractions at each time point was 
quantified and normalized to the amount of PLCγ1 in the pellet in unstimulated cells.  
Data represent averages from four independent experiments +/- SEM.  *, p<0.05.  C, 
The amount of PLCγ1 phosphorylated at Y783 in the pellet fractions at each time 
point was quantified and normalized to the amount of PLCγ1 phosphorylated at Y783. 
.the pellet in unstimulated cells. Data represent averages from four independent 
experiments +/- SEM.  *, p<0.05;  **, p<0.01. 
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To observe directly the effects of HS1 on PLCγ1 dynamics, we analyzed the 
formation of signaling microclusters in Jurkat cells expressing PLCγ1-eYFP during 
spreading on anti-CD3 coated coverslips.  In control cells, as reported previously 
(Braiman et al., 2006), PLCγ1 assembled into microclusters at the T cell-coverslip 
interface.  As spreading progressed, new microclusters were formed within actin-rich 
lamellipodial protrusions, near the edge of the spreading cell (Figure 3.8A).  HS1-
suppressed cells also formed microclusters, but these clusters were often disorganized 
and formed large aggregates (Figure 3.8B).  The formation of microclusters at the cell 
periphery was also impaired, presumably because HS1-deficient cells do not spread 
normally.  To assess this phenotype, individual microclusters were identified in video 
sequences, and pseudocolored in order of appearance.  As shown in Figure 3.8C, in 
control cells, microclusters were formed at distinct sites in a concentric fashion, with 
newer microclusters in the periphery.  In contrast, HS1-deficient T cells exhibited 
formation of new microclusters that overlapped with older ones, resulting in aggregates 
of mixed age (Figure 3.8D).  We assessed the size of these mixed aggregates in each cell 
at 90 seconds after contact with the coverslip.  As shown in Figure 3.8E, suppression of 
HS1 resulted in a two-fold increase in average microcluster size.  This increase in 
average size was attributable to an abnormally disparate size distribution.  As shown in 
Figure 3.8F, the vast majority of microclusters in control cells were less than 0.5 µm in 
diameter.  HS1-deficient cells also showed numerous small microclusters, but nearly half 
of the microclusters in these cells exceeded 0.5 µm, with some as large as 6 µm.  Since 
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peripheral microclusters are key sites for early TCR signaling events (Campi et al., 2005; 
Varma et al., 2006; Yokosuka et al., 2005), the defect in Ca2+ responses in HS1-deficient 
T cells may reflect a role for HS1 in controlling PLCγ1 signaling at the level of 
microcluster dynamics. 
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Figure 3.8:  HS1 regulates PLC1 microcluster dynamics 
  
A, Jurkat cells stably expressing PLCγ1-eYFP were transfected with empty vector, 
plated on coverslips coated with anti-CD3, and imaged by confocal microscopy.  
Selected images from one time-lapse series are shown; these correspond to 
Supplemental video 7.  B, Jurkat cells stably expressing PLCγ1-eYFP were transfected 
with HS1 suppression vector and analyzed as in A.  Selected images from one time-
lapse series are shown; these correspond to Supplemental video 9.  C and D,  PLCγ1 
microclusters in empty vector (C) or HS1-suppressed (D) T cells were identified and 
color coded by order of appearance, with newer microclusters colored orange and red, 
and older microclusters colored blue and green.  Left hand panels show cells from the 
sequences shown shown in A and B.  Right hand panels show additional examples.  E, 
The area of individual microclusters was determined at 90 seconds after the initiation 
of contact with the coverslip.  At least 20 cells were analyzed per condition, yielding 
approximately 400 microclusters each.  Data represent mean +/- SEM.   **, p<0.0001.  
F, The areas of individual microclusters from E were grouped into the indicated bins. 
The percent of total microclusters falling into each size category is shown. 
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Discussion 
Regulation of actin dynamics in T cells involves coordination of multiple actin 
regulatory proteins by upstream kinases including Lck, ZAP70, and c-Abl (Huang et al., 
2008; Lowin-Kropf et al., 1998; Morgan et al., 2001).  Itk has also been demonstrated to 
play a role in regulating T cell actin responses, but this function is independent of its 
kinase activity and instead requires its SH2 domain (Dombroski et al., 2005; Donnadieu 
et al., 2001; Grasis et al., 2003; Labno et al., 2003).  We show here that one role of the 
SH2 domain of Itk is to recruit HS1 to the IS.  Video analysis shows that T cells lacking 
Itk or HS1 have similar defects in actin reorganization downstream of TCR engagement.  
In contrast to T cells lacking WAVE2 or Arp2/3 complex components, which fail to 
extend actin-rich lamellipodial protrusions (Gomez et al., 2007; Nolz et al., 2006), T cells 
deficient for HS1 or Itk can extend these structures, but they are unstable and retract 
frequently.  This phenotype is consistent with in vitro studies showing that HS1 functions 
to stabilize existing branched actin filaments (Uruno et al., 2003b; Weaver et al., 2001).  
In addition to stabilizing actin filaments directly, HS1, like Itk, has been implicated in 
regulating the localization of Vav1 at the IS (Gomez et al., 2006).  Localization of Vav1 
to the IS requires an intact Itk SH2 domain (Dombroski et al., 2005).  Since Vav1 binds 
directly to HS1, this suggests that HS1 links Vav1 to Itk during T cell activation.  It is 
important to point out, however, that these proteins also interact with other signalosome 
components including LAT, SLP-76, and PLCγ1, such that loss of any one of these 
molecules disrupts interactions among the others and perturbs T cell actin responses 
(Bunnell et al., 2006).  Finally, there is evidence that the actin scaffolds generated by 
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these signaling molecules function to stabilize newly formed signaling complexes (Campi 
et al., 2005), thereby generating a positive feedback loop to facilitate T cell activation.  
We have mapped binding of the Itk SH2 domain to phosphotyrosines 378 and 397 
of HS1.  These residues are phosphorylated upon TCR engagement in a ZAP70-
dependent manner and are required for recruitment of HS1 to the IS and for its functions 
in actin remodeling and signaling to the Il2 promoter (Gomez et al., 2006).  Interestingly, 
these two tyrosines also serve as docking sites for Vav1 binding.  It is unclear whether 
one molecule of HS1 can bind simultaneously to Itk and Vav1.  This need not be the 
case, since multiple molecules of HS1 would be present in any given actin-associated 
signaling complex.  Although our in vitro data clearly indicate that HS1 and Itk associate 
via activation-dependent phosphotyrosine-based interactions, these two molecules can be 
co-immunoprecipitated constitutively from T cell lysates.  This constitutive interaction 
does not appear to involve the SH3 domain of either molecule.  This interaction can be 
explained, in part, by basal tyrosine phosphorylation of HS1, but it probably also involves 
mutual interactions of these proteins with other T cell signaling molecules.  Similar 
conclusions have been reached for other signalosome proteins, e.g. Itk and SLP-76 
(Jordan et al., 2008). 
In addition to their similarities with respect to actin dynamics, T cells lacking Itk 
or HS1 both have defects in Ca2+ store release (Gomez et al., 2006; Liu et al., 1998; 
Schaeffer et al., 1999).  In the case of Itk-deficient T cells, the defects in Ca2+ store 
release are well-studied and stem from the requirement for Itk-dependent phosphorylation 
of PLCγ1.  Since HS1 binds to Itk, we considered the possibility that HS1 binding 
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promotes Itk kinase activity, as has been documented for Slp76 and Itk (Bogin et al., 
2007).  However, HS1 appears to be dispensable for Itk kinase activity, since HS1-
deficient cells show normal kinetics and magnitude of PLCγ1 phosphorylation.  Based on 
these findings, we conclude that HS1 and Itk function to promote Ca2+ store release 
through distinct mechanisms.  While Itk phosphorylates PLCγ1 (Bogin et al., 2007), HS1 
appears to regulate PLCγ1 function by linking it to the actin cytoskeleton.  Interestingly, 
since Itk functions upstream of HS1 in the actin-regulatory pathway, this suggests that Itk 
may promote PLCγ1 activation in two ways: via its kinase activity and through SH2 
domain-mediated adaptor functions.  Further analysis will be required to test this idea and 
to address the interdependence of these two mechanisms. 
Consistent with this dual mode of PLCγ1 activation, Braiman et al. (Braiman et 
al., 2006) have shown that proper PLCγ1 function involves a complex interplay between 
phosphorylation and association with other signalosome components in signaling 
microclusters.  There is evidence in other cell types that PLCγ1 associates with the actin 
cytoskeleton, and this association can modulate PLCγ1 activity (Bar-Sagi et al., 1993; 
Nojiri and Hoek, 2000; Pei et al., 1996; Suzuki and Takahashi, 2001).  We now show that 
T cell activation induces partitioning of PLCγ1 into an F-actin rich fraction, and that the 
phosphorylated pool of PLCγ1 is enriched in this fraction.  HS1-/- T cells show impaired 
cytoskeletal association of PLCγ1.  Moreover, whereas control T cells spreading on anti-
CD3-coated surfaces show processive assembly of PLCγ1 microclusters near the 
periphery, HS1-deficient cells show disorganized microcluster assembly, with newly-
formed microclusters overlapping with older ones.  The simplest explanation for these 
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observations is that formation of new, active PLCγ1 microclusters is linked to formation 
of branched actin filaments at the periphery of spreading T cells.  Thus, in HS1-deficient 
cells, defects in stabilization of lamellipodial protrusions result in perturbation of 
processive microcluster assembly. 
It seems likely that the defects we observe in PLCγ1 dynamics underlie the 
defects in Ca2+ store release, and it will be interesting to explore the molecular 
mechanisms through which this occurs.  Recent studies have led to a paradigm in which 
microcluster dynamics are mechanistically linked to signal generation and extinction.  
According to this model, early TCR signaling events mostly take place in newly-formed 
peripheral microclusters.  Depending on the quality of the antigen, signaling can continue 
in centralized signaling complexes, but centralized complexes are ultimately subject to 
signal extinction via internalization and degradation (Balagopalan et al., 2007; Barr et al., 
2006; Cemerski et al., 2008; Lee et al., 2003).  Thus, the defects we observe in PLCγ1 
microcluster dynamics might result in aberrant signaling due to premature mixing with 
proteins responsible for signal extinction.  Alternatively, efficient TCR signaling may 
require the forces associated with myosin-based microcluster centralization (Ilani et al., 
2009; Varma, 2008).  If so, the spreading defects in HS1-deficient T cells may result in 
reduced PLCγ1 signaling as a result of diminished tension.  Finally, the observed defects 
in Ca2+ store release may arise as a result of altered cell geometry.  In a well-spread T 
cell, much of the endoplasmic reticulum is localized within a short distance of the cell 
surface, whereas in a poorly-spread T cell, the bulk of the endoplasmic reticulum is 
situated much further away. Since PLCγ1-induced IP3 production is very short-lived, 
 103 
typically peaking within a minute of TCR engagement (Olenchock et al., 2006), and 
activation of IP3 receptors is highly cooperative (Meyer et al., 1988), T cell spreading 
could serve to promote Ca2+ store release by bringing ER-associated IP3 receptors into 
proximity with sites of IP3 production.  Additional investigation will be required to test 
these possibilities and to explore in more general terms the importance of actin 
polymerization and cell spreading for T cell signaling. 
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Chapter 4: Analysis of T cells from HS1-/- mice 
 
Introduction 
 Mice with germline deletion of HS1 were described by the Watanabe lab in 1995 
(Taniuchi et al., 1995).  This report showed that HS1-/- mice have normal cellularity in all 
lymphoid organs.  A limited analysis of T cell development and peripheral T cell 
populations revealed no defects, although negative selection was shown to be impaired.  
However, these studies were limited in scope.  Thymocyte and peripheral T cell 
population analysis was limited to CD4 and CD8 staining.  Activation and memory 
markers were not examined, nor were regulatory T cells.  Functionally, T cells exhibited 
a mild defect in proliferative responses to anti-CD3, but effector T cell function was not 
tested.  These studies were conducted prior to the appreciation of HS1 as an actin 
regulatory protein.  Moreover, our understanding of T cell biology has advanced 
considerably since these studies were published.  In light of our data demonstrating that 
HS1 is important for T cell activation (Chapter 2), I have conducted an more extended 
analysis of the T cell compartment of HS1-/- mice, focusing primarily on responses to 
TCR engagement.  
I have conducted a more in-depth analysis of thymocyte development and 
peripheral T cell populations, and have confirmed that HS1 is not required for thymocyte 
development.  Peripheral T cell populations also appear normal in HS1-/- mice.  I have 
also tested responses to TCR engagement in several assays.  Although CTL function 
appears normal, loss of HS1 results in reduced IFNγ production and a decrease in the 
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development of TH1 cells accompanied by an increase in IL4-producing TH2 cells in 
vitro.  Several reports have described a role for cortactin, the non-hematopoietic homolog 
of HS1, in migration (Bryce et al., 2005; Huang et al., 1998; Kowalski et al., 2005; van 
Rossum et al., 2006).  Surprisingly, HS1 deficient T cells appear to home normally to 
lymphoid organs.  These data support a role for HS1 in specific TCR signaling pathways. 
 
Results 
Analysis of thymocyte development in HS1-/- mice 
HS1-deficient mice exhibit normal CD4 and CD8 single- and double-positive 
thymocyte populations and cell numbers (Taniuchi et al., 1995).  To verify and extend 
these observations, I analyzed thymocytes from wild-type and HS1-/- mice by flow 
cytometry.  There was no difference in the number of thymocytes isolated from either 
WT or HS1-/- mice.  Thymocytes were stained for CD4, CD8, CD44, and CD25 to 
analyze early development through the double-negative stages.  HS1-/- mice had normal 
percentages of single positive and double positive thymocytes (Figure 4.1a).  As shown 
in Figure 4.1b, the percentages of cells in the DN1 (CD4- CD8- CD44+ CD25-), DN2 
(CD4- CD8- CD44+ CD25+), DN3 (CD4- CD8- CD44- CD25+), and DN4 (CD4- CD8- 
CD44- CD25-) stages were comparable between WT and HS1-/- samples.  To examine 
NKT cell development, thymocytes were stained for CD3, CD4, CD8, and NK1.1.  
Comparable percentages of NKT cells were detected in WT and HS1-/- thymi (NK1.1+ 
CD4+ CD3+) (Figure 4.1c).  To examine the efficiency of signaling throughout thymocyte 
development, surface levels CD5 and CD69, both of which are upregulated in response to 
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TCR engagement, were examined and found to be comparable between WT and HS1-/- 
mice (Figure 4.1d and 4.1e).  In addition, CD3 levels were comparable  between WT and  
HS1-/- thymocytes (Figure 4.1f).  Taken together, these data show that HS1 is dispensable 
for thymocyte development. 
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Figure 4.1:  HS1 is not required for thymocyte development.   
Single-cell suspensions from WT or HS1-/- mice were stained for CD4 and CD8 and 
the indicated cell surface markers.  A, CD4 and CD8 expression on thymocytes.  B, 
Thymocytes stained for CD44 and CD25 were gated on CD4- CD8- double-negative 
cells to analyze early development.  C, Thymocytes stained for CD3 and NK1.1 were 
gated on CD4+ cells to analyze NKT cell development.  D, CD5 expression was 
analyzed at DN, DP, CD8SP and CD4SP stages.  E, CD3 expression was analyzed at 
DN, DP, CD8SP and CD4SP stages.  F, CD69 expression was analyzed at DN, DP, 
CD8SP and CD4SP stages. 
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Normal peripheral T cell populations in HS1 knockout mice 
To characterize the peripheral T cell compartment in HS1-/- mice, I began by 
conducting flow cytometry analysis.  Single cell suspensions were prepared from spleens 
and lymph nodes of WT and HS1-/- mice, and stained for CD4, CD8, CD25, CD69, 
CD44, and CD62L.  CD4+ T cells and CD8+ T cells were present at similar ratios in both 
WT and HS1-/- mice (Figure 4.2a), as reported previously (Taniuchi et al., 1995).  
Staining of CD44 and CD62L to distinguish naïve (CD44lo CD62Lhi) and memory 
(CD44hi CD62Llo) T cells revealed no difference between WT and HS1-/- mice (Figure 
4.2b).  Similarly, there was no difference in the fraction of freshly isolated T cells 
expressing the activation markers CD25 or CD69 (Figure 4.2c).  To determine if HS1 is 
required for regulatory T cell development, lymph node and spleen cells were stained 
with anti-CD4 and anti-CD25, then fixed, permeabilized, and stained with anti-FoxP3.  
Regulatory T cells (CD4+ CD25+ FoxP3+) were present at equal ratios in WT and HS1-/- 
mice (Figure 4.3). 
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Figure 4.2:  Normal peripheral T cell populations in HS1-/- mice.   
Single cell suspensions from spleens and lymph nodes were stained for CD4 
and CD8 and the indicated markers.  The percentage of cells in each gate is 
shown.  A, CD4 and CD8 expression.  B, Cells gated on CD4+ (top) or CD8+ 
(bottom) were analyzed for CD44 and CD62L expression.  C, Cells gated on 
CD4+ (top) or CD8+ (bottom) were analyzed for CD25 (left) and CD69 (right) 
expression. 
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Figure 4.3:  HS1 is not required for regulatory T cell development.   
Single cell suspensions from mesenteric lymph nodes, peripheral lymph nodes, 
spleens, and thymi from WT (top) or HS1-/- (bottom) mice were surface-
stained for CD4, CD8, and CD25, then fixed, permeabilized, and stained for 
FoxP3.  Treg were identified as CD25+ FoxP3+ cells within the CD4+ gate.  
The percentage of cells in each gate is shown.  Results are representative of 
two independent experiments. 
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HS1 in TH1/TH2 skewing 
CD4+ T cells respond to immunological challenge by differentiating into various 
effector subsets that secrete different sets of cytokines; each of these subsets is best suited 
to respond to a different type of infection (Schoenborn and Wilson, 2007).  TH1 cells 
secrete IFNγ and IL2, leading to the development of a cell-mediated immune response, 
which is required for the elimination intracellular pathogens such as viruses.  TH2 cells 
secrete IL4, IL5, and IL13, and promote the development of a humoral immune response, 
which promotes the clearance of intestinal helminths.   
Signaling through both cytokine receptors and through the TCR influences the 
decision to differentiate to the TH1 or TH2 lineage.  IL12 and IFNγ can lead to TH1 
differentiation, whereas IL4 promotes TH2 differentiation.  The strength of signal 
received through the TCR also influences the differentiation process: strong signals that 
promote robust, long-lived Ca2+ responses promote differentiation to the TH1 lineage, 
whereas weaker signals, such as those provided by partial agonists, tend to skew T cells 
to the TH2 lineage (Constant et al., 1995; Pfeiffer et al., 1995).  In light of our data 
showing defective Ca2+ responses in HS1-deficient cells (Chapter 2 and Chapter 3), we 
hypothesized that HS1-deficient T cells would be less likely to become TH1 cells and 
more likely to become TH2 cells following TCR engagement.  However, in Chapter 3, I 
describe a direct interaction between HS1 and Itk, which suggests an alternate possibility.  
Itk-/- T cells exhibit significant defects in vitro and in vivo (Fowell et al., 1999; Miller et 
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al., 2004; Schaeffer et al., 2001).  Together, these results suggest that HS1 deficiency 
may result in decreased TH2 skewing downstream of TCR engagement. 
To examine the role of HS1 in helper T cell differentiation and discriminate 
between the scenarios described above, CD4+ T cells from WT or HS1-/- mice were 
stimulated in vitro on plates coated with anti-CD3 and anti-CD28 for three days, then 
allowed to proliferate for four days.  Cells were then restimulated with PMA and 
ionomycin for four hours.  Brefeldin A was added for the last two hours of culture to 
prevent cytokine secretion.  Cells were then stained with anti-IFNγ and anti-IL4, and 
analyzed by flow cytometry.  As shown in Figure 4.4a, HS1-deficient cultures had a 
higher frequency of IL4-producing cells compared to WT and a lower frequency of IFNγ-
producing cells.  Although the fraction of cells that skewed to each population varied 
between experiments, HS1-deficient cells consistently exhibited significantly more TH2 
skewing than did WT cells.  These results support the first scenario described above, in 
which HS1, by promoting a strong Ca2+ response, promotes differentiation to IFNγ 
producing TH1 cells. 
IFNγ signaling plays a key role in the TH1 differentiation program by inducing 
production of the TH1-associated transcription factor Tbet (Lighvani et al., 2001; Mullen 
et al., 2001; Szabo et al., 2002).  Since NF-AT is involved in activation of the IFNg 
promoter (Lee et al., 2004; Schoenborn and Wilson, 2007; Sica et al., 1997; Sweetser et 
al., 1998), and HS1 deficiency results in reduced NF-AT activation (Chapter 2), I 
examined IFNγ production by ex vivo CD4+ T cells from WT or HS1-/- mice.  Cells were 
stimulated on plates coated with high (1 µg/ml) and low (0.1 µg/ml) doses of anti-CD3 
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and 1 µg/ml anti-CD28 for three days, after which supernatants were harvested and 
analyzed by ELISA for IFNγ production (Figure 4.4b).  At both high and low doses of 
anti-CD3, HS1-/- CD4+ T cells produced less IFNγ than WT CD4+ T cells. 
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Figure 4.4:  HS1-deficient T cells have defects in TH1 skewing and IFNγ  production.   
A, CD4+ T cells from WT or HS1-/- mice were stimulated on plates coated with the 
indicated concentration of anti-CD3 and 1 µg/ml anti-CD28 for three days.  Cells were 
then transferred to fresh plates and allowed to rest for four days.  Cells were 
restimulated with PMA and ionomycin in the presence of brefeldin-A, fixed, and 
stained for IFN-γ and IL-4, and analyzed by flow cytometry.  (Left), Representative 
flow cytometry plots.  The percentage of cells in each gate is shown.  (Right), 
Quantitation of triplicate samples showing the percent of cells that expressed either 
IFN-γ or IL4.  Error bars indicate +/- 1 standard deviation.  Results are representative 
of two independent experiments.  B, CD4+ T cells from WT or HS1-/- mice were 
stimulated for three days with plate-bound anti-CD3 and anti-CD28, and supernatants 
were assayed for IFN-γ by ELISA. 
 
 119 
Role of HS1 in cytotoxic T lymphocyte function 
Cytotoxic T lymphocytes (CTL) mediate adaptive immunity against intracellular 
pathogens such as viruses and tumors by lysing infected or malignant cells bearing the 
appropriate cognate antigen.  These cells are also a major source of IFNγ. 
To determine whether HS1 is required for CTL function, CTL were generated in 
vitro by stimulating CD8+ T cells isolated by negative selection from lymph nodes from 
WT or HS1-/- mice (C57Bl/6, H-2b) on plates coated with anti-CD3 and anti-CD28, in the 
presence of IL2.  After three days of stimulation, these cells were transferred to uncoated 
plates, and cultured in the presence of exogenous IL2 for 2-3 days.  WT and HS1-/- CTL 
were then assayed in vitro for cytotoxicity against allogeneic (H-2d) 51Cr-labeled P815 
target cells.  Target cell lysis was equivalent between WT and HS1-/- cells (Figure 4.5a), 
indicating that HS1 is not required for CTL function. 
CD8+ T cells produce substantial amounts of IFNγ upon TCR engagement (Szabo 
et al., 2002).  To determine if HS1 is required for IFNγ production by CD8+ T cells, WT 
or HS1-/- CD8+ T cells were stimulated using plate-bound anti-CD3 and anti-CD28 for 
three days.  As shown in Figure 4.5b, WT and HS1-/- CD8+ T cells produced equivalent 
amounts of IFNγ.  Thus, HS1 is not required for efficient IFNγ production by CD8+ T 
cells.  
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Figure 4.5:  HS1 is not required for CTL-mediated killing or IFNγ  production.   
 A, CTL generated in vitro from wild-type or HS1-/- C57Bl/6 mice were incubated 
with 51Cr-labeled P815 mouse mastocytoma cells at the indicated effector:target 
cell ratios.  Supernatants were harvested after 5 hours, transferred to a Luma plate, 
allowed to evaporate overnight, and measured using a TopCount scintillation 
counter.  Results are representative of two independent experiments.  B, CD8+ T 
cells from WT or HS1-/- mice were stimulated for three days with plate-bound anti-
CD3 and anti-CD28.  Supernatants were then assayed by ELISA for IFNγ content. 
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Activation-induced cell death 
Strong signaling through B cell or T cell antigen receptors induced by 
restimulation shortly after the initial activation of naïve lymphocytes leads to apoptosis 
through a process termed activation-induced cell death.  This process is important for the 
control of chronically activated T cells, and for downregulation of the immune response 
(Brenner et al., 2008). 
B cells in the peritoneal cavity of HS1-deficient mice are resistant to apoptosis 
induced by strong crosslinking of the B cell receptor (Taniuchi et al., 1995).  
Furthermore, two WEHI-231 B cell lines have been isolated that are strongly resistant to 
AICD.  These cells express low levels of HS1, and reexpression of HS1 rescues the death 
response in one of these lines (Fukuda et al., 1995).  Based on these findings, I asked if 
HS1-/- T cell blasts restimulated in vitro were sensitive to AICD. 
CD4+ T cells from the lymph nodes of WT or HS1-/- mice were stimulated on 
plate-bound anti-CD3 and anti-CD28 for 3 days, followed by an expansion phase of three 
days in fresh culture plates in the presence of exogenous IL2.  T cells were then 
harvested, and restimulated on plates coated with varying concentrations of anti-CD3 or 
left unstimulated.  After eight hours, cells were harvested, stained with Annexin-V to 
detect cells undergoing apoptosis and 7-AAD to detect dead cells, and analyzed by flow 
cytometry.  As shown in Figure 4.6, WT and HS1-/- T cells were equally sensitive to 
AICD at all doses tested.  These data demonstrate that HS1 is not required for AICD in 
mature T cells. 
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Figure 4.6:  HS1 is not required for AICD in T cells.   
WT or HS1-/- CD4+ T cell blasts were stimulated on plates coated with the indicated 
concentrations of anti-CD3 for eight hours, the harvested, and stained with anti-CD4, 7-
AAD, and Annexin-V.  A, Representative flow cytometry plots.  B, The percent specific 
cell death was calculated as
€ 
1− % Livetreated% Liveuntreated
×100 .  Results are representative of two 
independent experiments. 
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TCR Internalization 
After stimulation, TCRs are internalized via clathrin-coated pits (Dietrich et al., 
1994; Schneider et al., 1999) and degraded via a lysosomal pathway (Valitutti et al., 
1997).  TCR internalization, an actin dependent process (McGavin et al., 2001) is a 
critical for the regulation of T cell responses (Ferber et al., 1994; Geisler, 2004; 
Naramura et al., 2002; Schonrich et al., 1991; Viola and Lanzavecchia, 1996; Zanders et 
al., 1983).  The HS1 homolog cortactin, in conjunction with CD2AP and dynamin family 
members, is a critical component of the clathrin-dependent endocytic pathway (Cao et al., 
2003; Lynch et al., 2003).  T cells deficient for CD2AP have severe defects in TCR 
endocytosis after antigen encounter, and as such are hyperresponsive (Lee et al., 2003). 
Based on these observations, I asked whether HS1 is required for TCR 
endocytosis.  AND TCR transgenic CD4+ T cells derived from WT or HS1-/- mice were 
stimulated in vitro with CH27 B cells loaded with varying concentrations of MCC88-103 
for 10 minutes to 3 hours.  Conjugates were then harvested, stained with anti-Vα11, the α 
chain of the AND TCR, and analyzed by flow cytometry.  As shown in Figure 4.7, T 
cells lacking HS1 were able to downregulate surface TCR at rates equivalent to WT T 
cells, and responded equally well to high and low doses of peptide.  These data suggest 
that HS1 does not play a role in downregulation of surface TCR upon stimulation. 
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Figure 4.7:  HS1 is not required for TCR internalization.   
T cells from WT or HS1-/- AND TCR transgenic mice were stimulated with CD27 
B cells loaded with 0.3 or 10 µM MCC88-103 peptide for ten minutes to three hours, 
as indicated.  Cells were stained for CD4 and Vα11, and analyzed by flow 
cytometry.  (A), Representative flow cytometry plots.  (B), TCR internalization 
was calculated as the percent MFI remaining, compared to unstimulated cells. 
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Normal homing of HS1-/- T cells to lymphoid organs 
Several studies have identified a role for cortactin, the non-hematopoietic 
homolog of HS1, in cell migration (Lai et al., 2009; Patel et al., 1998).  Actin regulatory 
proteins such as WASp and WIP, which constitutively interact, play important roles in 
lymphocyte migration (Gallego et al., 2006; Haddad et al., 2001).  Therefore, we asked if 
HS1 is required for T cell homing to lymphoid organs.  Single-cell suspensions from 
lymph nodes and spleens from WT or HS1-/- mice were labeled with either CFSE or 
TRITC, and injected at a 1:1 ratio into WT C57BL/6 recipients.  Injected cells were 
allowed to migrate overnight, after which recipients were euthanized.  Liver, lungs, 
blood, spleen, and peripheral and mesenteric lymph nodes were analyzed by flow 
cytometry for the presence of labeled injected T cells.  As shown in Figure 4.8, WT and 
HS1-/- cells were able to home equally well to all tissues examined, suggesting that HS1 
is dispensable for T cell homing to lymphoid organs in the absence of an inflammatory 
response. 
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Figure 4.8:  HS1 is not required for naïve T cell migration to lymphoid organs.   
Single cell suspensions from spleens and lymph nodes of WT or HS1-/- mice were 
stained with CFSE (WT) or TRITC (HS1-/-) and mixed at a 1:1 ratio.  2x107 cells were 
injected into each WT recipient.  A small sample of input cells was saved as a control 
for variation in WT:HS1-/- ratios.  After twenty-four hours, recipients were sacrificed, 
and tissues were harvested, stained for CD4 and CD8, and analyzed by flow 
cytometry.   (A), Representative flow cytometry plots.  (B), Homing index was 
calculated according to the following equation:  
€ 
(%WT /%KO)in tissue
(%WT /%KO)input
 .  Data are 
representative of two independent experiments.  
 
 131 
 
Discussion 
Although HS1 seems to be important for efficient TCR signaling in mature T 
cells, the TCR signaling pathways that promote thymocyte maturation seem to be 
independent of HS1.  Alternatively, thymocyte signaling might be impaired only to the 
extent that negative selection is reduced, as described in (Taniuchi et al., 1995).  It may 
be that positive selection is also impaired in the absence of HS1, such that the TCR 
repertoire is skewed towards a more auto-reactive set.  However, we have not observed, 
and have not seen any reports detailing, a tendency towards autoimmune disease in HS1-/- 
mice.  If selection is altered in HS1-/- thymocytes, it may be that additional contributing 
factors are necessary to initiate an autoimmune response.  To that end, it might be 
interesting to breed HS1-/- mice to a model of autoimmunity (e.g., SLE1/2/3) to examine 
changes in the kinetics of development or magnitude of autoimmune disease. 
 Peripheral T cell populations also appear normal in HS1-/- mice, in 
agreement with the finding that HS1 is dispensable for T cell development.  Although 
regulatory T cell development appears normal, these cells may exhibit reduced function.  
WASp is not strictly required Treg development, several studies have now established 
that Treg from WASp-/- mice and from WAS patients are functionally impaired, leading 
to an increased risk of autoimmune disease (Adriani et al., 2007; Humblet-Baron et al., 
2007; Maillard et al., 2007; Marangoni et al., 2007).  This may be independent of the 
actin-regulatory function of these proteins, because WT Treg do not efficiently 
polymerize actin at the IS.  
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Negative selection in HS1-/- mice was originally studied in the HY TCR 
transgenic system, in which T cells specific for the male antigen are deleted in male mice.  
Expression of TCRα occurs abnormally early in this model system, leading to aberrant 
thymocyte development and selection.  Expression of the HY TCR α chain during the DP 
stage promotes a development and selection pattern that more closely reflects that seen in 
WT C57BL/6 mice (Baldwin et al., 2005).  Thus, the negative selection phenotype in 
HS1-/- mice may have been overstated.  To address this issue, negative selection could be 
studied in a superantigen model system, in which the presence of endogenous 
superantigens leads to the deletion of thymocytes expressing specific Vβ chains (Jordan 
et al., 2008).  Thymocyte CD5 levels correlate directly with TCR signal strength (Azzam 
et al., 1998).  That I did not observe alterations in CD5 levels at any stage of development 
suggests that HS1 does not affect thymocyte signal strength. 
Of all the phenotypes examined, the most striking is a significant decrease in the 
development of IFNγ-producing cells after in vitro stimulation.  The reason for a defect in 
TH1 differentiation in vitro in HS1-/- T cells is not clear.  Several possibilities exist.  HS1-
deficient T cells exhibit a defect in Ca2+ signaling (Chapters 2 and 3).  As discussed 
above, reduced Ca2+ signaling is associated with TH2 responses.  Stimulation of naïve T 
cells leads to the Ca2+-dependent activation of the NF-AT transcription factor, which is 
partly responsible, in concert with NFκB and AP1, for the activation of the IL2 and IFNg 
promoters (Schoenborn and Wilson, 2007).  The Ca2+ signaling defect leading to reduced 
NF-AT activation in HS1-/- T cells (Chapter 2) may lead to reduced production of IFNγ; 
this, in turn, may reduce the efficiency with which HS1-/- T cells differentiate to TH1 
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cells.  Differentiated TH1 cells, due to their higher usage of the Ca2+ signaling pathway 
(Sloan-Lancaster et al., 1997), may also be more dependent on HS1 for TH1 recall 
responses.  That is to say, HS1-deficient T cells may be able to differentiate to the TH1 
lineage normally, but may fail to produce IFNγ normally upon restimulation.  However, 
this scenario is less likely because to measure detect intracellular cytokines, cells were 
restimulated with PMA and ionomycin, which stimulate components downstream in the 
signaling cascade compared to where HS1 is thought to act. 
HS1 is required for efficient IFNγ production by freshly isolated CD4+ T cells 
(Figure 4.4).  Recent mathematical modeling studies have suggested that IFNγ is key to 
the initiation of TH1 differentiation by inducing expression of the TH1-associated 
transcription factor Tbet (Schulz et al., 2009).  Thus, without additional signals from 
other cells (e.g., cytokine signals derived from APCs or other bystander cells), inefficient 
IFNγ production by HS1-/- T cells in response to TCR and CD28 ligation may lead to 
inefficient differentiation to the TH1 lineage.  HS1 is required for full activation of the 
NF-AT and NF-κB transcription factors downstream of TCR engagement (Chapter 2 and 
(Gomez et al., 2006)), both of which are involved in transcription of the IFNg gene 
(Schoenborn and Wilson, 2007; Sica et al., 1997).  It would therefore be important 
directly characterize the activation of the IFNg promoter with respect to these as well as 
other key transcription factors in HS1-/- cells. 
Other actin regulatory proteins have been shown to influence helper T cell 
skewing and cytokine production.  CD4+ T cells from Wiskott-Aldrich syndrome patients 
exhibit severe defects in TH1 cytokine production in response to TCR stimulation, even 
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after culture in a TH1 skewing environment (Trifari et al., 2006).  These cells, as well as 
CD4+ T cells from WASp-/- mice (Cannon and Burkhardt, 2004) exhibit defects in NF-
AT nuclear translocation and maintenance.  This stands in contrast to T cells lacking 
Vav1, which preferentially produce TH1-associated cytokines at the expense of TH2 
cytokines (Tanaka et al., 2005).  Disruption of the WAVE2 complex through loss of 
Hem1 leads to normal IFNγ production, but substantially increased production of IL17 
These varied effects underscore the complexity of the signaling pathways leading to 
cytokine production and differentiation. 
Ultimately, it will be important to test how well HS1-/- mice respond to immune 
challenge using a variety of models.  The original report describing the HS1-/- mice 
demonstrated normal antibody responses to the T-dependent antigen NP-chicken 
gammaglobulin, but slightly reduced responses to the T-independent antigen TNP-Ficoll 
(Taniuchi et al., 1995).  These experiments suggest that B cell function in vivo is not 
grossly impaired.  HS1-/- CD4+ T cells produce less IFNγ upon initial stimulation, and are 
less likely to become IFNγ-producing TH1 effector cells, compared to WT CD4+ T cells.  
Therefore, it will be interesting to test how well these mice respond to pathogens, such as 
L. major, that require a robust TH1 response for clearance.  The reduction in TH1 cells 
accompanies an increase in the frequency of IL4-producing TH2 cells.  This may result in 
improved clearance of TH2 pathogens, but may also increase susceptibility to TH2-
mediated disease, such as allergy, asthma, and colitis.  Therefore, testing reactions to 
these conditions would also help determine if HS1 is a factor in these diseases.  A role for 
HS1 has not been described in other leukocytes.  However, studies in progress in our lab 
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suggest that antigen presentation by dendritic cells requires HS1.  Thus, any in vivo 
studies would require careful design and interpretation.  These may involve use of 
adoptive transfer experiments to generate and study mice that lack HS1 in specific cell 
types. 
The data presented here suggest that HS1 is dispensable for CTL killing.  In 
contrast, the Cooper lab has reported that human NK cell lines lacking HS1 fail to kill 
target cells, likely due to defects in NK-target cell conjugate formation (Butler et al., 
2008).  Although it is possible that the discrepancy between my data and those of the 
Cooper lab are attributable to the species difference, it is more likely that they are due to 
differences between the way T cells and NK cells employ the actin regulatory machinery.  
Indeed, the Wülfing group has shown that mild disruption of actin dynamics using low 
doses of jasplakinolide impairs the ability of NK cells, but not CTL, to kill target cells 
(Wulfing et al., 2003).  The reason for this apparent difference in sensitivity to actin 
disruption between CTL and NK cells is unclear.  The signals downstream of the TCR 
may be more robust (i.e., less sensitive to mild perturbations) compared to those 
downstream of NK cell activating receptors.  These studies were conducted using high-
dose peptide for P14 TCR transgenic CTL or high dose anti-CD3 for polyclonal CTL.  
Perhaps studies using lower dose or weaker agonists might uncover a situation in which 
CTL are sensitive to mild disruptions of actin dynamics or loss of HS1. 
My data suggest that HS1 is not required for T cell AICD.  This stands in contrast 
to the finding that HS1-deficient WEHI-231 cells (Fukuda et al., 1995) and peritoneal B 
cells (Taniuchi et al., 1995) are resistant to AICD.  The reason for the apparent difference 
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between B and T cell requirements for HS1 in AICD is not known; however, in addition 
to differences in the signaling pathways between the two cell types, it is possible that the 
different experimental approaches contribute.  The B cell experiments described by 
(Taniuchi et al., 1995) were conducted in vivo, whereas my studies were conducted by in 
vitro stimulation of CD4+ T cell blasts.  Alternatively, HS1 may play a role in AICD only 
at certain developmental stages.  WEHI-231 cells are an immature B cell line, 
representing a stage at which B cells undergo negative selection—strong signaling 
through the B cell receptor induces apoptosis to eliminate autoreactive B cells.  Similar to 
this, HS1-/- mice exhibit a defect in negative selection of thymocytes in the HY TCR 
transgenic system (Taniuchi et al., 1995).  Together with data presented here, this 
suggests that the role of HS1 in AICD is limited to its role in facilitating antigen receptor 
signaling in developing lymphocytes.   
 Several studies have demonstrated that cortactin interacts with 
components of the endocytic machinery, including Dynamin 2 and CD2AP, and have 
shown a requirement for these interactions in endocytosis (Cao et al., 2003; Lynch et al., 
2003; McNiven et al., 2000; Sauvonnet et al., 2005).  Moreover, preliminary data from 
our laboratory have demonstrated a role for HS1 in receptor-mediated endocytosis in 
dendritic cells (not shown).  It was therefore surprising to find that T cells lacking HS1 
downregulate surface TCR normally.  These experiments were conducted on T cells 
homozygous for the AND transgene.  Therefore, it is possible that developmental 
abnormalities resulting from premature TCR expression in developing thymocytes 
compensate for the lack of HS1 in these cells.  These studies should be repeated on T 
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cells hemizygous for the AND transgene, or on polyclonal T cells to rule out the 
possibility that these data are artifactual.   
Jurkat cells depleted of Dynamin 2 by RNAi internalize surface TCR normally 
after antibody stimulation, in spite of a severe defect in antigen receptor-induced actin 
polymerization at the IS.  The authors suggest that a more physiological stimulus (i.e., 
peptide/MHC) might reveal a role for Dynamin 2 in TCR internalization (Gomez et al., 
2005).  Together with my results, these data suggest that the endocytic machinery 
responsible for downregulating surface TCR upon antigen encounter differs from the 
cortactin/dynamin system found in other cell types. 
Data presented here demonstrate that HS1 is not required for homing to lymphoid 
organs (Figure 4.7).  This is somewhat surprising, considering abundant data in non-
hematopoietic cell types demonstrating that cortactin is important for regulating cell 
migration (Huang et al., 2008; Lai et al., 2009; Patel et al., 1998; van Rossum et al., 
2006).  Moreover, in NK cells, HS1 is required for efficient chemotaxis to SDF-1α, a 
CXCR4 ligand, and for LFA1-mediated adhesion (Butler et al., 2008).  More work is 
necessary to determine whether HS1 is important for chemokine receptor or integrin 
function in T cells.   
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Chapter 5: Discussion 
 
Summary 
Regulation of cytoskeletal dynamics is a key component of T cell activation.  
Early experiments showed that disruption of actin filaments using pharmacological 
agents can severely impair several aspects of T cell function.  This includes interaction 
with APCs, early signaling events, cytokine production, and killing of target cells by 
CTL.  Mutation in actin regulatory proteins can result in disease, as highlighted by the 
severe the immunodeficiency Wiskott-Aldrich syndrome.  More recently, investigators 
have begun to tease apart the role and regulation of the actin cytoskeleton in lymphocytes 
by examining the contributions of individual actin regulatory proteins.   
We have examined the role and regulation of HS1 in T cell activation, under the 
hypothesis that efficient signal transduction downstream of the TCR would depend on 
HS1.  HS1 is a hematopoietic lineage-restricted protein that undergoes tyrosine 
phosphorylation upon immunoreceptor ligation.  It has been shown to regulate the actin 
cytoskeleton through Arp2/3 complex.  Our data show that HS1 is important for the 
stabilization of F-actin-rich structures, and that it acts as an adaptor protein that can 
interact with multiple signaling molecules upon T cell activation.  HS1 interacts directly 
with Vav1 and stabilizes it at the IS.  HS1 recruitment to the IS depends on Itk, with 
which it also interacts directly.  We show that HS1-deficient T cells have defects in IL2 
production stemming from inefficient Ca2+ responses.  This is likely to be due to 
regulation of PLCγ1 cytoskeletal association and microcluster dynamics by HS1. 
 139 
We have also examined the role of HS1 on other aspects of T cell function using 
HS1-/- mice.  Thymocyte development proceeds normally, and peripheral T cell 
populations are grossly normal based on their expression of characteristic cell-surface 
markers.  HS1-/- CD8+ T cell function appears to be normal, but HS1-/- CD4+ T cells 
exhibit defects in IFNγ production upon initial TCR stimulation, and are subsequently 
less likely to become IFNγ-producing TH1 effector cells.  Here, I discuss the overall 
significance of these data and potential new avenues for research. 
 
Why does T cell development proceed normally in the absence of HS1? 
 The loss of HS1 in mice does not result in any detectable perturbations in T cell 
development or in peripheral populations (Chapter 4).  Moreover, HS1-/- mice do not 
develop any detectable autoimmune disease that would suggest significant defects in 
negative selection.  Developing thymocytes pass through several developmental 
checkpoints that require TCR signaling, yet HS1 is seemingly dispensable for these 
processes.  Another actin regulatory protein that is essential for T cell activation, WASp, 
also appears to be dispensable for thymocyte development (Snapper et al., 1998).  It is 
not known why these proteins, which are essential for efficient signaling in peripheral T 
cells, are seemingly dispensable for thymocyte development.  It may be that the signaling 
pathways in mature T cells in which these proteins participate are different in developing 
thymocytes. 
 In addition to differences in signaling pathways between mature and developing T 
cells, compensatory mechanisms may be at play:  one actin regulatory protein may offset 
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the loss of another.  It is possible that thymocytes express low levels of cortactin, which 
might compensate for loss of HS1.  However, we have not detected cortactin mRNA in 
WT or HS1-/- T cells or in mouse thymus (Chapter 2 and (Gomez et al., 2006)).  
Compensation between homologous proteins has been demonstrated for WASp.  
Although mice lacking either WASp or N-WASp exhibit normal thymocyte 
development, loss of both proteins results in severe defects in thymocyte development 
and function (Cotta-de-Almeida et al., 2007).  Compensation may also exist between 
non-homologous proteins.  It is possible that the activity of WASp masks a role for HS1 
in thymocyte development, and vice-versa.  To resolve these issues, it would be 
necessary to generate HS1-/- x WASp-/- mice.  It seems likely that such a model would 
reveal cooperativity or compensation between the two proteins. 
 In chapter 3, I discuss a direct biochemical and functional interaction between 
HS1 and Itk in the pathway leading to actin polymerization.  This leads one to ask if 
HS1-deficient T cells or mice resemble Itk-deficient T cells or mice in other respects.  Itk 
deficiency results in the abnormal development of memory-like CD8+ T cells in the 
periphery and deficient CD8+ T cell responses (Atherly et al., 2006a; Atherly et al., 
2006b; Broussard et al., 2006; Hu et al., 2007).  HS1 deficiency does not result in the 
development of these abnormal cells (Chapter 4).  Moreover, Itk is required for efficient 
TH2 responses (Fowell et al., 1999; Miller et al., 2004), whereas HS1 is required for 
efficient TH1-associated cytokine production (Chapter 4).  These results highlight the 
complexity of T cell signaling pathways.  Although we can detect a constitutive 
interaction between HS1 and Itk in T cell blasts, the phenotypic differences between  
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HS1-/- and Itk-/- mice and T cells make it clear that they participate in different aspects of 
T cell function.   
 
How does HS1 influence helper T cell differentiation? 
We have found that HS1-/- T cells produce reduced amounts of IFNγ, and 
subsequently are less likely to become TH1 effector cells, compared to WT T cells 
(Chapter 4).  Signals that induce potent Ca2+ responses favor differentiation to TH1 cells, 
whereas signals associated with weak Ca2+ responses, such as altered peptide ligands or 
low peptide dose, tend to favor the development of TH2 cells (Constant et al., 1995; 
Pfeiffer et al., 1995).  Moreover, prolonged NF-AT activity has been associated with 
increased IFN-γ production and a concomitant decrease in IL4 production (Porter and 
Clipstone, 2002).  Thus, by promoting increased Ca2+ flux responses (Chapter 2 and 
Chapter 3) and therefore sustained NF-AT activity, HS1 may influence IFNγ production, 
and thus helper T cell differentiation.  Thus, in this context, HS1 may function, at least in 
part, by modulating signal strength.  Although this work has not addressed whether the 
effect of HS1 on IFNγ production and helper T cell differentiation involves its role in 
regulating actin dynamics, this seems likely to be the case.  Disruption of actin dynamics 
using cytochalasin D results in decreased IFNγ production.  The effect is most 
pronounced when the drug is added 10-60 minutes after APC encounter and is 
substantially blunted when added later (Valitutti et al., 1995).    
 Our work with Vav1 (Chapter 2) and PLCγ1 (Chapter 3) shows that HS1 is 
important for the organization of signaling molecules at the IS downstream of TCR 
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engagement.  In Chapter 4, I show that HS1 is required for the efficient development of 
IFNγ-producing TH1 cells.  Work from the Glimcher group has demonstrated a 
correlation between cytokine receptor localization to the IS and helper T cell 
differentiation (Maldonado et al., 2004).  The IFNγ receptor, but not the IL4 receptor, 
localizes to the IS upon TCR engagement.  The IFNγ receptor is more likely to 
redistribute to the IS in T cells isolated from TH1-prone C57Bl/6 mice than in T cells 
from TH2-prone BALB/c mice.  Moreover, this process is can be inhibited by the addition 
of IL4.  More recent work from this group has extended these findings to signaling events 
downstream of the IFNγ receptor:  STAT1 localization mirrors that of IFNγ receptor and 
IL4 signaling impairs this process (Maldonado et al., 2009).  The signaling and cell 
biological mechanisms that control IFNγ receptor redistribution have not been elucidated.  
However, it is conceivable that actin-dependent processes regulate the localization of 
cytokine receptors and downstream signaling molecules.  Although a decrease in IFNγ 
production associated with loss of HS1 is likely to contribute to the observed reduction in 
the development of IFNγ producing effector cells, abnormal IFNγ receptor redistribution 
may also play a role.    
 IFNγ is preferentially secreted into the immunological synapse, whereas IL4 
secretion appears to be multidirectional (Huse et al., 2006).  The mechanisms controlling 
cytokine secretion are not well understood.  However, actin-dependent processes may 
contribute to these events: WASp is required for IFNγ secretion, but not for its production 
(Morales-Tirado et al., 2004).  This suggests that a defect in secretion of IFNγ by freshly 
isolated HS1-/- T cells may underlie the phenotype observed by ELISA (Chapter 4).  It 
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should be noted that this hypothesis is not mutually exclusive with the idea that HS1 
regulates IFNγ at the level of promoter activation.   
 
Is there a role for HS1 in endocytosis? 
We have found that HS1 is dispensable for TCR internalization following APC 
encounter (Chapter 4).  It has been shown that TCRs are internalized via clathrin-coated 
vesicles (Boyer et al., 1991; Telerman et al., 1987).  This involves the phosphorylation of 
clathrin heavy chain (Crotzer et al., 2004), a process implicated in clathrin-mediated 
endocytosis (Stoddart et al., 2002; Wilde et al., 1999).  T cells lacking CD2ap, a 
component of the endocytic machinery, exhibit substantial defects in TCR internalization 
(Lee et al., 2003).  In contrast, Jurkat cells suppressed for Dynamin 2, another component 
of the endocytic machinery, downregulate surface TCR normally (Gomez et al., 2005).  
Cortactin has been shown to interact with these components of the endocytic machinery 
and to be required for efficient endocytosis (Cao et al., 2003; Lynch et al., 2003; 
McNiven et al., 2000; Sauvonnet et al., 2005).  Moreover, preliminary data from our lab 
has demonstrated a requirement for HS1 in receptor-mediated endocytosis in dendritic 
cells (not shown).  It is therefore surprising that HS1 is not required for TCR 
internalization.  It may be that a protein other than HS1 fulfills the role of cortactin in 
endocytosis in T cells.   
Even if it is dispensable for TCR endocytosis, HS1 may play a role in the 
internalization of other surface receptors, e.g., the IL2 receptor.  In a system involving 
ectopic expression of the β chain of the IL2 receptor (IL2Rβ, CD122) in an epithelial cell 
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line, it was found that cortactin, together with dynamin, is required for IL2Rβ 
internalization in a clathrin-independent manner (Grassart et al., 2008).  The same group 
also found that endocytosis of the common gamma chain (γc), a component of the IL2, 
IL4, IL7, IL9, IL15, and IL21 receptors, requires cortactin (Sauvonnet et al., 2005).  
Because these studies were conducted in a cell line that does not normally express these 
receptors, it would be necessary to validate these results in a more physiologically 
relevant system, and to determine if HS1 plays a similar role. 
 
Why is CTL function independent of HS1? 
 Given the role of HS1 in efficient IFNγ production in CD4+ T cells, it is striking 
that HS1 is not required for production of IFNγ in CD8+ T cells.  Similarly, considering 
work showing a requirement for actin in cytotoxicity (Cerottini and Brunner, 1972; 
O'Rourke et al., 1991; Plaut et al., 1973; Wulfing et al., 2003), it is surprising that HS1-/- 
CTL kill target cells efficiently (Chapter 4).  In CD4+ T cells, IFNγ production and 
differentiation to the TH1 lineage, as well as killing by NK cells, depend on the 
transcription factor T-bet (Mullen et al., 2001; Szabo et al., 2002).  In contrast, IFNγ 
production and killing by CD8+ T cells instead relies on the related transcription factor 
Eomesodermin (Pearce et al., 2003).  Given that I find a defect in IFNγ production only 
in CD4+ T cells and no defect in killing by HS1-/- CD8+ T cells, it is possible that HS1 
may be required for the induction of T-bet but not Eomesodermin.  No role for HS1 in 
cytokine production by NK cells has been described. 
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 Pharmacological studies have demonstrated that the actin cytoskeleton is 
important for cytotoxicity (Cerottini and Brunner, 1972; O'Rourke et al., 1991; Plaut et 
al., 1973; Wulfing et al., 2003).  However, in these studies, inhibition of CTL-mediated 
killing required relatively high drug doses.  Interestingly, Wülfing et al. showed that 
killing by NK cells, but not by CD8+ T cells, is sensitive to low doses of jasplakinolide, a 
drug that stabilizes branched actin filaments (Wulfing et al., 2003).  Our data show that 
HS1 is not absolutely required for actin polymerization in T cells, and instead primarily 
functions to stabilize existing F-actin (Chapter 2).  HS1 deficiency results in defects in 
cytotoxicity in NK cells (Butler et al., 2008).  Moreover, while NK cells from WAS 
patients exhibit clear defects in cytotoxicity (Orange et al., 2002), no such defect has 
been reported for CTL.  No clear explanation has arisen for this difference between T 
cells and NK cells.  While our data suggest that HS1 deficiency results in unstable 
immunological synapses, it has been shown that CTL can kill efficiently even in the 
absence of a stable IS (Purbhoo et al., 2004).  While IS organization may be important for 
signaling events, taken together, all these studies point to fundamental differences in the 
cell biology of CTL and NK cell killing.  This is an area that warrants future study. 
 
Is there a role in T cells for HS1 in integrin or chemokine receptor 
function? 
In addition to describing a role in NK cell-mediated cytotoxicity, the Cooper lab 
study has implicated HS1 in NK cell adhesion and migration processes (Butler et al., 
2008).  This study showed that HS1-deficient NK cells exhibit defects in adhesion to 
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target cells and in migration to CXCL12 (SDF1α), a CXCR4 ligand.  Moreover, several 
studies have implicated cortactin in migration of non-hematopoietic cells (Bryce et al., 
2005; Huang et al., 1998; Kowalski et al., 2005; van Rossum et al., 2006).  Our 
laboratory has also shown that the tyrosine kinase c-Abl, which can interact with HS1 in 
T cells, is required for chemokine-induced migration (Huang et al., 2008).  In contrast to 
these results, data presented in Chapter 4 indicate that HS1 is not required for homing of 
T cells to lymphoid organs.  Moreover, although we have not conducted a systematic 
analysis of adhesion responses in HS1-deficient T cells, we have never detected a 
requirement for HS1 in T cell adhesion to APCs (not shown).   
Homing of naïve T cells to lymph nodes depends on CD62L (L-selectin), the 
chemokine receptors CCR7 and possibly CXCR4, and LFA-1 (αLβ2) and α4β7 integrins 
(Bradley et al., 1994; Forster et al., 2008; Marelli-Berg et al., 2008).  The signaling 
pathways downstream of chemokine receptors are poorly understood, although CXCL12 
binding to CXCR4 induces tyrosine phosphorylation of cortactin (Luo et al., 2006).   
It is therefore surprising that HS1 does not appear to be required for naïve T cell 
migration through lymphoid tissues.  In addition to using NK cells, the Cooper lab studies 
were conducted in vitro, which contrasts with the in vivo studies presented here.  
Differences in cell type and experimental methodology, as well as the developmental 
stage of the cells used, may account for some of these discrepancies.  Effector T cells use 
a different set of chemokine receptors to enter sites of inflammation (Marelli-Berg et al., 
2008), and HS1 may function specifically in this context.  It will therefore be important 
to test the role of HS1 in migration to sites of inflammation. 
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How is HS1 function regulated downstream of TCR engagement? 
 One of the first identified features of HS1 was its prominent tyrosine 
phosphorylation upon antigen receptor engagement (Hata et al., 1994; Takemoto et al., 
1995; Yamanashi et al., 1993).  We have shown that HS1 is phosphorylated in Jurkat 
cells at Tyr 378 and Tyr 397, most likely by ZAP-70 (Chapter 2 and (Gomez et al., 
2006)).  Mutation of these sites prevents Itk-dependent recruitment of HS1 to the IS and 
prevents HS1-dependent downstream signaling (Chapters 2 and 3).  Because these 
tyrosines mediate binding to a host of signaling molecules, it seems unlikely that 
defective Itk-dependent IS recruitment is the sole cause of the signaling defects in cells 
expressing a variant of HS1 with TyrPhe mutations at these sites. 
 High-resolution video microscopy studies have demonstrated that signaling 
molecules are rapidly recruited to microclusters at sites of TCR engagement (Bunnell et 
al., 2002; Bunnell et al., 2006; Yokosuka et al., 2005).  The cell spreading process that 
accompanies T cell activation, as well assembly of these signaling microclusters, are 
actin-dependent processes (Bunnell et al., 2001; Campi et al., 2005).  WASp has been 
shown to localize initially to signaling microclusters, then to actin-rich sites (Barda-Saad 
et al., 2005).  It seems likely that HS1 would follow a similar pattern, being initially 
recruited to signaling microclusters where it would undergo ZAP-70-dependent tyrosine 
phosphorylation.  It would then redistribute to the periphery.  Although we can detect 
some puncta suggestive of signaling microclusters at very early time-points, our data 
suggest that HS1 is primarily situated at the cell periphery in a pattern similar to that of 
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actin (Chapter 2).  It is possible that HS1 is transiently recruited to these clusters before 
rapid redistribution, and that we have not detected these events in our experiments. 
 
How does actin binding of HS1 influence its function? 
Disease-associated variants provide particularly appealing tools to probe protein 
function, in that they are demonstrably physiologically relevant.  A striking example is 
the discovery of mutations in WASp as the cause of Wiskott-Aldrich syndrome (Derry et 
al., 1994).  Mutations in HS1, however, appear instead to contribute to a genetically 
complex disease, SLE.  Although the individual contributions of the disease-associated 
variants, HS1HTH2.5 or HS1EP8, to SLE are likely to be small, and HS1 must interact with 
other risk factors to cause disease, these variants identify physiologically important 
features of these proteins.  In this instance, the loss of an actin-binding repeat has 
provided us with a tool to assess the importance of actin binding in the regulation and 
function of HS1. 
In preliminary studies, we have compared the function of a disease-associated 
actin-binding mutant, HS1HTH2.5, with the more common variant, HS1EP6.  In a B cell 
AICD assay, HS1HTH2.5 signals more efficiently than HS1EP6 (Sawabe et al., 2003).  
Efficient F-actin binding by HS1 is required for efficient activation Arp2/3 complex and 
intact actin responses at the IS (Chapter 2).  It is not clear from these studies whether the 
primary effect is on Arp2/3 complex activation, on the stability of actin branches, or is a 
combination of both.  Moreover, the observed defect may reflect changes in the 
localization of HS1.  We have not examined the effect of the HTH2.5 mutation on HS1 
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localization.  However, cortactin requires the presence of the fourth HTH repeat for both 
actin binding and localization to the cell cortex (Weed et al., 2000), so it is anticipated 
that HS1HTH2.5 will exhibit defects in localization to the IS.  Proper interpretation of these 
data will require analysis of the half-life of branched actin filaments in vitro and kinetic 
analyses of actin polymerization and HS1 recruitment to the IS.  These studies are 
currently underway.  As HS1 deficiency also results in defects in Ca2+ flux and IL2 
production, it will be interesting to examine the role of HS1 actin binding on TCR 
signaling.   
Mutations in the HTH repeat region may not only directly affect actin binding, but 
may also have larger-scale effects on the structure of HS1.  A structure for cortactin has 
been proposed in which the SH3 domain lies close to the HTH repeat region (Cowieson 
et al., 2008).  If this structure also applies to HS1 and represents a closed, inactive form 
of the molecule, loss of one HTH repeat may alter the overall structure to a more open 
structure.  In this model, the C-terminus, including Tyr 378 and 397 as well as the SH3 
domain, is more exposed to potential binding partners.  HS1HTH2.5 was originally 
discovered in a SLE patient (Sawabe et al., 2003).  It has not been determined how this 
mutant influences disease, or even in which cell type it is relevant.  However, if this 
mutation alters the structure of HS1 as proposed, then signaling might occur more 
efficiently.   
An allelic variant of HS1 containing eight glutamic acid-proline repeats, HS1EP8, 
(Figure 1.4) instead of the more common six is more common in SLE patients than in 
healthy controls; this variant has been shown to have functional consequences for BCR 
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signaling that are similar to the HTH2.5 variant (Otsuka et al., 2004).  These repeats lie 
four amino acids N-terminal to Tyr 378, a known phosphorylation site.  Moreover, HS1 
can be serine/threonine phosphorylated (Ruzzene et al., 2000) and contains a consensus 
MAP kinase recognition site at Thr 352 (Takemoto et al., 1995).  MAP kinase-mediated 
phosphorylation of cortactin at Ser 405/418 can potentiate its ability to activate Arp2/3 
complex, implying that this phosphorylation event induces a conformational change 
(Martinez-Quiles et al., 2004).  The EP8 insertion may alter the structure of HS1 towards 
a more open conformation, due to either the negative charge of the insertion, which may 
be phospho-memetic, or to a simple increase in the overall length. 
 
How does HS1 integrate with other components of the T cell actin 
regulatory machinery? 
 HS1 is required for to stabilize F-actin at the immunological synapse (Chapter 2).  
This results in the formation of unstable lamellipodial protrusions, and may explain the 
defects observed in Vav1 (Chapter 2) localization and PLCγ1 microcluster dynamics in 
HS1-deficient cells (Chapter 3).  Although HS1 is capable of stimulating Arp2/3 
complex-mediated actin branching, its activity in this regard is weaker than that of 
cortactin and the WASp VCA fragment (Uruno et al., 2001; Uruno et al., 2003b).  
Instead, HS1 extends the half-life of existing branched actin filaments, in agreement with 
apparent instability of F-actin structures that we have observed in T cells.  
Itk is also required for actin responses in T cells and for Vav1 localization at the 
IS (Dombroski et al., 2005; Grasis et al., 2003; Labno et al., 2003).  We now find that the 
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spreading defects in Itk-deficient cells resemble those of HS1-deficient cells, and that Itk 
is required for recruitment of HS1 to the IS (Chapter 3).  Because Itk lacks a region that 
can directly interact with the actin cytoskeleton, the mechanism by which it regulates 
actin dynamics has been unclear.  These data now establish HS1 as an effector of Itk in 
regulating actin dynamics.  Itk is recruited to the plasma membrane via an interaction 
between its PH domain and PtIns(3,4,5)P3 (August et al., 1997).  In this model (Figure 
5.1), TCR engagement leads to HS1 phosphorylation and binding to the SH2 domain of 
Itk.  Localization at the IS allows HS1 to cross-link existing branched actin filaments, as 
well as to participate in the activation of Arp2/3 complex either through its own activity, 
or through interaction with other NPFs such as WASp.  This also allows for the 
stabilization of Vav1 at the IS, where it can activate Cdc42 and Rac.  This would in turn 
generate localized pools of Cdc42-GTP and Rac-GTP, which can activate WASp (Kim et 
al., 2000) or recruit WAVE2 (Steffen et al., 2004), respectively.  Our laboratory has 
previously shown that Itk and Slp76 are required for the recruitment and localized 
activation of Vav1 (Dombroski et al., 2005; Labno et al., 2003; Zeng et al., 2003).  Our 
data now establish HS1 as an additional player in this complex.  Recruitment of Vav1 to 
the IS depends on the coordinate activity of these molecules.  This is a complex process, 
and each protein to some extent probably plays a unique role.  HS1 mostly likely 
functions to stabilize Vav1 and other signaling molecules such as PLCγ1, discussed 
below, at the IS by linking signaling complexes to the actin cytoskeleton.  In the absence 
of Itk, HS1 is not recruited to the IS and to signaling complexes, and therefore cannot 
carry out this function.  This would result in a loss of localized WASp activity, 
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potentially leading to more severe defects.  Neither HS1 nor WASp is absolutely required 
for actin polymerization at the IS (see Chapter 2 and (Gomez et al., 2006) for HS1, and 
(Cannon and Burkhardt, 2004; Nolz et al., 2006) for WASp).  In this respect, it would be 
interesting to test actin responses in cells lacking HS1 and WASp to probe for a 
compound phenotype.  It is worth noting that WAVE2-deficient cells exhibit actin 
defects much more severe than cells lacking HS1, WASp, or Itk (Nolz et al., 2006).  
Therefore, it is likely that WAVE2 functions either independently of the pathways 
described here, or that other proteins, perhaps other Vav isoforms, can compensate for 
perturbations in this pathway.   
Coronins are a set of poorly-understood F-actin-binding proteins that appear to 
function by inhibiting Arp2/3 complex-dependent nucleation (Humphries et al., 2002).  
Coronin1 deficiency results in increased F-actin content in resting as well as activated T 
cells (Foger et al., 2006; Mueller et al., 2008; Mugnier et al., 2008).  In particular, upon 
APC encounter, the duration as well as the amount of F-actin at the IS in Coronin-
deficient cells is increased.  This is almost the opposite phenotype of HS1-deficient cells.  
It has been proposed that Coronin1 and cortactin antagonize one another in regulating 
lamellipodial actin dynamics  (Cai et al., 2008).  Loss of both proteins results in 
comparatively normal actin dynamics in HEK (human embryonic kidney) 293 cells.  
These two proteins localize at the leading edge, although cortactin lies somewhat farther 
from the periphery than cortactin.  In T cells, HS1 and Coronin1 may exhibit a similar 
relationship.  Although we have not attempted to colocalize these proteins in spreading T 
cells, the same may apply to HS1 and Coronin1.  During the spreading process, HS1 is 
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responsible for stabilizing existing branched actin filaments at the leading edge.  
Coronin1, localized more towards the center, might disassemble branches, recycling actin 
monomers and Arp2/3 complex.  Working together, these two proteins might regulate 
actin dynamics by controlling branch assembly and disassembly at specific locations 
within the cell. 
 
What is the role of actin in Ca2+ signaling? 
In Chapter 2 and Chapter 3, I show that HS1 is an important component of the 
signaling pathway leading to Ca2+ responses downstream of TCR engagement.  As of this 
writing, no studies have been published on the regulation of Ca2+ signaling by cortactin, 
the non-hematopoietic homolog of HS1.  Ca2+ flux responses in T cells consist of two 
phases.  In the initial phase, endoplasmic reticulum stores are depleted, leading to the 
second phase, entry of Ca2+ from the extracellular milieu.  Store depletion is initiated 
through the action of PLCγ isoforms (predominantly PLCγ1 in T cells (Ting et al., 
1992)), which generate Ins(1,4,5)P3 and DAG by hydrolyzing the membrane lipid 
PtIns(4,5)P2 (Majerus et al., 1986; Rhee, 2001; Singer et al., 1997).   
There is a precedent for phosphorylation-independent regulation of PLCγ1 
activity by actin regulatory proteins.  T cells lacking Coronin1 have also been shown to 
exhibit defects in Ca2+ store release as a consequence of reduced Ins(1,4,5)P3 production, 
yet these cells do not have gross defects in PLCγ1 phosphorylation at the activating 
tyrosines (Mueller et al., 2008).  PLCγ1 microcluster dynamics have not been examined 
in Coronin1-deficient cells.
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Figure 5.1:  Itk-mediated recruitment of HS1 to the IS activates actin regulatory 
pathways.   
TCR engagement leads to phosphorylation of HS1 (1).  This allows Itk, which 
interacts with PtIns(3,4,5)P3 (PIP3, in this figure) at the plasma membrane, to 
bind via its SH2 domain, enabling recruitment of HS1 to the IS (2).  Once at 
the IS, HS1 can bind to and activate Arp2/3 complex, and stabilize branched 
actin filaments (3).  HS1 also stabilizes Vav1 at the IS, leading to localized 
activation of Cdc42 and Rac1 and subsequent actin polymerization by WASp 
and WAVE2 (4). 
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It has been shown that Coronin1 and cortactin antagonize one another in 
regulating actin dynamics (Cai et al., 2008).  If the same is true for Coronin1 and HS1, 
then the Ca2+ defects in HS1-deficient cells may be rescued by deletion of Coronin1 in 
those cells.  Several groups have identified links between PLCγ isoforms and the actin 
cytoskeleton (Bar-Sagi et al., 1993; Dearden-Badet and Mouchiroud, 2005; Nojiri and 
Hoek, 2000; Payrastre et al., 1991; Yang et al., 1994).  Together with the work presented 
here, these findings suggest that PLCγ1 function depends on intact actin dynamics.  I 
propose that HS1 functions to stabilize PLCγ1 at the membrane, near its substrate, by 
tethering active PLCγ1 molecules to the actin cytoskeleton (Figure 5.2).  This may be a 
general mechanism by which HS1 facilitates signaling.  However, the mechanisms by 
which the actin cytoskeleton influences Ca2+ responses in T cells are complex, as 
discussed later in this section.   
It is possible that PLCγ1 microclusters in HS1-deficient cells exhibit increased, 
albeit disordered mobility, due to loss of interactions with actin scaffolds.  However, our 
experimental system, confocal microscopy imaging of cells expressing conventional 
YFP-tagged signaling molecules, does not permit single-molecule tracking, precluding 
direct testing of this hypothesis.  Increased, disordered PLCγ1 mobility may prevent 
sufficiently stable interactions with its membrane-bound substrate to promote efficient 
Ins(1,4,5)P3 production.   
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Figure 5.2:  Model for HS1-mediated facilitation of PLCγ1 signaling 
Phosphorylation of HS1 at Tyr 378 and Tyr 397 allows PLCγ1 to bind via its C-
terminal SH2 domain.  This interaction links PLCγ1 to actin scaffolds, restricting it 
near the membrane and facilitating interactions with the substrate, PtIns(4,5)P2 (PIP2 
in this figure). 
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In addition to acting as an adaptor protein linking PLCγ1 to the actin 
cytoskeleton, HS1 is also likely to be a component of larger scale signaling complexes.  
This is highlighted by our finding that phosphorylated HS1 can interact with a host of 
SH2 domain-containing proteins (Chapter 2).  Loss of one component or uncoupling of 
the signalosome from the actin cytoskeleton may destabilize these macromolecular 
complexes (Bunnell et al., 2006), which may in turn impair PLCγ1 signaling.  In support 
of this idea, low-dose Latrunculin B treatment of epithelial cells leads to severely reduced 
Ins(1,4,5)P3 production (Suzuki et al., 2007).  In this study, disruption of the actin 
cytoskeleton led to altered cell-surface receptor dynamics.  This, in turn, reduced the 
specific, localized activation of PLCγ.  There is evidence that the TCR, the relevant cell- 
surface receptor in T cells, interacts with the actin cytoskeleton (Rozdzial et al., 1995).  
We have not studied the effect of HS1 deficiency on TCR microcluster dynamics, but it 
may be that, in addition to regulating PLCγ1 microcluster dynamics, HS1 may affect 
TCR microclusters. 
To more fully understand the roles that HS1 and other actin regulatory proteins 
play in microcluster dynamics would require a different experimental approach.  Our 
current assay system, stimulation of cells on glass coverslips coated with anti-CD3, 
allows the formation of signaling microclusters, but in many instances they remain 
stationary rather than moving to a c-SMAC structure; a notable exception is Slp76 
(Bunnell et al., 2002).  This is probably because the activating ligand is immobilized on a 
glass substrate.  The most physiologically relevant system would be to image 
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microcluster dynamics in T cells responding to APCs presenting peptides, which requires 
imaging over the Z-axis.  However, due to the poor spatial and temporal resolution of 
three-dimensional images reconstructed from multiple sequentially imaged planes, it is 
necessary to employ a system in which the events of interest occur in the X-Y plane 
(Bunnell et al., 2003).  The planar lipid bilayer system, notably employed by Dustin and 
coworkers, in which peptide-MHC complexes are incorporated and are free to diffuse 
laterally, is more amenable to the study of microcluster movement.  In addition, this 
system employs a physiological ligand.  However, it remains highly artificial in that it 
does not account for contributions from the cytoskeleton of the APC.  Cytoskeletal 
rearrangements in dendritic cells are important for T cell activation (Al-Alwan et al., 
2001a, b).  The use of artificial “molecular mazes” in the lipid bilayer system to restrict 
the movement of peptide-MHC complexes (and other embedded molecules) may allow 
this system to more closely resemble a dendritic cell (Mossman et al., 2005).  
Nonetheless, it would be illuminating to examine the effect of HS1 deficiency on Slp76 
microcluster dynamics (movement, lifetime, localization, and size), even with our current 
system.  However, the lipid bilayer system with or without artificial barriers, particularly 
when employed with high-resolution TIRF (total internal reflection microscopy) imaging, 
may enable more elaborate and physiologically relevant analysis of the role of HS1 in 
microcluster assembly. 
Ins(1,4,5)P3 binding to its receptors on ER membranes induces store release.  This 
is a highly cooperative process requiring the binding of three to four Ins(1,4,5)P3 
molecules (Marchant and Taylor, 1997; Meyer et al., 1988).  This cooperativity has been 
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proposed to be a safeguard against spontaneous activation (Marchant and Taylor, 1997), 
but also implies that small, localized changes in PLCγ activity can lead to relatively large 
changes in the magnitude of store release.   
Although it remains possible that HS1 influences store release independently of 
PLCγ1, this seems unlikely.  We have shown that HS1 interacts with PLCγ1 in a 
phosphorylation-dependent manner (Chapter 2), and that HS1 deficiency results in 
abnormal PLCγ1 microcluster dynamics (Chapter 3).  To further support the hypothesis 
that HS1 influences PLCγ1 activity would require direct measurement of PLCγ1-
mediated Ins(1,4,5)P3 production.  This could be accomplished by measuring Ins(1,4,5)P3 
levels in lysates from WT or HS1-/- T cells.  These assays are notoriously difficult, and 
although we could detect significant defects in Ins(1,4,5)P3 production in HS1-/- T cells, 
these findings were not reproducible (not shown).  Alternatively, a FRET (Förster 
resonance energy transfer)-based Ins(1,4,5)P3 biosensor would permit assessment of 
Ins(1,4,5)P3 levels in living cells (Remus et al., 2006).  This system exploits the 
conformational change induced in the Ins(1,4,5)P3 receptor upon ligand binding.  These 
assays are appealing in that they enable analysis at the single-cell level over time, 
allowing one to gather information about variability within a population.  Moreover, 
FRET-based assays can be read with flow cytometer, which would enable bulk 
measurement of Ins(1,4,5)P3  production in complex populations, as has been done for 
protein phosphorylation (Krutzik et al., 2005a; Krutzik et al., 2005b).  More relevant to 
the questions at hand, using a microscope would enable direct correlation of Ins(1,4,5)P3 
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production with other parameters of T cell activation such as microcluster assembly and 
movement.   
Other actin regulatory proteins also regulate Ca2+ flux responses downstream of 
TCR engagement, although they do so through a variety of mechanisms.  The large 
GTPase Dynamin 2 is required for Ca2+ flux responses at the level of PLCγ1 
phosphorylation (Gomez et al., 2005).  Although total PLCγ1 phosphorylation is intact in 
Vav1-deficient Jurkat line J.Vav1 (Cao et al., 2002), Vav1-/- T cells also exhibit defects in 
PLCγ1 Tyr 783 phosphorylation (Reynolds et al., 2002).  In contrast, WAVE2 is not 
required for PLCγ1 phosphorylation or release of Ca2+ from intracellular stores, but 
instead regulates Ca2+ entry from the extracellular environment (Nolz et al., 2006).  
WASp-/- T cells fail to sustain elevated levels of cytoplasmic Ca2+ (Zhang et al., 1999) 
and consequently have defects in NF-AT nuclear translocation (Cannon and Burkhardt, 
2004), although the reason for this is unknown as of this writing.  Interestingly, Jurkat 
cells suppressed for Arp2/3 complex expression, which respond to TCR engagement by 
generating actin-rich filopodia, have normal Ca2+ flux responses (Gomez et al., 2007).  
These varied findings indicate that regulation of Ca2+ by actin regulatory proteins such as 
HS1 is not merely through the organization of actin dynamics at the IS.  Rather, it is 
likely that these proteins function as adaptors, linking signaling molecules, such as 
PLCγ1, to cytoskeletal scaffolds.  Our finding that PLCγ1 localizes poorly to F-actin-rich 
fractions in HS1-/- cells supports this hypothesis (Chapter 3).  Moreover, HS1-deficient 
Jurkat cells exhibit abnormal PLCγ1 microcluster dynamics (Chapter 3).  
Pharmacological disruption of actin dynamics has shown that microcluster assembly at 
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the p-SMAC, where active signaling is thought to occur, requires an intact actin 
cytoskeleton (Campi et al., 2005).   
In some instances, disruption of the actin cytoskeleton can lead to increased Ca2+ 
flux responses or Ins(1,4,5)P3 production (DeBell et al., 1992; Rivas et al., 2004; Valitutti 
et al., 1995).  I have, under certain conditions, noted increased IL2 production from HS1-
/- T cells relative to controls (not shown); even in these conditions, HS1-/- T cells exhibit a 
defect in actin polymerization at the IS.  It is difficult to reconcile these findings with the 
model in which intact cytoskeletal dynamics are important for signaling microcluster 
assembly.  However, this may reflect the fact that the actin cytoskeleton is also important 
for movement of existing microclusters from the p-SMAC to the c-SMAC, where signal 
downregulation occurs (Varma et al., 2006).  
Using our conjugate assay system, we have shown that HS1 is required for the 
stability of F-actin and of two signaling molecules, Vav1 and PLCγ1, at the 
immunological synapse (Chapter 2 and Chapter 3).  However, gross IS localization of 
these molecules is normal at early time points, during which the bulk of TCR-proximal 
signaling occurs.  TCR-proximal signaling must proceed for hours for productive T cell 
activation to occur.  Interruption of TCR engagement, even hours after APC encounter, 
impairs productive T cell activation (Huppa et al., 2003).  Similarly, pharmacological 
inhibition of ZAP-70 kinase activity blocks Ca2+ signaling, even when the inhibitor is 
introduced after signaling has been initiated (Levin et al., 2008).  Based on these findings, 
it is likely that the effects of HS1 on long-term Vav1 and PLCγ1 localization to the IS are 
physiologically important, even though these signaling molecules are associated with 
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very early TCR signaling events.  I have discussed above a model whereby HS1 
functions to facilitate Ca2+ signaling by tethering PLCγ1 molecules to the actin 
cytoskeleton (Figure 5.2).  This is likely to be a general mechanism by which HS1 
interacts with and regulates other components of the T cell signaling machinery. 
  
Is there a role for HS1 in other signaling events? 
PLCγ activity leads to the production of diacylglycerol in addition to Ins(1,4,5)P3.  
DAG activates the Erk signaling cascade, which in turn activates the AP-1 transcription 
factor, a component of the IL2 promoter (Smith-Garvin et al., 2009; Zhang and Dong, 
2005).  Although HS1 appears to be required for PLCγ1 activity, we have thus far found 
no defects in Erk phosphorylation or in AP-1 transcriptional activity in a luciferase 
reporter assay.  The reason for this discrepancy is unknown. 
 HS1, through its proline-rich region, constitutively interacts with the SH3 domain 
of Lck (Takemoto et al., 1995).  In addition, phosphorylation of HS1 creates binding sites 
for the SH2 domain of Lck (Chapter 2 and (Gomez et al., 2006)).  As discussed in 
Chapter 1, this may represent a mechanism that allows Lck to phosphorylate HS1 at other 
sites, such as Tyr 222, a site identified in vitro (Brunati et al., 1999) and in platelets 
(Brunati et al., 2005).  Using mass spectrometry, we did not detect, but cannot rule out, 
phosphorylation at this site.  Another implication for this interaction is that HS1 binding 
may regulate Lck kinase activity.  Proteins that interact in this way with kinases have 
been shown to promote tyrosine kinase activity by stabilizing the open, active 
conformation of the enzyme.  This has been proposed both for the interaction between 
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Lck and Unc119, a poorly understood T cell signaling molecule, (Gorska et al., 2004) and 
for the interaction between Itk and Slp76 (Bogin et al., 2007).  Lck is a crucial signaling 
molecule that is positioned at the earliest stage of the TCR signaling cascade and is 
required for HS1 tyrosine phosphorylation (Chapter 2 and (Gomez et al., 2006)).  HS1-
deficiency results in much milder signaling defects than Lck deficiency (Palacios and 
Weiss, 2004), and many tyrosine phosphorylation events are grossly intact.  Therefore, 
HS1 cannot be absolutely required for Lck function.  Instead, if HS1 binding enhances 
Lck kinase activity, it may serve to promote long-term signaling.  It would be interesting 
to test the ability of HS1 to regulate kinase activity using in vitro kinase assays with 
purified proteins as well as with Lck immunoprecipitated from WT or HS1-deficient T 
cells.  Unc119 has also been shown to be important for Lck trafficking, an actin-
dependent process (Gorska et al., 2009).  Disruption of actin dynamics through loss of 
HS1 may impair Lck trafficking.  However, this would have to be a partial defect, 
because signaling is not completely blocked in HS1-deficient cells. 
 
Concluding Comments 
This work has demonstrated a role for HS1 in T cell function.  We have shown 
that HS1 contains two tyrosines that are phosphorylated upon TCR engagement and 
mediate interactions with several molecules involved in TCR signaling.  We showed that 
the interaction via these tyrosines with Itk is required for HS1 recruitment to the IS, 
where HS1 can stabilize actin filaments.  These sites mediate an interaction with Vav1, 
and stabilize it at the IS, which may represent an additional mechanism by which HS1 
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regulates cytoskeletal dynamics.  We showed that HS1 is required for release of Ca2+ 
from intracellular stores, likely due to a regulation of PLCγ1 dynamics by HS1.  This 
study represents one of the first analyses of the regulation of signaling microclusters by a 
specific actin regulatory protein.  Our studies of the HS1 knockout mouse demonstrated a 
role for HS1 in IFNγ production by CD4+ T cells.  However, it was surprising to find that 
several aspects of T cell function, including CTL-mediated killing and cytokine 
production, TCR endocytosis, and migration, were unaffected by the loss of HS1.  
Several open questions remain, as described in this chapter. 
Studies using actin depolymerizing agents have demonstrated that intact actin 
dynamics are required for T cell function.  In spite of this, this work has shown that HS1 
deficiency does not result in severe signaling or functional defects.  It seems likely that at 
least part of the reason for this is that other actin regulatory proteins, even non-
homologous ones such as WASp, may play compensatory roles.  However, it is also 
likely that each of these proteins plays selective roles within the context of T cell 
signaling.  The challenge now is to probe for functional interactions among these 
molecules. 
In vivo studies may ultimately provide insight into a potential role for HS1 in 
human disease.  Many human diseases are genetically complex, involving contributions 
from multiple genetic polymorphisms that individually may be benign.  A notable 
example of this is systemic lupus erythematosus (Moser et al., 2009).  Already, two 
studies have linked polymorphisms in HS1 with SLE (Otsuka et al., 2004; Sawabe et al., 
2003).  Interestingly, a recent study has linked Coronin1 deficiency to SLE resistance in 
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mice (Haraldsson et al., 2008).  Although the mechanism of action of HS1 in this disease 
is unknown, these studies establish a role for HS1 in disease.  A more comprehensive 
genetic screen of patient samples (SLE and others) is likely to uncover additional 
associations.  Ultimately, detailed study of disease-associated polymorphisms may 
require generation of “knock-in” mouse models expressing the genetic change in 
question. 
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Chapter 6: Materials and Methods 
 
Reagents and Antibodies 
All reagents are from Sigma unless otherwise specified. Antibodies against PLCγ1, Vav1, 
Lck and ZAP-70 have been previously described (Billadeau et al., 2000; Karnitz et al., 
1992; Ting et al., 1992; Williams et al., 1998).  Anti-human HS1, anti-mouse HS1, and 
anti-WIP were obtained by immunization of rabbits with a GST-fusion protein containing 
AA330-407 of human HS1, a GST-fusion protein containing AA226-351 of mouse HS1, 
or a KLH-conjugated synthetic peptide corresponding to AA468-494 of human WIP 
(Cocalico Biologicals).  Rabbit anti-PLCγ1 phosphorylated at Y783 was from Cell 
Signaling Technologies.  Mouse anti-PLCγ1 was from ECM Biosciences.  Rabbit anti-
WASp, mouse anti-Itk (clone 2F12) and anti-phosphotyrosine (4G10) were from 
Millipore.  Anti-GST, anti-actin (C-2) and anti-Lamin B (M-20) were from Santa Cruz.  
Anti-GAPDH was from Calbiochem.  Anti-MBP was from Immunology Consultants 
Laboratory.  The anti-human CD3 (OKT3) was from the Children’s Hospital of 
Philadelphia Pharmacy; anti-TCR (C305) was a gift from Dr. G. Koretzky (University of 
Pennsylvania).  Antibodies against mouse CD3e (2C11) and CD28 (PV-1) were from the 
University of Chicago monoclonal facility.  Anti-mouse CD3ε (500.A2) and mouse anti-
human HS1 were from BD Pharmingen.  Antibodies against Thy 1 (AT83.A) and CD24 
(J11D) were gifts from Dr. A. Sperling (University of Chicago).  Anti-CD3-PE, anti-
CD4-allophycocyanin, anti-CD8-Pe/Cy7 (CD28.2), anti-CD25-PE, anti-CD69-PE, anti-
CD44-FITC, anti-CD62L-PE, and anti-FoxP3-AlexaFluor488 were from Biolegend.    
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Goat anti-mouse IgG-IRDye800 was from Rockland Immunochemicals and goat anti-
rabbit IgG Alexa Fluor 680 was from Molecular Probes.  Goat anti-mouse IgG1 Alexa 
Fluor 555 and goat anti-mouse IgG Alexa Fluor 594 were from Molecular Probes and 
donkey anti-mouse IgG Cy3 was from Jackson Immunoresearch. 
 
Plasmids  
Human HS1 was amplified from a cDNA library and mutated to generate the 
Y397F, Y378/397F, and shRNA-resistant mutants using the Quik Change kit from 
Stratagene (see Table 7.1). The IL2p.luc, NFκB.luc, and NF-AT.luc reporter constructs 
have been described (Cao et al., 2002).  
The shRNA vectors pFRT-H1P and pCMS3.eGFP.H1p have been described 
(Gomez et al., 2005; Trushin et al., 2003). pCMS4.eGFP.H1p, derived from 
pCMS3.eGFP.H1p, contains an additional CMV promoter for driving the expression of 
shRNA-resistant proteins for reconstitution studies. shHS1b and shHS1f targeting 
sequences are in Table 7.1 along with the control shHS1mut sequence. The shRNA 
vector against Vav1 has been described (Zakaria et al., 2004).  cDNA for human HS1 
was tagged with the bright YFP variant Venus (Nagai et al., 2002) and cloned into the 
MSCV2.1 retroviral expression vector.  
The Itk-myc expression constructs were gifts of Dr. L. Berg, University of 
Massachusetts.  The shRNA vectors pFRT.H1p  and pCMS3.eGFP.H1p, and the shHS1f 
targeting sequence have been described (Gomez et al., 2005; Gomez et al., 2006; Trushin 
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et al., 2003).  siRNA duplexes against human Itk (Dombroski et al., 2005) were 
synthesized by Qiagen.  For some studies, Itk suppression sequences were cloned into 
pFRT.H1p and pCMS3.eGFP.H1p as previously described (Gomez et al., 2005; Trushin 
et al., 2003).  The following targeting sequences were used: shItkc: 
GAAGAAACGAGGAATAATA and shItke: GCACTATCCGATCCTCATC.  All results 
were confirmed using both targeting constructs; results with only one construct are shown 
for simplicity.  Electroporation was done using an ECM 830 square wave electroporator 
(BTX) in 500 µl antibiotic-free RPMI using a 310 V, 10ms pulse.  Cells were used 24 
hours after transfection with 40 µg Itk-myc expression constructs or 1.5 µg siRNA 
duplexes, or 72 hours after transfection with 40 µg shRNA vectors.  In each case, 
suppression efficiency in the bulk population of cells was at least 60%. 
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Table 7.1: PCR primers and shRNA targeting sequences 
Name Sequence Used for 
5’ HS1 5’-CTTGCACAGGTGAAGCTTTGGAAGTCTGTAGTGGGC-3’  PCR of HS1 cDNAa 
3’ HS1 5’-TTGCAGTAGACAGCGGCCGCTAGTCACTCCAGGAGCTTGACATAATTTGC-3’ PCR of HS1 cDNAa 
shHS1b 
resistant mt 
5’-GCAGCTCTGGGATATGAtTAtAAaGGAGAGACGGAGAAA-3’  Mutagenesis of HS1 
cDNA making it resistant 
to shHS1b targetingb 
shHS1b 5’-GACTACAAGGGAGAGACGGAG-3’ shHS1b targeting 
sequence 
shHS1f 5'-GAACCAGAGGGGGACTATG-3' shHS1f targeting 
sequence 
shHS1bmut 5’-GACTAgAAGGcAcAGAgGGAG-3’ shHS1bmut non-targeting 
mutant sequenceb 
shItkc GAAGAAACGAGGAATAATA shItkc targeting sequence 
shItke GCACTATCCGATCCTCATC shItke targeting sequence 
a Underlining in these oligos indicates unique restriction sites used for subcloning the amplified HS1 cDNA. 
b  Lower case nucleotides indicate point mutations introduced into the primary sequence of HS1 cDNA or shHS1b.
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Cell culture 
All tissue culture reagents were from Invitrogen.  Jurkat-E6, JCaM-1, P116, and primary 
human peripheral blood CD4+ T cells, NALM6 B cells, Raji B cells, and EBV B cells 
were grown in RPMI-1640 supplemented with 5% FBS, 5% newborn calf serum, 25 mM 
HEPES, and 4mM glutamine.  A Jurkat-E6 T cell line stably expressing GFP-actin was 
generated using the pEGFP-actin vector (Clontech).  These cells express GFP-actin at 
~37% of endogenous levels.  Jurkat T cells stably expressing PLCγ1-eYFP ((Braiman et 
al., 2006), gift of Dr. L. Samelson, NIH) were maintained in RPMI containing 10% FBS, 
penicillin/streptomycin, glutamine, and 1 mg/ml G418.  P815 mouse mastocytoma cells 
and the mouse B cell line CH27 were cultured in Glutamax DMEM (Gibco), with 5% 
FBS, non-essential amino acids, β-mercaptoethanol, penicillin and streptomycin, and 25 
mM HEPES.  DO11.10 T cell blasts were cultured as described (McKean et al., 2001).  
Murine CD4+ T cells were isolated from lymph nodes and spleens by negative selection 
using a mixture of anti-MHC class II (M5/114.15.2) and anti-CD8 (2.43) followed by 
magnetic bead-conjugated goat anti-rat Ig (Qiagen).  Where specified, total T cells were 
isolated using anti-MHC II alone.  T cell blasts from WT or HS1-/- C57Bl/6 mice were 
prepared from CD4+ T cells by stimulation on plates coated with anti-CD3 (2c11) and 
anti-CD28 (PV1) for 3 days, followed by 3-8 days of resting culture.  Cells were 
maintained using DMEM supplemented with 10% FBS, non-essential amino acids, 
penicillin, streptomycin, HEPES and β-Mercaptoethanol (Sigma), supplemented with 50 
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U/ml rhIL2 (obtained through the AIDS Research and Reference Reagent Program, 
Division of AIDS, National Institute of Allergy and Infectious Diseases, National 
Institutes of Health; human rIL2 from M. Gately, Hoffmann-LaRoche, Nutley, NJ). 
 
Mice 
HS1-/- mice on the C57Bl/6J background have been previously described (Taniuchi et al., 
1995) and were a gift of Dr. D. Rawlings (University of Washington).  WT C57Bl/6 mice 
were from Jackson Laboratories.  To generate T cells specific for moth cytochrome C 88-
103 (MCC88-103) presented on I-Ek, HS1-/- mice were crossed to AND TCR transgenic 
mice (Jackson Labs) (Kaye et al., 1989; Kaye et al., 1992; Vasquez et al., 1992), and 
maintained as heterozygotes for the AND transgene.  C57Bl/6J mice were obtained from 
Jackson Laboratories.  All mice were housed under pathogen-free conditions in the 
Children’s Hospital of Philadelphia animal facility.  All studies involving animals were 
reviewed and approved by the Children’s Hospital of Philadelphia Institutional Animal 
Care and Use Committee.  
 
Isolation of primary T cells and primary APCs 
T cells were prepared from spleens and lymph nodes by negative selection using either 
complement lysis (Chapter 2) or magnetic beads (Qiagen Biomag Goat anti-Rat) 
(Chapter 3 and Chapter 4.  Primary APCs were prepared from wild type splenocytes by 
complement enrichment using anti-Thy1 (AT83.A), yielding less than 1% CD3+ cells.  
Single cell suspensions were depleted of erythrocytes using Ack lysis buffer (150 mM 
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NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) and incubated with hybridoma supernatants for 
30-60 minutes.  Anti-CD24 (clone J11d), a kind gift of Dr. Anne Sperling, was used for 
complement lysis, and anti-MHCII (clone M5/114), anti-CD8.2 (2.43), and anti-CD4 
(GK1.5) were used for magnetic bead isolation.  For complement lysis, cells were 
incubated with rabbit complement H2 (Pel-Freez) for 30 minutes at room temperature 
with shaking then washed in DMEM.  Dead cells were removed by centrifugation at 2000 
RPM for 20 minutes over a Histopaque (Sigma) gradient.  For magnetic bead isolation, 
cells were collected by centrifugation and incubated with Biomag Goat anti-rat IgG beads 
for 15 minutes at 4ºC.  Bead-bound cells were removed with a Dynal magnet.  Typical 
purity as assessed by flow cytometry staining was > 85%. 
 
Preparation of T cell blasts   
CD4+ T cells from spleens and lymph nodes of WT or HS1-/- mice were activated on 6-
well plates coated with (clone 145-2c11) and anti-CD28 (clone PV-1) for three days in 
the presence of 50 U/ml exogenous rhIL2 (recombinant human IL2).  Blasting cells were 
transferred to fresh, uncoated 6-well plates and cultured in the presence of exogenous 
rhIL2 (100 U/ml) for three to eight additional days.   
 
Transfection of Jurkat cells by electroporation 
Jurkat cells growing in log phase were collected by centrifugation and resuspended at 
2x107 cells/ml in RPMI-1640 supplemented with 5% FBS, 5% newborn calf serum, 25 
mM HEPES, and 4mM glutamine.  500 µl of cells were transferred to a 4 mm gap 
 173 
cuvette, mixed with DNA, and electroporated at 310 V, 1 ms pulse using a BTX ECM 
830 electroporator (Harvard Apparatus).  For shRNA experiments, cells were allowed to 
recover for 48-96 hours prior to use.  For overexpression experiments, cells were used 
16-24 hours after transfection. 
 
Luciferase reporter assays 
Transient expression and/or suppression and luciferase reporter assays in Jurkat were 
done as previously described (Cao et al., 2002; Nolz et al., 2006). For cell-cell 
stimulation in reporter assays, live NALM6 B cells (1x106) and 0.5µg/ml Staphylococcal 
Enterotoxin E (SEE, Toxin Technologies) were added to each well. For cell-cell 
stimulation time courses, Jurkat cells were activated with fixed, SEE-pulsed NALM6 or 
RAJI B cells as described (Gomez et al., 2005).  
 
Retroviral transduction of primary mouse T cells   
CD4+ T cells were stimulated for three days as described under “Preparation of T cell 
blasts.”  Cells were then transduced by resuspending in 1 ml retroviral supernatant 
containing 8 mg/ml polybrene and 50 U/ml rhIL2 and centrifugation at 823 x g in a 24 
well plate for 2 hours at room temperature.  Transduced cells were cultured in 24 well 
plates in media containing 50 U/ml rhIL2 for four to five days.  Transduction efficiency 
was assessed by flow cytometry at 48 hours after transduction by staining with mouse 
anti-NGFR hybridoma supernatant (ME20.4) and PE-anti-mouse IgG (Biolegend) as 
described above. 
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Magnetic sorting of retrovirally transduced cells   
T cells were resuspended in MACS buffer (PBS containing 0.5% BSA, 2mM EDTA) 
supplemented with 25% anti-NGFR hybridoma supernatant and incubated at 4ºC for 15 
minutes.  Cells were then collected, washed twice in MACS buffer, and incubated with 
anti mouse IgG MACS beads (Miltenyi Biotec) at 4ºC for 15 minutes.  Bead-bound cells 
were positively selected using MACS LS columns, and cultured for overnight prior to 
use. 
 
Flow cytometry 
For cell-surface staining, samples were washed in FACS buffer (5% FBS, 2 mM EDTA, 
and 0.02% NaN3 in PBS), resuspended in 100 µl of FACS buffer, and incubated at 4ºC 
with appropriate antibodies for 20 minutes.  Samples were washed in FACS buffer, 
incubated with secondary antibodies as necessary for 15-20 minutes, and washed twice.  
Samples were analyzed immediately or fixed in 0.5% paraformaldehyde.  For 
intracellular cytokine staining, cells were fixed at room temperature for 10 minutes with 
3% paraformaldehyde, then washed once in FACS buffer and once in permeabilization 
buffer (1% FBS, 0.1% saponin in PBS).  Samples were incubated in 100 µl 
permeabilization buffer containing anti-IFNγ and anti-IL4 for 30 minutes, followed by 
two washes in FACS buffer and immediate analysis.  All flow cytometry data acquisition 
was conducted on a FACSCalibur (BD Biocsciences) and analyzed using FlowJo 6.0 
(TreeStar). 
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Helper T cell differentiation   
CD4+ T cells (2.5x105/well) from WT or HS1-/- mice were stimulated on 24-well plates 
coated with 1 or 0.1 µg/ml anti-CD3 (145-2c11) and 1 µg/ml anti-CD28 (PV-1) for three 
days.  Cells were then transferred to fresh plates and cultured in the presence of 50 U/ml 
rhIL2 for four days.  Cells were assayed for cytokine production by stimulating with 
PMA (32 nM) and Ionomycin (500 nM) for two to three hours, then exposed to Brefeldin 
A (1 µg/ml) for two hours.  Cells were washed in FACS buffer, and then stained as 
described above.  
 
Generation of Jurkat cells stably expressing VenusHS1 
Jurkat cells were transfected with MSCV-Venus-HS1 expression vector and allowed to 
recover for two days prior to selection in 1 mg/ml G418.  After two weeks, a population 
of G418-resistant cells emerged.  This culture was expanded and sorted on cells 
expressing low, medium, and high levels of Venus using a FACSVantage cell sorter (BD 
Biosciences).  Sorted cells were then plated at one cell per well of a flat-bottom 96 well 
plate by limiting dilution.  Two clones, 6c7 and 8g5, expressing approximately a 1:1 ratio 
of Venus-HS1:endogenous HS1 were selected for future use. 
 
Cytotoxicity assays 
CTL were generated in vitro by stimulating CD8+ T cells from lymph nodes and spleens 
of WT or HS1-/- mice on the C57Bl/6 background (H-2b) on plates coated with anti-CD3 
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and anti-CD28 for three days in the presence of 50 U/ml exogenous rhIL2.  Cells were 
then transferred to fresh plates and cultured for two additional days prior to use.  For 
cytotoxicity assays, effector CTL were plated in plated in 96-well round bottom plates at 
3-fold serial dilutions, starting with 5x105 cells per well.  Allogeneic target cells (P815 
mouse mastocytoma cells, H-2d) were loaded with 51Cr, washed, and plated (1x104 
cells/well).  Cells were incubated at 37ºC for four to five hours. To control for 
spontaneous 51Cr release, some wells received only target cells.  To determine maximal 
release, some wells received only target cells, which were lysed with 1% NP40 (Sigma).  
Supernatants (100 µl) were harvested to 96-well Luma plates (PerkinElmer) and allowed 
to evaporate overnight.  Plates were read on TopCount scintillation counter 
(PerkinElmer). 
 
TCR internalization 
TCR internalization studies were conducted according to (Cemerski et al., 2007).  All 
manipulations were conducted in DMEM containing 1% FBS.  CD4+ T cells prepared by 
negative selection from WT or HS1-/- AND TCR transgenic mice.  For peptide loading, 
CH27 B cells were incubated at 37ºC with 0.1-10 µM MCC88-103 peptide for four hours.  
CH27 cells without preloaded peptide served as controls.  T cells and B cells were each 
washed and resuspended at 1x106/ml.  T cells and B cells were then mixed at a 1:1 ratio 
in V-bottom plates, 1x105 of each cell type, and incubated for the indicated length of 
time.  Conjugates were then harvested, washed in FACS buffer, and stained with anti-
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CD4, anti-Vα11, and anti-Vβ3 for analysis by flow cytometry.  Only CD4+ events were 
analyzed to exclude CH27 cells not in conjugates. 
 
Activation-induced cell death   
AICD studies were conducted according to a protocol from Dr. Richard Siegel (NIH).   
CD4+ T cell blasts (above) were used three days after removal from stimulatory plates.  
To induce AICD, cells were resuspended at 2x106/ml in DMEM containing 50 U/ml 
rhIL2 and stimulated on flat-bottom 96-well plates coated with the indicated 
concentrations of anti-CD3 for eight hours.  Cells were harvested and stained for 20 
minutes with Annexin-V-AlexaFluor 647 (Molecular Probes) and 7-AAD (Molecular 
Probes) in Annexin binding buffer (10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM 
CaCl2).  Data were acquired on a FACSCalibur (BD Biosciences) and analyzed using 
FlowJo (TreeStar, Inc.).  Percent specific cell death was calculated according to the 
following equation: . 
 
ELISA   
For IL2 ELISA, total T cells (2x105 cells per well) were plated in a 96-well round-bottom 
TC plate (Costar) with 50,000 T-depleted splenocytes and SEB (Toxin Technologies). 
After incubation at 37ºC for 24h, plates were frozen at -80ºC.  IL2 ELISAs were 
performed using the mouse IL2 Ready-SET-Go! ELISA kit (eBiosciences).  For IFNγ 
ELISA, CD4+ or CD8+ T cells isolated from spleens and lymph nodes of WT or HS1-/- 
mice were stimulated at 1x106 cells/ml on 96-well flat-bottom plates (2x105 cells per 
! 
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well) coated with anti-CD3 (clone 145-2c11, 1.0 or 0.1 µg/ml) and anti-CD28 (clone PV-
1, 1 µg/ml) for three days, after which plates were frozen at -80ºC.  Supernatants were 
assayed for IFNγ content using the mouse IFNγ Ready-SET-Go! kit (eBioscience) 
according to the manufacturer’s instructions. 
 
Analysis of surface marker upregulation 
Total T cells were stimulated as described for IL2 ELISA except that 1 µg/ml anti-CD3 
(145-2c11) was used instead of SEB.  After 24 hours, samples were stained and analyzed 
by flow cytometry as described above. 
 
F-actin binding assay 
Recombinant GST-tagged HS1EP6 or HS1HTH2.5 was produced in Escherichia coli and 
affinity purified on a glutathione resin (Amersham) and used in an Actin Binding Protein 
Spindown Assay Kit for non-muscle actin (Cytoskeleton, Inc.) according to the 
manufacturer’s instructions.  Briefly, 1 µM GST-HS1 was incubated with the indicated 
concentrations of F-actin for 30 minutes at room temperature in .  Samples were then 
centrifuged at 150,000 x g for 90 minutes at room temperature.  Supernatants were 
transferred to fresh tubes, and both supernatants and pellets were analyzed by coomassie 
staining or by western blotting for GST.  BSA was used as a negative control, and α-
actinin was used as a positive control. 
 
Actin polymerization assay 
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In vitro actin polymerization was assessed using an actin polymerization kit 
(Cytoskeleton, Inc.), according to the manufacturer’s instructions.  Briefly, recombinant 
GST-tagged WASp VCA fragment (80 nM) or GST-tagged HS1EP6 or HS1HTH2.5 (100 
mM) were incubated with 70 nM Arp2/3 complex in actin polymerization buffer (50 mM 
KCl, 2 mM MgCl2, 1 mM ATP) in a 96-well plate.  Reactions were initiated by the 
addition of actin containing 20% pyrene labeled actin and monitored every 30 seconds 
using a fluorescence plate reader. 
 
Immunofluorescence microscopy 
Jurkat T cells were conjugated to Raji B cells at 37ºC as described previously (Cannon et 
al., 2001) and stained for F-actin using Alexa Fluor 647-phalloidin (Molecular Probes) 
and for HS1 followed by anti-mouse IgG Alexa Fluor 594 or anti-mouse IgG Cy3.  For 
experiments involving CD4+ T cells from AND transgenic mice, CH27 B cells were 
labeled with CMAC (Cell tracker blue, Molecular Probes) and incubated with 5 µM moth 
cytochrome C peptide (MCC88-103).  Equal numbers of T cells and B cells were 
centrifuged together, incubated at 37ºC for various times, and plated on poly-L-lysine-
coated coverslips followed by fixation in 3% paraformaldehyde.  Excess aldehyde groups 
were quenched by incubation in 0.5 mg/ml NaBH4.  Samples were blocked in TSGxx.  
Conjugates were stained for PLCγ1, Itk, or F-actin using Alexa Fluor 647-phalloidin 
followed by anti-mouse IgG1 Alexa Fluor 555.  Conjugates were analyzed on a Zeiss 
Axiovert 200M microscope equipped with a 63x planapo 1.4 NA objective.  Images were 
collected using a Photometrics Coolsnap FX-HQ (Roper Scientific) camera and 
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deconvolution was performed using a constrained iterative algorithm (Slidebook v. 4.2, 
Intelligent Imaging Innovations).  Alternatively, conjugates were imaged on a Zeiss 
Axiovert 200 equipped with a Perkin Elmer Ultraview ERS6 spinning disk confocal 
system and a 63x planapo 1.4 NA objective.  Images were collected using an Orca ER 
camera (Hamamatsu) and analyzed using Volocity v. 5 (Improvision).  For analysis, 
conjugates were identified at random as a blue B cell in contact with a T cell, and scored 
for the presence of a bright band of protein at the cell-cell contact site.  All experiments 
were analyzed by an individual blinded to the experimental conditions.  At least 50 
conjugates were scored per condition in each experiment. 
 
Live cell imaging 
Eight well Lab-Tek II chambered coverglasses (Nalge Nunc) were cleaned with 70% 
ethanol containing 1 M HCl prior to incubation for 15 minutes with 0.1 mg/ml poly-L-
lysine.  Prior to use, coverglasses were coated with 10 µg/ml OKT-3 for 2 hours at 37ºC 
or overnight at 4ºC.  Coverglasses were rinsed in PBS and covered with 400 µl RPMI 
without phenol red immediately prior to imaging and equilibrated to 37°C on the 
microscope stage within a Solent environmental chamber.  Cultured cells were 
resuspended in phenol red-free RPMI at 2x106/ml, and spreading was initiated by adding 
5-10 µl of cell suspension to the coverglass chamber.  Time-lapse images were collected 
at 63X using a Perkin-Elmer ERS6 Ultraview spinning disk confocal system.  Stacks of 
3-7 images were collected at 0.5 µm spacing every 3-5 seconds for approximately 6 
minutes.  GFP-actin dynamics were analyzed using Volocity Quantitation for area 
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measurements and Slidebook for radial variance as follows:  Projections were created 
from the 4D datasets, masks created for each cell at each time point and the areas 
determined in pixels.  For radial variance calculations, 64 radii were struck from the 
centroid of each mask, and the standard deviation of the radii was calculated for each cell 
at each time point.  Video sequences from several cells were aligned based on initial 
contact with the coverslip and the average of the cell area and of the radial variance were 
calculated for the population of cells, at each time point.  At least 40 cells were analyzed 
per condition.  To assess PLCγ1 microcluster dynamics, maximum intensity projections 
were generated, and individual objects were identified based on pixel intensity and 
tracked using Volocity.  Microcluster area at 90 seconds after contact with the coverslip 
for each individual size.  At least 20 cells were analyzed per condition.  Objects were 
pseudocolored based on time of appearance, relative to the total duration of each time-
lapse sequence.  
 
Ca2+ assays 
For single cell Ca2+ measurements, freshly isolated CD4+ T cells were loaded with the 
cell-permeant Ca2+ indicator Fura-2 AM (3.0 µM, Molecular Probes) for 15 min in 
normal bath solution (155 mM NaCl, 4.5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM 
glucose, and 10 mM Hepes (pH 7.4)). Cell suspensions were placed into the recording 
chamber on an inverted fluorescence microscope (Nikon) and allowed to adhere to Poly-
L-lysine-treated (100 µg/ml, Sigma) coverslips for 5 minutes.  Extracellular Fura-2 AM 
was removed by perfusion with additional normal bath solution.  Before stimulation, the 
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chamber was perfused with Ca2+ free bath solution containing 155 mM NaCl, 4.5 mM 
KCl, 1 mM MgCl2 and 0.5 mM EGTA, 10 mM glucose and 10 mM Hepes (pH = 7.4).  
Intracellular Ca2+ mobilization was initiated by addition of anti-CD3 (500.A2) in Ca2+-
free bath solution; consequently, the initial Ca2+ transient observed in Ca2+-free solution 
is due to Ca2+ release from stores.  The activation state of calcium entry channels was 
then examined by replacing the Ca2+-free solution with normal (Ca2+-containing) bath 
solution.  Where indicated, 1 µM thapsigargin was added to block SERCA pump activity, 
thereby depleting intracellular Ca2+ stores.  Fura-2 was alternately excited at 340 nm and 
380 nm and fluorescence emission (plotted as the 340 nm/380 nm ratio) of individual 
cells was measured by digital imaging microscopy using Metafluor software (Molecular 
Devices).  
 
Western blotting 
Lysates were separated on Tris-Glycine SDS-PAGE gels, transferred to immobilon-FL 
(Millipore) or nitrocellulose (Bio-Rad) membranes, blocked in 3% non-fat dry milk in 
TBS and probed with primary antibodies in 3% milk in TBST or 3% BSA in TBST for 
phospho-specific antibodies.  Blots were probed with goat anti-mouse IgG-IRDye800 or 
goat anti-rabbit IgG-Alexa Fluor 680 and imaged on a Licor Odyssey infrared 
fluorescence scanner.  
 
GST Pulldowns 
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Fragments comprised of the SH3-SH2 domains (AA154-352) or the SH2 domain alone 
(aa 237-352) of human Itk were cloned into pGEX-KG and mutations to inactivate the 
SH3 (W208/209Y) and/or SH2 (R265A) domains were incorporated using standard 
molecular biology techniques.  The SH3 domain of HS1 (AA415-486) was cloned into 
pGEX-KG and inactivating mutations (W455Y, W456Y) were incorporated.  
Recombinant GST fusion proteins were generated in bacteria and bound to glutathione 
resin (Amersham).  Jurkat cells were harvested, resuspended in PBS with Ca2+ and Mg2+, 
allowed to rest at 37ºC for 20 minutes, and treated with pervanadate (1:33 dilution) for 3-
5 minutes or left untreated.  Pervanadate was prepared by mixing equal parts Na3VO4 and 
3% H2O2 and allowed to react at room temperature for 10 minutes.  Cells were collected 
by centrifugation and lysed in NP40 lysis buffer (50 mM Tris-HCl pH 8, 1% NP40, 100 
mM NaCl, 5 mM EDTA, 0.5mM CaCl2, protease inhibitors, 1 mM Na3VO4, and 5 mM 
NaF).  Lysates were clarified by centrifugation and exposed to glutathione resin-bound 
GST fusion proteins for 1-2 hours.  Beads were washed three times in NP40 lysis buffer 
and analyzed by western blotting and Coomassie staining.  Phosphorylated GST-HS1 
fusion peptides (AA361-436) were made in the TKB1 E. coli (Stratagene). For in vitro 
binding assays, 30µg of p-GST fusion protein was bound to glutathione-agarose, washed, 
incubated with 2 µg of maltose binding protein (MBP)-fused Vav1-SH2 proteins, rotated 
at 4°C for 20 minutes, and then washed four times with lysis buffer.  
 
Coimmunoprecipitations 
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Cultured CD4+ T cell blasts were harvested and resuspended at 1x108/ml in serum-free 
DMEM for antibody stimulation or in PBS with Ca2+ and Mg2+ for pervanadate 
treatment.  Cells were allowed to rest for 30 minutes at 37ºC, then labeled on ice with 10 
µg/ml biotinylated anti-CD3 (2c11) for 20 minutes.  Signaling was initiated by the 
addition of 2.5 µg/ml streptavidin at 37ºC.  At the indicated time points, cells were 
collected by centrifugation and lysed in NP40 lysis buffer.  Postnuclear lysates from 
4x107 cells were incubated with anti-mouse HS1 bound to protein A-sepharose for two 
hours at 4ºC, washed in lysis buffer, eluted in 2x SDS-PAGE sample buffer, and analyzed 
by western blotting for HS1, Itk, and phosphotyrosine.  
 
Preparation and phosphorylation of recombinant HS1 
His-Tagged HS1 was expressed in E. coli. Following IPTG induction, bacteria were lysed 
with phosphate buffer (20mM NaPO4, 1% NP40, 500mM NaCl, 20mM Imidazole, pH 
7.2) with EDTA-free protease inhibitors (Roche). Lysates were clarified by centrifugation 
and loaded onto a HiTrap column (Amersham), pre-charged with 100mM NiSO4 on an 
AKTA FPLC. The column was washed with phosphate buffer and eluted with a gradient 
to 500mM Imidazole. The appropriate fraction was polished over a HiTrap Q HP column 
and eluted with a gradient to 1M KCl. 20µg of recombinant HS1 was incubated with or 
without 0.5µg recombinant Syk (Upstate) in 50mM Tris pH7.5, 100µM NaVO4, 0.1% β-
mercaptoethanol, 5mM MgCl2,100µM ATP for 10 min. at 30°C. 
 
Mass Spectrometry 
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Recombinant HS1 or HS1 immunoprecipitated from Jurkat cells was resolved by SDS-
PAGE, stained with Coomassie R-250 (Pierce), excised, and washed extensively with 
50:50 (acetonitrile/25 mM ammonium bicarbonate, pH 8.0). Rehydrated gel pieces were 
infused with trypsin (Promega; 12.5ng/µl) or Glu-C (Roche; 20 ng/µl), at pH 8.0, and 
digested at 37°C for 18-24h. Reactions were stopped by addition of 5% TFA. Non-
peptide impurities were removed using C18 or SCX ziptips (Millipore) and analysis was 
carried out in 0.1% phosphoric acid. MALDI-TOF spectra were acquired on a Ciphergen 
SELDI mass spectrometer in the linear mode. vMALDI Ion-Trap spectra were acquired 
on a Finnegan LTQ mass spectrometer. Following the MS scan, a data-dependent “Top 
9” experiment was acquired such that 1 full MS spectrum was first acquired followed by 
9 MS2 spectra. For database searching we used Bioworks 3.2 employing the SEQUEST 
algorithm, against the SWISSPROT database. To confirm that phosphopeptides were 
present, a neutral loss-dependent MS3 experiment was performed, and peaks that showed 
loss of 98 Daltons were subjected to further MS/MS.  
 
Analysis of PLCγ1 phosphorylation and cytoskeletal association 
Total T cells isolated from the spleen and lymph nodes of wild-type or HS1-/- C57Bl/6 
mice were resuspended at 1x108/ml in DMEM and rested at 37ºC for 30 minutes.  Cells 
were stimulated by the addition of 5 µg/ml anti-CD3 (500.A2).  Stimulation was stopped 
by transferring an aliquot of cells to a tube containing ice-cold PBS.  Cells were collected 
by centrifugation, lysed in RIPA buffer (50 mM Tris pH 8, 1% NP40, 0.5% sodium 
deoxycholate, 0.1% SDS, 150 mM NaCl, protease inhibitors, 5 mM NaF, 1 mM Na3VO4, 
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5 mM EDTA).  Lysates were incubated on ice for 20 minutes, then clarified by 
centrifugation at 16,000 x g.  Samples were analyzed by western blotting.  For isolation 
of insoluble F-actin-rich fractions, cells were lysed in cytoskeletal stabilizing lysis buffer 
(80 mM PIPES pH6.9, 1% Triton X-100, 1 mM EGTA, 1 mM MgCl2, protease 
inhibitors, 5 mM NaF, 1 mM Na3VO4), and centrifuged immediately at 5,000 x g for 5 
minutes (Gatfield et al., 2005).  The F-actin rich pellet was resuspended in high salt 
buffer (20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, protease inhibitors, 5 mM 
NaF, 1mM Na3VO4) and vortexed for 1 hour at 4ºC to extract proteins.  Samples were 
centrifuged at 16,000 x g for 10 minutes, and supernatants were used as the insoluble 
fraction for western blot analysis.  The amount of PLCγ1 or phospho-PLCγ1 in the pellets 
was quantified by normalizing to Lamin B intensity within each lane, then to the 
normalized value for unstimulated cells.  Lamin B was used as a loading control because 
the insoluble fractions contain nuclei. 
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